Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download JUNE 13, 2006 - AIM Group International
Document related concepts
no text concepts found
Transcript
08:00 - 09:00 Room 107 Smoking and hypertension Breakfast Workshop 1 Chairmen P. SLEIGHT (Oxford, UNITED KINGDOM) T. HEDNER (Goteborg, SWEDEN) Cardiovascular effects of smoking K. Narkiewicz Gdansk, POLAND Is smoking cessation the most effective measure to reduce cardiovascular risk in a hypertensive patient ? P. Sleight Oxford, U.K. Conclusions T. Hedner Goteborg, SWEDEN 1 08:00 - 09:00 When to use an ARB in a hypertensive patient with heart failure Room 108 Breakfast Workshop 2 Use of ARBs in the hypertensive patient with heart failure: facts and hopes F. Martinez Cordoba, ARGENTINA Conclusions & Discussion F. Martinez, J.L. Zamorano Cordoba, ARGENTINA, Madrid, SPAIN 2 08:00 - 09:00 The value of creatinine clearance in the aged: does it the mean the same in the young ? Room 118 Breakfast Workshop 3 J.F. Macias Nunez Salamanca, SPAIN 3 08:30 - 10:30 Auditorium Joint Session ESH-ASH Topical Workshop 2 Chairmen S. KJELDSEN (OSLO, NORWAY) CT. GILES (NEW ORLEANS, USA) What is new in ESH guidelines G. Mancia Monza, Milan, ITALY New definition of arterial hypertension T. Giles New Orleans, U.S.A. The role of vascular compliance in arterial hypertension J. Izzo Buffalo, U.S.A. Should we put more emphasis on recent high precision outcome trials ? S. Kjeldsen Oslo, NORWAY 4 08:30 - 10:30 Room 101/102 1B Heart Paraller Oral Session Chairmen: R. SEABRA GOMES (CARNAXIDE, PORTUGAL) M. VINTILA (BUCHAREST, ROMANIA) ONTOGENY OF CARDIAC VASOPRESSIN: POTENTIAL ROLE IN CARDIOMYOCYTE DIFFERENTIATION *JOLANTA. Gutkowska, MALGORZA. Miszkurka, BOGDAN. Danalache, SAMUEL M. McCaan, MAREK. Jankowski Montreal, CANADA ,Montreal, CANADA ,Montreal, CANADA ,Montreal, CANADA ,Montreal, CANADA IMPACT OF LEFT VENTRICULAR MASS INDEX (LVMI) AND LEFT VENTRICULAR HYPERTROPHY (LVH) ON MORTALITY IN GENERAL POPULATION. ADJUSTMENTS FOR CLINIC, HOME AND AMBULATORY BLOOD PRESSURE. *M. BOMBELLI, R. SANVITO, H. POLO FRIZ, M. RONDINELLI, R. FACCHETTI, A. CORTICELLI, I. RONCHI, A. CASATI, L. PRIMITZ, C. GIANNATTASIO, R. SEGA, G. MANCIA MILANO, ITALY ,MILANO, ITALY ,MONZA (MI), ITALY ,VIMERCATE (MI), ITALY ,MILANO, ITALY LECTURE: TREATMENT OF HEART FAILURE IN THE ELDERLY A.M.M. Vintila Bucharest, ROMANIA SPONTANEOUS BAROREFLEX SENSITIVITY AS A PREDICTOR OF ATRIAL FIBRILLATION RECURRENCES *K. Styczkiewicz, M. Facchini, G.B. Perego, G. Bilo, G. Malfatto, G. Branzi, M. di Rienzo, D. Czarnecka, G. Mancia, K. Kawecka-Jaszcz, G. Parati Milan, ITALY ,Cracow, POLAND ,Monza, ITALY ,Milan, ITALY VALSARTAN AMLODIPINE COMBINATION AND PREVENTION OF ATRIAL FIBRILLATION RECURRENCE IN HYPERTENSIVE DIABETIC PATIENTS *A. Mugellini, P. Preti, M. Destro, P. Lazzari, A. Rinaldi, T. Perrone, F. Musca, R. Fogari Pavia, ITALY CARDIAC OVEREXPRESSION OF ACE2 PROTECTS THE HEART FROM ISCHEMIC INJURY *S. Der Sarkissian, J.L. Grobe, G.A. Walter, M.J. Katovich, M.K. Raizada Gainesville, FL,, USA ,Gainesville, FL,, USA METABOLIC SYNDROME POTENTIATES THE SYMPATHETIC AND BAROREFLEX DYSFUNCTION OF HEART FAILURE STATE F. ARENARE, *F. QUARTI TREVANO, R. DELL'ORO, G. SERAVALLE, V. ILARDO, A. ROZZONI, G. GRASSI, G. MANCIA Monza, Milan, ITALY ,Milan, ITALY 5 13\06\2006 - 08:30 - 10:30 1C Experimental Hypertension and Pharmacology Room 103 Parallel Oral Session 1C OS Chairman: V. CACHOFEIRO RAMOS (MADRID, SPAIN) Chairman: M. PAUL (BERLIN, GERMANY) PROTEIN KINASE C ALPHA DEFICIENCY PROTECTS AGAINST ANGIOTENSIN II INDUCED MYOCARDIAL HYPERTROPHY AND HEART FAILURE *A. Kranzhöfer, P.C. Shukla, J. Menne, M. Leitges, D. Hilfiker-Kleiner, H. Drexler, H. Haller Hannover, GERMANY DECREASED APOPTOSIS RATE OF ARTERIAL SMC IN SHR CAUSES ACCUMULATION OF ELASTIN-PRODUCING CELLS AND INSUFFICIENT ELASTIN REMODELLING *SM. Arribas, C. Hermida, MC. Gonzalez, A. Hinek Madrid, SPAIN ,Toronto, ON, CANADA URIDINE-ADENOSINE-POLYPHOSPHATES: A NEW GROUP OF STRONG VASOCONSTRICTIVE SUBSTANCES *VERA. Jankowski, MARKUS. Toelle, MARKUS. van der Giet, LARS. Henning, WALTER. Zidek, JOACHIM. Jankowski CBF, GERMANY REGRESSION OF L-NAME-INDUCED HYPERTENSION: THE ROLE OF NO-PATHWAY AND ENDOTHELIUM-DERIVED CONSTRICTING FACTOR *L. Paulis, J. Zicha, J. Kunes, S. Hojna, S. Kojsova, O. Pechanova, F. Simko Prague, CZECH REPUBLIC ,Bratislava, SLOVAK REPUBLIC ,Bratislava, SLOVAK REPUBLIC LOW CONCENTRATION OF OUABAIN INCREASES BLOOD PRESSURE WITHOUT MODIFYNG THE PRESSOR REACTIVITY IN SPONTANEOUS HYPERTENSIVE RATS FDM. Siman, DV. Vassallo, M. Salaices, V. Cachofeiro, V. Lahera, *AS. Padilha Vitória, ES, BRAZIL ,Vitória, ES, BRAZIL ,Madrid, SPAIN ,Madrid, SPAIN ,Madrid, SPAIN ,Madrid, SPAIN THE RAPID DECLINE OF MTT REDUCTION IS NOT A MARKER OF DEATH SIGNALING IN OUABAIN-TREATED CELLS *O.A. Akimova, P. Hamet, S.N. Orlov Montreal, PQ, CANADA MICE LACKING THE THE RHO/RAC EXCHANGE FACTOR VAV3 ARE HYPERTENSIVE DUE TO AN OVERACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM V. Sauzeau, J.V. Rivas-Elena, M. Jerkic, M.A. Sevilla, Y. El-Mir, M.J. Montero, X.R. Bustelo, *J.M. Lopez-Novoa Salamanca, SPAIN ,Salamanca, SPAIN CHARACTERIZATION OF ALPHA-2-ADRENOCEPTOR SUBTYPES INVOLVED IN CATECHOLAMINE RELEASE FROM THE ADRENAL MEDULLA OF MICE *E. Moura, J. Afonso, M.A. Vieira-Coelho Porto, PORTUGAL ,Porto, PORTUGAL 6 08:30 - 10:30 Room 104 1A Clinical Trials and Therapeutics Paraller Oral Session Chairmen: H. PARDELL ALENTA (BARCELONA, SPAIN) G. LEONETTI (MILANO, ITALY) LECTURE: MULTIPLE RISK INTERVENTION FOR CARDIOVASCULAR PROFILE. JEWEL I-II trial A. Manolis Piraeus, GREECE CONTINUED BENEFIT ON CARDIOVASCULAR OUTCOMES IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT) TWO YEARS AFTER CLOSURE OF THE LIPID-LOWERING ARM (LLA) *PETER. Sever, BJORN. Dahlof, NEIL. Poulter, HANS. Wedel, FOR THE. ASCOT Investigators London, UNITED KINGDOM ,Goteborg, SWEDEN ,Goteborg, SWEDEN REDUCED INCIDENCE OF NEW ONSET ATRIAL FIBRILLATION WITH ANGIOTENSIN II RECEPTOR BLOCKADE: THE VALUE-TRIAL *ROLAND. Schmieder, SVERRE. Kjeldsen, STEVO. Julius, GORDON T. McInnes, ALBERTO. Zanchetti, TSUSHUNG. Hua Erlangen, GERMANY ,Oslo, NORWAY ,Michigan, USA ,Glasgow, UNITED KINGDOM ,Milan, ITALY ,East Hannover, USA THE EFFECT ON BLOOD PRESSURE AND LIPID PROFILES OF DOXAZOSIN GITS AS A THIRD-LINE ANTIHYPERTENSIVE AGENT IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT) C.L. CHANG, *J.N. CHAPMAN, P.S. SEVER, B. DAHLÖF, H. WEDEL, N.R. POULTER, ASCOT. INVESTIGATORS LONDON, UNITED KINGDOM ,GOTHENBURG, SWEDEN ,GOTHENBURG, SWEDEN FALL OF SYSTOLIC BLOOD PRESSURE CORRECTED FOR REGRESSION-TO-THE-MEAN IN THE ACTION TRIAL WAS RELATED TO REDUCTION OF STROKE AND HEART FAILURE BUT NOT TO CORONARY INTERVENTIONS *J. Lubsen, Z. Vokó, P.A. Poole-Wilson, B-A. Kirwan, S. de Brouwer Rotterdam, THE NETHERLANDS ,Debrecen, HUNGARY ,London, UNITED KINGDOM ,Nyon, SWITZERLAND HEMOGLOBIN LEVELS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY. A LIFE SUBSTUDY. *ML. Smebye, EK. Iversen, A. Hoieggen, A. Flaa, I. Os, SE. Kjeldsen, A. Chattopadhyay, PA. Lyle, RB. Devereux, B. Dahlof Oslo, NORWAY ,Oslo, NORWAY ,Oslo, NORWAY ,Oslo, NORWAY ,Oslo, NORWAY ,Oslo, NORWAY ,Whitehouse Station, New Jersey, USA ,Whitehouse Station, New Jersey, USA ,New York, New York, USA ,Goteborg, SWEDEN OUTCOMES IN SUBGROUPS OF HYPERTENSIVE PATIENTS TREATED WITH REGIMENS BASED ON VALSARTAN AND AMLODIPINE: AN ANALYSIS OF FINDINGS FROM VALUE *A. Zanchetti, S. Julius, S. Kjeldsen, G.T. McInnes, T. Hua, M. Weber, J.H. Laragh, F. Plat, VALUE. Investigators Milano, ITALY ,Ann Arbor, MI, USA ,Oslo, NORWAY ,Glasgow, UNITED KINGDOM ,East Hanover, NJ, USA ,New York, NY, USA ,New York, NY, USA ,Basel, SWITZERLAND 7 08:30 - 10:30 Room 105/106 Adipose tissue and CV risk-mechanisms Topical Workshop 9 Chairmen V. LAHERA (MADRID, SPAIN) M. LAFONTAN (TOULOUSE, FRANCE) Functional role of atrial natriuretic peptides in adipose tissue M. Lafontan Toulouse, FRANCE Renin-angiotensin system and adipose tissue A. Sharma Hamilton, CANADA Role of perivascular adipose tissue in regulation of arterial contractility M. S. Fernandez Alfonso 8 11:00 - 12:30 Optimizing suppression of renin-angiotensin-aldosterone system Auditorium Topical Workshop 1 - Co-organized with the Renin Academy Chairmen N. HOLLENBERG (BOSTON, MA, USA) J. NUSSBERGER (LAUSANNE, SWITZERLAND) Optimizing RAAS blockade L. Ruilope Madrid, SPAIN Prorenin: what is it doing in the diabetic patient with microvascular disease and why ? J. Danser Rotterdam, THE NETHERLANDS Diabetic nephropathy: the state of the RAAS N. K. Hollenberg Boston, U.S.A. RAAS: the current mysteries M. Azizi Paris, FRANCE 9 11:00 - 12:30 Room 101/102 2A Clinical Aspects Paraller Oral Session Chairmen: J. POLONIA (PORTO, PORTUGAL) M. BURNIER (LAUSANNE, SWITZERLAND) LECTURE: COMPLIANCE IN ARTERIAL HYPERTENSION M. Burnier Lausanne, SWITZERLAND PREOPERATIVE CHARACTERISTICS OF MEN AND WOMEN OPERATED ON A CONN ADENOMA: THE COMETE-CONN SFHTA STUDY *T. Dart, D. Mouradian, G. Chatellier, PF. Plouin, SFHTA group Paris, FRANCE ,Paris, FRANCE ,France, FRANCE HIGH FREQUENCY OF SDHB MUTATIONS IN A SERIES OF HEAD AND NECK PARAGANGLIOMA FROM BELGIUM *A. PERSU, V. GREGOIRE, P. GARIN, H. REYCHLER, G. MORTIER, J-F. DE PLAEN, M. HAMOIR, M. VIKKULA BRUSSELS, BELGIUM ,BRUSSELS, BELGIUM ,YVOIR, BELGIUM ,BRUSSELS, BELGIUM ,GENT, BELGIUM ,BRUSSELS, BELGIUM ,BRUSSELS, BELGIUM ,BRUSSELS, BELGIUM HETEROGENEITY OF ALDOSTERONE PRODUCING ADENOMAS REVEALED BY GENE EXPRESSION PROFILING WITH DNA MICROARRAY ANALYSIS *T.M. Seccia, L. Lenzini, D. Sticchi, L. Giuliani, A. Fassina, A.C. Pessina, G.P. Rossi PADOVA, ITALY ,BARI, ITALY ,PADOVA, ITALY INTERACTION BETWEEN CURRENT WEIGHT AND BIRTH WEIGHT IN OFFICE AND AMBULATORY BLOOD PRESSURE PHENOTYPE IN ADOLESCENTS *E. Lurbe, E. Carvajal, MI. Torro, F. Aguilar, C. Garcia-Vicent, J. Redón VALENCIA, SPAIN ,VALENCIA, SPAIN 10 11:00 - 12:30 Room 103 2B Large Arteries Paraller Oral Session Chairmen: M. CARRAGETA (ALMADA, PORTUGAL) C. CUSPIDI (MILANO, ITALY) ARTERIAL STIFFNESS EVALUATED FROM ABPM PULSE PRESSURE/MEAN BP SLOPE *P. Gosse, Y. Papaioannou, M. Safar chu Bordeaux, FRANCE ,Paris, FRANCE IS AGE RELATED COMMON CAROTID ARTERY STIFFENING IN MIDDLE-AGED SUBJECTS GENDER DEPENDENT? *S. Vermeersch, E. Rietzschel, M. De Buyzere, D. De Bacquer, L. Van Bortel, G. De Backer, T. Gillebert, P. Verdonck, P. Segers Ghent University, Ghent, BELGIUM ,Ghent University, Ghent, BELGIUM ,Ghent University, Ghent, BELGIUM ,Ghent University, Ghent, BELGIUM DEBATE: CENTRAL PULSE PRESSURE VERSUS ARTERIAL STIFFNESS J. Cockcroft, S. Laurent Cardiff, U.K., Paris, FRANCE OBESITY-ASSOCIATED SLEEP APNEA SYNDROME IS CHARACTERISED BY INTRINSEC LARGE ELASTIC ARTERY STIFFNESS *B. Pannier, J. Raison, K. Le Dudal, E. Roi, M. Safar Fleury-Merogis, FRANCE ,Paris, FRANCE 11 11:00 - 12:30 Sympathetic mechanism and cardio-renal risk: clinical and prognostic implications Room 104 Topical Workshop 6 - Working Group 7 on Hypertension and the Heart Chairmen G. GRASSI (MILANO, ITALY) P. VAN ZWIETEN (AMSTERDAM, THE NETHERLANDS) Sympathetic activation in heart failure and myocardial infarction P. van de Borne Bruxelles, BELGIUM Sympathetic dysfunction in primary and secondary hypertension M. Hausberg Muenster, GERMANY Sympathetic overactivity in metabolic diseases G. Grassi Milan, ITALY Sympathetic activation in renal failure P.J. Blankestijn Utrecht, THE NETHERLANDS 12 11:00 - 12:30 Room 105/106 2C Blood Pressure Measurement Paraller Oral Session Chairmen: M. VIIGIMAA (Tallinn, ESTONIA) C. FARSANG (BUDAPEST, HUNGARY) ADVERSE CARDIOVASCULAR (CV) PROGNOSTIC SIGNIFICANCE OF BLOOD PRESSURE VARIABILITY (BPV) IN A GENERAL POPULATION. DATA FROM THE PAMELA STUDY. *R. SEGA, M. BOMBELLI, A. CORTICELLI, H. POLO FRIZ, R. FACCHETTI, M. RONDINELLI, I. RONCHI, A. CASATI, L. BELTRAME, L. PRIMITZ, G. MANCIA MILANO, ITALY ,MONZA (MI), ITALY ,VIMERCATE (MI), ITALY ,MILANO, ,MILANO, HOME BLOOD PRESSURE NORMALCY IN CHILDREN AND ADOLESCENTS: THE ARSAKION SCHOOL STUDY *G. Stergiou, N. Yiannes, V. Rarra, D. Panagiotakos Athens, GREECE ,Athens, GREECE CIRCADIAN PROFILE OF BLOOD PRESSURE IN SPANISH HYPERTENSIVE PATIENTS. THE NATIONAL ABPM REGISTRY OF SEHLELHA *J. Segura, J. Sobrino, C. Sierra, E. Vinyoles, M. Gorostidi, R. Hernandez, E. Robles, C. Mendiz, A. Egido, R. Lopez, A. Coca, L.M. Ruilope Sociedad Española de Hipertension, SPAIN WEATHER RELATED CHANGES IN 24-HOUR BLOOD PRESSURE PROFILE: IMPLICATIONS FOR HYPERTENSION MANAGEMENT *P.A. Modesti, M. Morabito, I. Bertolozzi, L. Massetti, G. Panci, A. Giglio, G. Bilo, G. Caldara, L. Lonati, S. Orlandini, G. Maracchi, G. Mancia, G.F. Gensini, G. Parati ITALY ITALY ITALY ITALY LECTURE:KIDNEY & ABPM J. Redon Valencia, SPAIN 13 12:30 - 15:30 P01 Therapeutics and Clinical Pharmacology Hall 10 1 Poster Session THE EFFECT OF ANTIHYPERTENSIVE THERAPY WITH IMIDAPRIL AS MONOTHERAPY AND IN COMBINATION WITH CHLORTHALIDONE ON ARTERIAL BLOOD PRESSURE AND OTHER CARDIOVASCULAR RISK FACTORS IN HYPERTENSIVE PATIENTS *P. Zebekakis, I. Tziolas, L. Hatzistavri, S. Gousopoulos, D. Petridis, P. Sarafidis, A. Diamantopoulos, I. Pidonia, A. N. Lasaridis AHEPA University Hospital, Thessaloniki, GREECE 2 BLOOD PRESSURE LOWERING EFFICACY OF OLMESARTAN RELATIVE TO OTHER ANGIOTENSIN II RECEPTOR ANTAGONISTS. AN OVERVIEW OF RANDOMIZED CONTROLLED STUDIES *FAIEZ. ZANNAD, RENAUD. FAY Hôpital Jeanne d'Arc, Dommartin les Toul, FRANCE 3 NEW APPROACH OF USING SILDENAFIL IN THE TREATMENT OF SCLERODERMA PULMONARY HYPERTENSION *ROMAN. Yatsyshyn, YEVGEN. Neyko, NATALYA. Yatsyshyn Ivano-Frankivsk, UKRAINE 4 EFFECT OF ANTIHYPERTENSIVE TREATMENT ON BLOOD PRESSURE VARIABILITY IN ESSENTIAL HYPERTENSIVE PATIENTS ACCORDING TO TIME OF DRUG ADMINISTRATION A. Niklas, K. Jankowska, A. Rutz-Danielczak, A. Pozadzy-Malaczynska, *A. Tykarski Poznan, POLAND 5 EFFECT OF TIME OF ANTIHYPERTENSIVE DRUG ADMINISTRATION ON NIGHT BLOOD PRESSURE FALL IN HYPERTENSIVE PATIENTS A. Niklas, K. Jankowska, A. Radziemski, *A. Tykarski Poznan, POLAND 6 DETERMINANTS OF REDUCTION IN PULSE PRESSURE AND CARDIOVASCULAR EVENTS IN HYPERTENSIVES WITH TYPE 2 DIABETES. *AI. Tropeano, S. Katsahian, A. Grimaldi, D. Molle, P. Boutouyrie, S. Laurent Pompidou Hospital, FRANCE ,Saint Louis Hospital, FRANCE ,Pitié Salpétrière Hospital, FRANCE ,Paris, FRANCE 7 REGRESSION OF LEFT VENTRICULAR HYPERTROPHY (LVH) AND DIASTOLIC DYSFUNCTION (DD) AFTER TREATMENT WITH CPAP IN OBESE AND PRE-OBESE HYPERTENSIVES WITH OBSTRUCTIVE SLEEP APNEA (OSAS) J. Cabau Rúbies, *G. Torres Cortada, O. Sacristan Garcia, J.R. Rozadilla Secanell, F. Abella Pons, A. Quesada Almacelles, M. Franch Calvet, T. Soler Rosell 14 8 AMBULATORY BLOOD PRESSURE MONITORING (ABPM) OF OBESE AND PREOBESE PATIENTS WITH HYPERTENSION AND OBSTRUCTIVE SLEEP APNEA SYNDROME BOTH BEFORE AND AFTER TREATMENT WITH CPAP *G. Torres Cortada, J. Cabau Rubies, O. Sacritan Garcia, JR. Rozadilla Secanell, T. Soler Rosell, F. Abella Pons, A. Quesada Almacelles, M. Franch Calvet Lleida, SPAIN 9 ATENOLOL VS NEBIVOLOL VS PERINDOPRIL: COMPARATIVE INFLUENCE ON RESPIRATORY SYSTEM FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION UNDER ACUTE REMEDY TEST *R.I. Sydorchuk, L.P. Sydorchuk, I.I. Sydorchuk Chernivtsi, UKRAINE 10 ABSTRACT WITHDRAWN 11 DIFFERENT EFFECTS OF URAPIDIL AND DOXAZOSIN ON HEART RATE *G. Stoschitzky, H. Brussee, K. Stoschitzky Medizinische Universitätsklinik Graz, AUSTRIA 12 LONG-TERM SAFETY AND EFFICACY OF ANTIHYPERTENSIVE THERAPY WITH VALSARTAN 320 MG ONCE-DAILY *R. Asmar, T. Mengden, P. Brudi, A. Kandra, R. DiGiovanni, G. Parati Paris, FRANCE ,Bonn, GERMANY ,Basel, SWITZERLAND ,Milano, ITALY 13 EFFICACY AND SAFETY OF VALSARTAN 160 MG AND 320 MG OD AS MONOTHERAPY IN MILD TO MODERATE ESSENTIAL HYPERTENSION *G. Parati, T. Mengden, P. Brudi, A. Kandra, R. DiGiovanni, R. Asmar Milano, ITALY ,Bonn, GERMANY ,Basel, SWITZERLAND ,Paris, FRANCE 14 WHY AND HOW DO WE USE ACE INHIBITORS *J. Spinar, O. Ludka, I. Kalabkova-Cisarova Brno, CZECH REPUBLIC 15 A COMPARISON OF COMBINATION THERAPY WITH AMLODIPINE/VALSARTAN AND LISINOPRIL/HYDROCHLOROTHIAZIDE IN PATIENTS WITH HYPERTENSION *D. Poldermans, R. Gamboa, I. Fomina, M. Wernsing, J. Kaczor, J. Li, R. Glazer Rotterdam, THE NETHERLANDS ,Lima, PERU ,Moscow, RUSSIA ,East Hanover, NJ, USA 16 EFFICACY OF ADD-ON ALDOSTERONE-RECEPTOR BLOCKER IN UNCONTROLLED HYPERTENSION: EFFECT OF PLASMA POTASSIUM LEVELS *YEHONATA. Sharabi, ELDAD. Adler, ARI. Shamis, NAOMI. Nussinovitch, AVINOAM. Markovitz, EHUD. Grossman Tel Hashomer, ISRAEL 2 15 17 IMMEDIATE IMPROVEMENT OF ENDOTHELIAL FUNCTION AND VASCULAR ELASTICITY IN RESPONSE TO ORAL RAMIPRIL *E. SANCHEZ-LARGO, O. SANCHEZ, M. FABREGATE, R. FABREGATE, A. UGALDE-CANITROT, J. SABAN-RUIZ MADRID, SPAIN ,MADRID, SPAIN ,MADRID, SPAIN ,MADRID, SPAIN ,MADRID, SPAIN ,MADRID, SPAIN 18 THE DIPPING STATUS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION BEFORE AND AFTER THE TREATMENT WITH CARDIO SELECTIVE BETA-BLOCKERS. *I. RIHACEK, M. SOUCEK, P. FRANA, M. PLACHY BRNO, CZECH REPUBLIC 19 EFFECT OF TELMISARTAN ADDED TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN REDUCING MORBIDITY AND MORTALITY IN HAEMODIALYSIS PATIENTS WITH CHRONIC HEART FAILURE *G. CICE, A. DI BENEDETTO, S. D'ISA, A. D'ANDREA, P. DE GREGORIO, R. CALABRÒ NAPLES, ITALY ,NAPLES, ITALY 20 FACTORS DETERMINANTS OF ANTIHYPERTENSIVE ACTIVITY OF THE ANGIOTENSIN RECEPTOR BLOCKERS (ARBS). A META-ANALYSIS FROM 24-HOUR AMBULATORY BLOOD PRESSURE STUDIES MJ. Fabia, N. Abdilla, RM. Oltra, C. Fernandez, *J. Redon Valencia, SPAIN 21 24-H MONITORING OF ANTIHYPERTENSIVE EFFICACY OF TWO LONG-ACTING FORMS OF METOPROLOL - A CROSSOVER STUDY *D. RAEV SOFIA, BULGARIA 22 24-H ANTIHYPERTENSIVE EFFICACY OF BISOPROLOL VS METOPROLOL IN MILD AND MODERATE HYPERTENSIVE PATIENTS - A CROSSOVER STUDY *D. RAEV SOFIA, BULGARIA 23 EFFECT OF LISINOPRIL (DIROTON) ON AMBULATORY EARLY MORNING BLOOD PRESSURE IN ELDERLY PATIENTS WITH HYPERTENSION *D. RAEV SOFIA, BULGARIA 24 COADMINISTERED AMLODIPINE AND ATORVASTATIN REDUCES FRAMINGHAM CARDIOVASCULAR RISK: RESULTS FROM THE RESPOND TRIAL *R.A. Preston, J.W. Jukema, P. Harvey, O. Herfert, G. Dykstra, F. Sun, D. Gillen Miami, FL,, USA ,Leiden,, THE NETHERLANDS ,Addlestone, Surrey,, UNITED KINGDOM ,Stuttgart,, GERMANY ,Bartlesville, OK,, USA ,New York, NY,, 16 25 DISSPARATE EFFECT OF ACE INHIBITOR AND THIAZIDE DIURETIC ON DAY/NIGHT BLOOD PRESSURE FALL IN POSTMENOPAUSAL HYPERTENSIVE WOMEN ACCORDING TO HORMONE REPLACEMENT THERAPY(HRT) TAKING *A. POSADZY-MALACZYNSKA, J. GLUSZEK, A. TYKARSKI POZNAN, POLAND 26 IS BUHLER SCHEME A USEFUL GUIDE FOR DRUG ROTATION IN MONOTHERAPY ? *P. PONCELET, P. CLERSON, C. TRESCA, J.P. BERROU, N. SENN HENIN BEAUMONT, FRANCE ,ROUBAIX, FRANCE ,SURESNES, FRANCE 27 CAN THE SHORT-TERM RESPONSE ASSESSED BY SELF MEASUREMENT BE USED TO GUIDE THE CHOICE OF FIRST LINE ANTIHYPERTENSIVE TREATMENT? *P. PONCELET, P. CLERSON, C. TRESCA, J.P. BERROU, N. SENN HENIN BEAUMONT, FRANCE ,ROUBAIX, FRANCE ,SURESNES, FRANCE 28 LOSARTAN VERSUS OLMESARTAN IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CONCENTRIC LEFT VENTRCULAR HYPERTROPHY *M. Picca, F. Agozzino, GC. Pelosi ITALY ITALY ITALY 29 EFFECT OF ANTIHYPERTENSIVE DRUGS ON THE AMPLITUDE OF 24-H SYSTOLIC AND DIASTOLIC BLOOD PRESSURE RHYTHMS S. Perez-Lloret, J.E. Toblli, D.P. Cardinali, *J. Milei Buenos Aires, ARGENTINA ,Buenos Aires, ARGENTINA 30 PECULIARITIES OF EFFECTS OF CARVEDILOL, BETAXOLOL AND CELIPROLOL ON HEART RATE VARIABILITY IN PATIENTS WITH ESSENTIAL HYPERTENSION *T. Ovdiienko Kyiv, UKRAINE 31 ANTIHYPERTENSIVE EFFICACY OF ZOFENOPRIL PLUS HYDROCHLOROTHIAZIDE FIXED COMBINATION IN PATIENTS WITH METABOLIC SYNDROME *E. Malacco, S. Omboni Milano, ITALY ,Somma Lombardo, Varese, ITALY 32 USEFULNESS OF ALPHA-BLOCKER DOXAZOSIN AS A THIRD LINE ANTIHYPERTENSIVE DRUG *YUKO. Ohta, TAKUYA. Tsuchihashi, URAN. Onaka, KIMIKA. Eto, MICHIO. Ueno JAPAN 33 ARE NO PRODUCTION AND PROINFLAMMATORY CYTOKINE ACTIVATION INVOLVED TO THE HEART FAILURE EXPANSION IN PATIENTS WITH HYPERTENSIVE HEART? O. Bilovol, *O. Nyzhegorodtseva Kharkov, UKRAINE ,Kharkov, UKRAINE 17 34 ATTENUATION OF MORNING BLOOD PRESSURE SURGE WITH CANDESARTAN 32 MG ONCE A DAY IN HYPERTENSIVE PATIENTS NOT CONTROLLED WITH MONOTHERAPY *J. Mora-Macia, F. Moreso, S. Armengol, A. Matali, J. Aguilera Barcelona, SPAIN ,Barcelona, SPAIN ,Barcelona, SPAIN ,Tarragona, SPAIN 35 WHEN IS THE BEST TIME OF ANTIHYPERTENSIVE DRUG ADMINISTRATION FOR 24 HOUR BLOOD PRESSURE CONTROL? *HIDEO. Matsuura, KOJI. Kido, KOJI. Matsumoto, MIHO. Kusaka Kure, JAPAN ,Akigun, JAPAN ,Kure, JAPAN 36 EFFECT ON BETA-ADRENORECEPTOR ACTIVITY AFTER IMMEDIATE RELEASE METOPROLOL (IR) AND CONTROLLED RELEASE METOPROLOL (CR) ADMINISTRATION IN PATIENTS WITH MILD TO MODERATE HYPERTENSION *O. MANESHINA, M. LEONOVA, YU. BELOUSOV, A. DUKHANIN, A. SOKOLOV, I. TISCHENKOVA MOSCOW, RUSSIA 37 A LOW-DOSE ANTI-HYPERTENSIVE POLYPILL- THE WAY FORWARD? *AZRA. Mahmud, JOHN. Feely 1, IRELAND ,1, IRELAND 38 PREDICTORS OF BLOOD PRESSURE RESPONSE- AGE AND RENIN? *AZRA. Mahmud, JOHN. Feely 1, IRELAND ,1, IRELAND 39 MANIDIPINE AS THIRD ANTIHYPERTENSIVE DRUG IN HYPERTENSIVES NOT CONTROLLED WITH A COMBINATION OF DIURETICS AND ANTAGONITS OF THE RENIN ANGIOTENSIN SYSTEM *M. Luque, N. Martell, F. de Alvaro, F. Gutierrez, J. Luño, J. Segura SPAIN SPAIN SPAIN SPAIN SPAIN 40 TOTAL CARDIOVASCULAR RISK IN TREATED HYPERTENSIVES ATTENDING AN HOSPITAL-BASED HYPERTENSION UNIT *B. Alvarez, M. Luque, N. Martell, M. Avila, M. Lopez-Eady, A. Fernandez-Cruz SPAIN SPAIN 41 EFFECTS OF FIXED PERINDOPRIL/INDAPAMIDE AND CAPTOPRIL/HYDROCHLOROTHIAZIDE COMBINATIONS ON CARDIAC HYPERTROPHY AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION *YURI. Lopatin, TAMERLAN. Kaplanov, VITALY. Ivanenko Volgograd, RUSSIA ,Volgograd, RUSSIA ,Volgograd, RUSSIA 18 42 CYTOKINES LEVELS CHANGES IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY TREATED WITH PRAVASTATIN *E.V. Levasheva, Z.D. Kobalava, Y.V. Kotovskaya, Y.L. Karaulova, E.A. Korovina, V.S. Moiseev RUSSIA RUSSIA RUSSIA RUSSIA RUSSIA RUSSIA 43 COMPARISON BETWEEN THE ANTHYPERTENSIVE DRUGS TO MODIFY BNP LEVELS IN THE TREATMENT OF ESSENTIAL HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR DIASTOLIC DISFUCTION (LVD). S. Lenti, G. Peruzzi, *C. Frigerio, L. Ralli Arezzo, ITALY ,Arezzo, ITALY ,Arezzo, ITALY ,Arezzo, ITALY 44 THE THERAPEUTIC EFFECTS OF AMLODIPINE IN HYPERTENSIVE EMERGENCIES. S. Lenti, G. Peruzzi, *C. Frigerio, L. Ralli Arezzo, ITALY ,Arezzo, ITALY ,Arezzo, ITALY ,Arezzo, ITALY 45 EFFECTS OF DUAL BLOCKADE OF THE RENIN-ANGIOTENSIN SYSTEM ON LEFT VENTRICULAR REMODELING:RANDOMIZED, DOUBLE- BLIND STUDY IN ESSENTIAL HYPERTENSION *E. LAURITA, F. SOLBIATI, AM. MARESCA, C. MARCHESI, M. GIANNI, M. MONZA, E. NICOLINI, AM. GRANDI VARESE, ITALY ,VARESE, ITALY ,VARESE, ITALY ,VARESE, ITALY ,VARESE, ITALY ,VARESE, ITALY ,VARESE, ITALY ,VARESE, ITALY 46 EFFECTS OF RILMENIDINE ON 24H RHYTHMICITY OF BP AND BAROREFLEX SENSITIVITY IN ESSENTIAL HYPERTENSIVE SUBJECTS *D. LAUDE, E. FINTA, S. ALFOLDI, C. FARSANG, JL. ELGHOZI Paris, FRANCE ,Budapest, HUNGARY 47 EFFECTS OF LACIDIPINE VS FELODIPINE ON BLOOD PRESSURE CONTROL AND ON PULSE WAVE VELOCITY IN MILD AND MODERATE ARTERIAL HYPERTENSION PATIENTS *S. Kushnir, YU. Sirenko, G. Radchenko, YU. Kudina Kiev, UKRAINE 48 THE INFLUENCE OF COMBINED THERAPY: PERINDOPRIL AND AMLODIPINE ON THE CARDIOVASCULAR REMODELING PARAMETERS IN PATIENTS WITH ESSENCIAL HYPERTENSION AND 2 TYPE OF DIABETES MELLITUS *S.N. Koval, L.A. Reznik, H.O. Krochmalova Kharkiv, UKRAINE 49 BP DAILY PROFILE CHANGES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS UNDER THE COMBINED THERAPY: PERINDOPRIL WITH ÀMLODIPINE AND PERINDOPRIL WITH BETAXOL *S.N. Koval, L.V. Maslyaeva, T.G. Starchenko Kharkiv, UKRAINE 19 50 ENDOTHELINPROTECTIVE SIMVASTATIN PROPERTIES IN THE PATIENTS WITH ESSENTIAL HYPERTENSION AND ISCHEMIC HEART DISEASES *Y.N. Shaposhnikova, V.I. Molodan, V.D. Nemtsova, V.V. Shkolnik, N.I. Klimenko Kharkiv, UKRAINE 51 ANTIHYPERTENSIVE EFFICACY OF NEBIVOLOL IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH DIFFERENT 24-H BLOOD PRESSURE PROFILE *O.V. Mysnychenko, I.A. Snegurskaya, S.N. Kova, D.K. Myloslavsky, Y.N. Shaposhnikova, D.S. Koval Kharkiv, ,Kharkiv, 52 COMBINATION THERAPY WITH ANGIOTENSINE II ANTAGONIST AND STATIN MAY IMPROVE ARTERIAL ELASTICITY IN HYPERTENSIVE PATIENTS *S. Villevalde, T. Mirilashvili, Z. Tigay, Y. Kotovskaya, Z. Kobalava Moscow, RUSSIA 53 ANTIINFLAMMATORY PROPERTIES OF STATIN THERAPY IN HYPERTENSIVE PATIENTS WITH DYSLIPIDEMIA *S. Villevalde, T. Mirilashvili, Y. Kotovskaya, Z. Kobalava Moscow, RUSSIA 54 THE ANTIHYPERTENSIVE PRACTICE IN HUNGARY. DATA FROM THE HUNGARIAN HYPERTENSION REGISTRY *I. Kiss, E. Kekes, Z. Schanberg, L. Pall, C. Farsang HUNGARY 55 ” PHARMACORESISTANT“ HYPERTENSION - A CASE REPORT *I. KACIROVA, M. GRUNDMANN OSTRAVA, CZECH REPUBLIC 56 COMPARISON OF THE EFFECT OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS RILMENIDINE AND CLONIDINE ON PSYCHOMOTOR SKILLS IN MEN WITH MILD-TO-MODERATE ESSENTIAL HYPERTENSION *P. Gryglas, P. Jedrusik, P. Pruszczyk, Z. Gaciong Warsaw, POLAND 57 PLACEBO-CONTROLLED COMPARISON OF THE ADVERSE EFFECTS OF ANTIADRENERGIC BLOOD PRESSURE-LOWERING AGENTS DURING 3-WEEK TREATMENT IN MEN WITH MILD-TO-MODERATE ESSENTIAL HYPERTENSION *P. Gryglas, P. Jedrusik, P. Pruszczyk, Z. Gaciong Warsaw, POLAND 20 58 COMPARISON OF THE EFFECT OF DIFFERENT BETA-BLOCKERS ON PSYCHOMOTOR SKILLS IN MEN WITH MILD-TO-MODERATE ESSENTIAL HYPERTENSION *P. Gryglas, P. Jedrusik, P. Pruszczyk, Z. Gaciong Warsaw, POLAND 59 COMPARATIVE STUDY OF MODIFIED RELEASE ALPHA-BLOCKER EXPOSURE IN ELDERLY PATIENTS WITH FRACTURES *G C. Hall, A D. McMahon London, UNITED KINGDOM ,Glasgow, UNITED KINGDOM 60 SEXUAL DISTURBANCES: A FREQUENT CAUSE OF POOR COMPLIANCE WITH ANTIHYPERTENSIVE MEDICATION IN YOUNG MEN *K. GKOGKOS, G. PAVLIDIS, A. KARAKOZOGLOU, P. PRIZIOS, A. KIMIONIS, E. MEMI THESSALONIKI, GREECE 61 BARNIDIPINE:ASSESSMENT OF SAFETY AND EFFICACY:1 YEAR EXPERIENCE *K. GKOGKOS, G. PAVLIDIS, A. KARAKOZOGLOU, A. KOPRAS, E. MEMI, V. TSOUTSOULI THESSALONIKI, GREECE 62 GENERAL PRACTITIONERS' CHOICE OF ANTIHYPERTENSIVE TREATMENT WITH TWO OR MORE DRUGS N. Gotcheva, *B. Georgiev, D. Gotchev, V. Baytcheva, V. Christov, Z. Kamenov Sofia, BULGARIA ,Sofia, BULGARIA ,Sofia, BULGARIA 63 ALTERATIONS IN GENERAL PRACTITIONERS' APPROACH FOR DRUG CHOICE IN THE MONOTHERAPY OF HYPERTENSION N. Gotcheva, *B. Georgiev, D. Gotchev, V. Baytcheva, V. Christov, Z. Kamenov Sofia, BULGARIA ,Sofia, BULGARIA ,Sofia, BULGARIA 64 CHOICE OF DRUG COMBINATION FOR TREATMENT OF HYPERTENSION BY GENERAL PRACTITIONERS *B. Georgiev, N. Gotcheva, D. Gotchev, V. Baytcheva, V. Christov, Z. Kamenov Sofia, BULGARIA ,Sofia, BULGARIA ,Sofia, BULGARIA 65 EVOLUTION OF GENERAL PRACTITIONERS' CHOICE OF MEDICATIONS FOR THE INITIAL TREATMENT OF HYPERTENSION *B. Georgiev, N. Gotcheva, D. Gotchev, V. Baytcheva, V. Christov, Z. Kamenov Sofia, BULGARIA ,Sofia, BULGARIA ,Sofia, BULGARIA 66 PERINDOPRIL – ITS ANTIHYPERTENSIVE EFFICACY IN CLINICALLY RELEVANT SUBGROUPS OF HYPERTENSIVE PATIENTS. AN INDIVIDUAL-PATIENT--DATA METAANALYSIS OF FIVE POLISH STUDIES. *J. Gasowski, T. Grodzicki Cracow, POLAND 21 67 EFFECT OF VALSARTAN ADDITION TO AMLODIPINE ON ANKLE OEDEMA AND SUBCUTANEOUS TISSUE PRESSURE IN HYPERTENSIVE PATIENTS *R. Fogari, T. Perrone, F. Musca, P. Lazzari, L. Corradi, P. Preti, A. Mugellini, A. Rinaldi Pavia, ITALY 68 TOTAL MORTALITY RISK REDUCTION IN A HYPERTENSIVE DIABETIC COHORT UNDER STATIN DRUG TREATMENT *C. Galarza, S. Figar, J. Tortella, A. Beratarrechea, E. Langlois, M. Marchetti, L. Camera, G. Waisman, L. Litwak, F. Gonzalez B de Quirós Buenos Aires, ARGENTINA 69 DIETARY COMPOSITION AND BLOOD PRESSURE CONTROL *A L. Ferrara, S. Viola, F. Ricci, G. De Luca, F. Ferrara, R. Castaldo, S. Limauro, R. Russo ITALY 70 EFFICACY AND SAFETY OF TENOCHEC (AMLODIPINE 5 MG +ATENOLOL 50 MG), A NEW COMBINEDANTIHYPETENSIVE DRUG IN PATIENTS WITH ARTERIAL HYPERTENSION COUPLED WITH CORONARY ARTERY DISEASE N. MEZENTCEVA, *S. EROFEEVA, M. LEONOVA, YU. BELOUSOV MOSCOW, RUSSIA 71 EFFECT OF TELMISARTAN ON AORTIC STIFFNESS IN VERY HIGH RISK PATIENTS FROM THE TRANSCEND STUDY: THE TRANSCEND ARTERIAL STIFFNESS STUDY INCLUSION DATA *J. TOPOUCHIAN, R. EL FEGHALI, B. PANNIER, R. ASMAR PARIS, FRANCE 72 FEMALE SEXUAL DYSFUNCTION IN HYPERTENSIVE WOMEN WITH OR WITHOUT TREATMENT *M. Doumas, A. Tsakiris, S. Douma, ANG. Papadopoulos, G. Paraskeuakou, A. Karagianni, E. Manali, C. Ellinas, K. Kanellakopoulou, H. Giamarellou GREECE GREECE GREECE GREECE GREECE 73 BETA1-BLOCKERS AND ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AFFECT DIFFERENTLY PLASMA LIPIDS AND ANTIOXIDANT STATUS IN PATIENTS WITH ESSENTIAL HYPERTENSION *D. KROUF, A. CHERRAD, J. BELLEVILLE, J. PROST, M. BOUCHENAK 1, ALGERIA ,2, ALGERIA ,3, FRANCE ,3, FRANCE ,1, ALGERIA 74 DISTRICT PROGRAM TO IMPROVE THE CARDIOVASCULAR RISK OF RESISTANT HYPERTENSIVE PATIENTS *T. DENOLLE, Y. EON, H. LE NEEL, H. SEIGNARD, J. BATTINI DINARD AND RENNES, FRANCE ,RENNES, FRANCE ,RENNES, FRANCE ,RENNES, FRANCE 22 75 THE MAISH ( MANIDIPINE VS AMLODIPINE IN ISOLATED SYSTOLIC HYPERTENSION ) STUDY IN AGED PATIENTS: AMBULATORY BLOOD PRESSURE RESULTS AFTER 3 MONTHS OF TREATMENT. *A. Coca, D. Dacoronias SPAIN ITALY 76 THE ROLE OF DOXAZOSIN IN THE TREATMENT OF DRUG RESISTANT ARTERIAL HYPERTENSION *J. Ceral, M. Solar, M. Borovec Hradec Kralove, CZECH REPUBLIC 77 REDUCTION OF TARGET ORGAN DAMAGE INDUCED BY AT1 ANTAGONIST THERAPY: EFFECTS OF VALSARTAN AFTER 1 YEARS FOLLOW-UP S. Pizzocri, *L. beltrami, B. Caimi, M. Pozzi, G. Rossetti, F. Brasca, G. Bolla, F. Magrini, S. Carugo 1, ITALY ,2, ITALY 78 REGRESSION OF ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY BY CANDESARTAN IN CLINICAL PRACTICE. THE SARA STUDY *V. Barrios, A. Calderón, C. Escobar, S. Barrios, L. Barrios, LM. Molinero, O. Vegazo, R. Fernandez, E. Asín Madrid, SPAIN ,Madrid, SPAIN ,Madrid, SPAIN ,Madrid, SPAIN 79 COMPARISON BETWEEN ANGIOTENSIN II RECEPTOR BLOCKER AND BETA-BLOCKER ON BLOOD PRESSURE, HEMODINAMIC, AND LIPID IN HYPERTENSIVE HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH STATIN *M.G. PRANDIN, A. DORMI, M. VERONESI, S. BACCHELLI, V. IMMORDINO, E. AMBROSIONI, C. BORGHI ITALY 80 THE EFFECT OF 6-MONTHS THERAPY WITH SIMVASTATIN ON INTIMA-MEDIA THICKNESS IN NORMOTENSIVE PATIENTS WITH HYPERCHOLESTEROLAEMIA *H. Swiatek, K. Kunicka, E. Swierblewska, E. Drzazga, E. Miszkowska, J. Neubauer-Geryk, P. Kruszewski, L. Bieniaszewski, B. Wyrzykowski Gdansk, POLAND ,Gdansk, POLAND 81 HYPERTENSION TREATMENT PRACTICES AND MANAGEMENT IN UNCONTROLLED HYPERTENSION IN SPANISH PRIMARY HEALTH CARE CENTERS. RESULTS OF DISEHTAE 2003 STUDY *S. Pérez-Zamora, T. Ureña-Fernández, I. Flores-Becerra, MI. Egocheaga-Cabello, M. Domínguez-Sardiña, E. Paja-Fano Badalona, SPAIN ,Jaén, SPAIN ,Navalmoral de la Mata (Cáceres), SPAIN ,Madrid, SPAIN ,Vigo, SPAIN 82 THE THIRD GENERATION CALCIUM ANTAGONIST LACIDIPIN DEMONSTRATES MILD BRONCHODILATOR EFFECT IN ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASES *V. Kasantzev, A. Barsukov, A. Nikolaev, M. Talantzeva Saint-Petersburg, 23 83 MINIMUM CLINICALLY IMPORTANT DIFFERENCES (MCID) FOR ANTIHYPERTENSIVE TREATMENT IN SOUTH ASIANS AND CAUCASIANS *M. AARABI, J. SKINNER, C. PRICE, P.R. JACKSON SHEFFIELD, UNITED KINGDOM ,SHEFFIELD, UNITED KINGDOM 84 BLOOD PRESSURE CONTROL IN THE UK: HOW ARE WE DOING? *M. AARABI, P.R. JACKSON SHEFFIELD, UNITED KINGDOM 85 IMIDAZOLIC AGONISM: EFFECTS IN ESSENTIAL HYPERTENSIVES WITH INSULIN RESISTANCE:. JOSÉ. Soler, RAMIRO A. Sanchez, *AGUSTÍN. Ramirez Buenos Aires, ARGENTINA ,Buenos Aires, ARGENTINA 86 EFFICACY OF BETAXOLOL IN PATIENTS WITH 1 AND 2 GRADE OF ESSENTIAL HYPERTENSION: INFLUENCE ON EXERCISE TOLERANCE *LO. Minushkina, EG. Saveljeva, DA. Zateyshchikov Moscow, RUSSIA 87 EFFICACY AND SAFETY OF A FIRST-LINE COMBINATION TREATMENT AND PATIENTS EDUCATION TO REDUCE TOTAL CARDIOVASCULAR RISK IN HYPERTENSION *R. Oganov, D. Nebieridze, A. Kalinina RUSSIA 88 INVESTIGATION OF CEREBROPROTECTIVE EFFICACY OF BETA-BLOCKER METOPROLOLI IN HYPERTENSIVE PATIENTS NL. Afanasyeva, *VF. Mordovin Tomsk, RUSSIA ,Tomsk, RUSSIA 89 EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH METABOLIC SYNDROME *F. D'AMICO PATTI, ITALY 90 COMPARISON OF ANTIHYPERTENSIVE EFFECT OF DIFFERENT COMBINATIONS IN HYPERTENSIVES NOT CONTROLLED WITH CALCIUM CHANNEL BLOCKER VARNIDIPINE AS MONOTHERAPY *A. Manolis, A. Pittaras, E. Adamopoulou, D. Beldekos Tzanio Hospital, GREECE 91 ALDEHYDE DEHYDROGENASE TYPE 2 AND THE DEVELOPMENT OF NITRATE TOLERANCE IN HUMANS *IS. Mackenzie, MJ. Brown, IB. Wilkinson Cambridge, UNITED KINGDOM 24 92 ABSTRACT WITHDRAWN 93 PRIMARY CARE MANAGEMENT OF HYPERTENSION IN PATIENTS CONSIDERED 'AT RISK' OF CARDIOVASCULAR DISEASE *C. Reid, A. Owen, K. Collopy, G. Jennings Melbourne, Australia ,Melbourne, Australia ,Melbourne, Australia 94 What do Spanish physicians know about therapeutic adherence in hypertension? *M. DE LA FIGUERA VON WICHMAN, E. MÁRQUEZ CONTRERAS, C. FERNANDEZ FERNANDEZ, L. ROIG PONSA, J. NAVAL CHAMOSA Huelva, Spain ,Barcelona, Spain ,Barcelona, Spain ,Barcelona, Spain ,Barcelona, Spain 95 What strategies do Spanish physicians use for improving treatment adherence in hypertension? *M. DE LA FIGUERA VON WICHMAN, E. MÁRQUEZ CONTRERAS, C. FERNANDEZ FERNANDEZ, L. ROIG PONSA, J. NAVAL CHAMOSA Huelva, Spain ,Barcelona, Spain ,Barcelona, Spain ,Barcelona, Spain ,Barcelona, Spain 96 TRAIL- The effectiveness of trandolapril based treatment regimen in reaching blood pressure goals: an Observational study R. Tytus, E. Burgess, L. Assouline, A. Vanjaka Hamilton, Ontario, Canada ,Calgary, Alberta, Canada ,Montreal, Quebec, Canada 25 12:30 - 15:30 Hall 10 97 P02 Heart Poster Session THE INSULIN-LIKE GROWTH FACTOR-1 AND MYOCARDIUM REMODELING IN HYPERTENSIVE PATIENTS *L.V. Zhuravlyova, O.N. Kovalyova Kharkov, UKRAINE ,Kharkov, UKRAINE 98 RELATION OF TYPE LEFT VENTRICLE GEOMETRY WITH LIFE EXPECTANCY IN HYPERTENSIVE PATIENTS DURING FOLLOW-UP *L. Zelenenka, E. Kupchinskaya, L. Bezrodna Kyiv, UKRAINE 99 8-ISOPROSTANE AS A MARKER OF OXIDATIVE STRESS AT THE PATIENTS WITH CHRONIC HEART FAILURE M.V. Zayika, *O.N. Kovalyova Kharkiv, UKRAINE ,Kharkiv, UKRAINE 100 THE PROGNOSTIC ROLE OF INFLAMMATORY BIOMARKERS IN HYPERTENSIVES AND NORMOTENSIVES WITH NON ST ACUTE CORONARY SYNDROMES *MN. Zairis, AJ. Manolis, EN. Adamopoulou, N. Patsourakos, P. Batika-Zairi, N. Kouremenos, D. Beldekos, SG. Foussas Piraeus, GREECE 101 HYPERINSULINEMIA AND LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH LONG TERM HYPERTENSION *O. Yarynkina, O. Kupchinska, L. Zelenenka, M. Mospan, N. Tchyrulneva Kiev, UKRAINE 102 SILENT MYOCARDIAL ISCHEMIA IN POSTMENOPAUSAL HYPERTENSIVE WOMEN *KH. Vatinyan, V. Gurgenyan, G. Nikogosyan YEREVAN, ARMENIA 103 THE INTERPLAY OF BRAIN NATRIURETIC PEPTIDE AND ARTERIAL STIFFNESS AS A STEP TOWARDS PAROXYSMAL ATRIAL FIBRILLATION IN HYPERTENSIVE SUBJECTS *I. SKIADAS, C. TSIOUFIS, D. SIRSELOUDIS, C. KATSARIS, E. VEZALI, E. TAXIARCHOU, C. STEFANADIS, I. KALLIKAZAROS ATHENS, GREECE 26 104 LEFT ATRIAL VOLUME IS ASSOCIATED WITH LEFT VENTRICULAR STRUCTURAL AND FUNCTIONAL ABNORMALITIES IN ESSENTIAL HYPERTENSIVE SUBJECTS *P. STOUGIANNOS, C. TSIOUFIS, E. TAXIARCHOU, D. SIRSELOUDIS, D. TSIACHRIS, V. CHATZISTAMATIOU, C. STEFANADIS, I. KALLIKAZAROS ATHENS, GREECE 105 LEFT ATRIAL ENLARGEMENT IS ACCOMPANIED BY INCREASED AORTIC STIFFNESS IN NEWLY DIAGNOSED SUBJECTS WITH ESSENTIAL HYPERTENSION *E. TAXIARCHOU, C. TSIOUFIS, P. STOUGIANNOS, D. SIRSELOUDIS, I. SKIADAS, K. DIMITRIADIS, C. STEFANADIS, I. KALLIKAZAROS ATHENS, GREECE 106 SPONTANEOUS BAROREFLEX SENSITIVITY AFTER PULMONARY VEINS ISOLATION IN PREDICTING RECURRENCE OF ATRIAL FIBRILLATION *K. Styczkiewicz, G. Spadacini, M. Tritto, P. Moretti, G.B. Perego, M. Facchini, G. Bilo, P. Castiglioni, J.A. Salerno-Uriarte, G. Mancia, K. Kawecka-Jaszcz, G. Parati Milan, ITALY ,Cracow, POLAND ,Castellanza, ITALY ,Monza, ITALY ,Milan, ITALY ,Varese, ITALY 107 ARTERIAL PLASMA NORADRENALINE PREDICTS LEFT VENTRICULAR MASS INDEPENDENTLY OF BLOOD PRESSURE AND BODY BUILD IN MEN WHO DEVELOP HYPERTENSION OVER 20 YEARS *A. Strand, H. Gudmundsdottir, I. Os, A. Westheim, R. Bjørnerheim, S. Kjeldsen NORWAY NORWAY 108 AUTONOMOUS NERVOUS HEART CONTROL IN PATIENTS WITH CARDIAC TRANSPLANTATION *J. Siegelova, B. Fiser, P. Homolka, H. Svacinova, F. Varnay, P. Vank, L. Mífkova, L. Spinarova, J. Vitovec Masaryk University Brno, CZECH REPUBLIC 109 SCREENING FOR LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC DYSFUNCTION WITH B-TYPE NATRIURETIC PEPTIDE IN GERIATRIC OUTPATIENTS *J.H.W. Rutten, N. van der Velde, T.J.M. van der Cammen, A.H. van den Meiracker Rotterdam, THE NETHERLANDS ,Rotterdam, THE NETHERLANDS 110 COMPARISON OF CARDIAC STRUCTURE AND FUNCTION IN SYSTO-DIASTOLIC AND ISOLATED SYSTOLIC ARTERIAL HYPERTENSION *M. PICCA, F. AGOZZINO, GC. PELOSI ITALY ITALY ITALY 111 TGF-BETA-INDUCED CARDIAC MYOFIBROBLASTS ARE LARGE NONPROLIFERATING CELLS WITH HIGH ACTIVITY OF MATRIX CONTRACTION AND REMODELING *VICTOR V. Petrov, ROBERT H. Fagard, PAUL J. Lijnen Leuven, BELGIUM 27 112 EFFECTS OF ALPHA- OR BETA- RECEPTOR BLOCKADE ON CARDIAC MAST CELL DEGRANULATION DURING EXPERIMENTAL PRESSURE-OVERLOAD HYPERTROPHY *C. Gatti, S. Fallarini, I. Ferrero, G. Palladini, R. Tozzi, AU. Ferrari, S. Perlini Pavia, ITALY ,Pavia, ITALY ,Milano, ITALY ,Milano, Pavia, Monza, ITALY 113 STUDY OF THE TIME COURSE OF CARDIAC MAST CELL DEGRANULATION DURING CHRONIC SYMPATHECTOMY IN EXPERIMENTAL PRESSURE-OVERLOAD HYPERTROPHY *R. Tozzi, S. Fallarini, I. Ferrero, C. Gatti, G. Palladini, AU. Ferrari, S. Perlini Pavia, ITALY ,Pavia, ITALY ,Milano, ITALY ,Milano, Pavia, Monza, ITALY 114 THE REGRESSION OF LEFT VENTRICULAR AND AORTIC HYPERTROPHY IN NO-DEFICIENT RATS: EFFECT OF L-ARGININE AND SPIRONOLACTONE *L. Paulis, J. Matuskova, M. Adamcova, V. Pelouch, O. Pechanova, F. Simko Bratislava, SLOVAK REPUBLIC ,Bratislava, SLOVAK REPUBLIC ,Hradec Kralove, CZECH REPUBLIC ,Prague, CZECH REPUBLIC 115 ABSTRACT WITHDRAWN 116 PRE-HYPERTENSIVE PHASE: EVALUATION BY CONVENTIONAL AND DOPPLER TISSUE ECHOCARDIOGRAPHY, HEART RATE VARIABILITY AND BLOOD PRESSURE MONITORING IN OFFSPRING OF HYPERTENSIVE SUBJECTS *G. Pelà, P. Pattoneri, MA. Passera, G. Tirabassi, S. Ferraro, G. Bruschi Parma, ITALY 117 EVIDENCE FOR ACTIVATION OF HEME OXYGENASE FOLLOWING ACUTE MYOCARDIAL INFARCTION IN HUMANS *RYOJI. Ozono, KOICHIRO. Okuhara, TETSUYA. Oshima, SATOSHI. Kurisu, ICHIRO. Inoue Hiroshima, JAPAN JAPAN 118 SLOW CORONARY FLOW - THE INFLUENCE OF NITROGLYCERINE AND VERAPAMIL. PRELIMINARY RESULTS. *P. Nowicki, A. Derkacz, K. Poczatek, R. Poreba, H. Nowosad, W. Mazurek Wroclaw, POLAND ,Wroclaw, POLAND ,Wroclaw, POLAND 119 ARTERIAL HYPERTENSION IS MAJOR RISK FACTOR FOR FREE WALL RUPTURE IN STEMI PATIENTS *K. Novak, V. Carevic, Z. Rumboldt, J. Bagatin SPLIT, CROATIA 28 120 LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSIVES WITH CHRONIC RENAL INSUFFICIENCY *A. PALERMO, E. NARDI, G. MULE', S. COTTONE, P. CUSIMANO, G. CERASOLA PALERMO, ITALY 121 SYMPATHETIC CONTROL AFTER CARDIAC RESYNCHRONIZATION THERAPY: RESPONDERS VS NONRESPONDERS. *BOUTAÏNA. Najem, PHILIPPE. Unger, NICOLAS. Preumont, JEAN-LUC. Jansens, ANNE. Houssière, ATUL. Pathak, OLIVIER. Xhaet, LAURENCE. Gabriel, ALAIN. Friart, LUC. De Roy, JEAN-LUC. Vandenbossche, PHILIPPE. ven de Borne Brussels, BELGIUM ,Mont-Godinne, BELGIUM ,La Louvière, BELGIUM ,Brussels, BELGIUM 122 MULTIPLE WITHIN BURST FIRING OF SINGLE VASOCONSTRICTOR NEURONS IS AN IMPORTANT ROLE DURING EXCESSIVE SYMPATHOEXCITATION IN HUMANS CONGESTIVE HEART FAILURE *T. Ikeda, S. Takata, M. Maruyama, H. Murai, K. Otowa, M. Takamura, S. Kaneko Kanazawa, JAPAN 123 DIFFERENT SYMPATHOEXCITATION PATTERN OF SINGLE VASOCONSTRICTOR FIBER IN CONGESTIVE HEART FAILURE *H. Murai, S. Takata, M. Nakano, D. Kobayashi, K. Otowa, M. Maruyama, M. Takamura, S. Kaneko Kanazawa, JAPAN 124 LOW FREQUENCY COMPONENTS OF PERIPHERAL VASCULAR RESISTANCE VARIABILITY REFLECTS SYMPATHETIC NERVE ACTIVITY IN CONGESTIVE HEART FAILURE *M. Nakano, S. Takata, M. Maruyama, H. Murai, Y. Mitamura, M. Takamura, S. Kaneko Kanaza, JAPAN 125 CARDIOPROTECTION BY MOXONIDINE INCLUDE ANTI-INFLAMMATORY ACTION ON THE HEART *A. Menaouar, P-A. Paquette, J. Gutkowska, S. Mukaddam-Daher CANADA 126 LEFT VENTRICULAR FIBROBLASTS BUT NOT MYOCYTES ARE TARGET FOR MOXONIDINE ACTION *S. Mukaddam-Daher, S. Bentaibi, G. Thibault, J. Gutkowska Montreal, CANADA ,Montreal, CANADA 127 LEFT VENTRICULAR MASS INDEX AND DIASTOLIC FUNCTION AS MAJOR DETERMINANTS OF LEFT ATRIAL VOLUME IN ESSENTIAL HYPERTENSIVE PATIENTS A. Milan, M. Caserta, S. Del Colle, A. Dematteis, D. Naso, C. Magnino, E. Puglisi, E. Testa, C. Comoglio, P. Mulatero, F. Rabbia, *F. Veglio ITALY ITALY 29 128 SPIROVELOERGOMETRY FOR EXERCISE TOLERANCE ASSESSMENT IN PATIENTS WITH PRIMARY PULMONARY HYPERTENSION. T.V. Martynyk, *O.O. Matvienko, N.M. Danilov, S.N. Nakonechnikov, I.YE. Chazova Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA 129 A DOUBLE ROLE FOR CARDIOTROPHIN-1 PATHWAY IN THE CARDIAC AFFECTATION OF THE SPONTANEOUSLY HYPERTENSIVE RAT. *N. López, J. Díez, MA. Fortuño Pamplona, SPAIN ,Pamplona, SPAIN 130 CYTOKINE LEVELS IN PATIENTS WITH DIFFERENT TYPES OF LEFT VENTRICULAR HYPERTROPHY *E.V. Levasheva, Z.D. Kobalava, Y.V. Kotovskaya, Y.L. Karaulova, V.S. Moiseev RUSSIA RUSSIA RUSSIA RUSSIA RUSSIA 131 ANTHROPOMETRIC AND HAEMODYNAMIC DETERMINANTS OF MITRAL ANNULAR VELOCITIES IN A GENERAL POPULATION *T. Kuznetsova, L. Thijs, T. Richart, J.A. Staessen Leuven, BELGIUM 132 THE ROLE OF TRANSFORMING GROWTH FACTOR-ß1 IN DIFFERENT TYPES OF HYPERTENSIVE HEART REMODELING *O.N. Kovalyova, N.V. Bila Kharkov, UKRAINE 133 IS THERE ANY RELATION BETWEEN NOCTURNAL BLOOD PRESSURE REDUCTION AND HEART RATE VARIABILITY IN HYPERTENSIVE PATIENTS? *E. Onrat, C. Kilit, A. Avsar, M. Melek, A. Taner, A. Celik Afyonkarahisar, TURKEY 134 DOES HEART RATE TURBULENCE CHANGE IN NEW ONSET UNTREATED HYPERTENSION? *C. Kilit, E. Onrat, A. Avsar, M. Melek, A. Taner, A. Celik Afyonkarahisar, TURKEY 135 THE RELATION BETWEEN NOCTURNAL BLOOD PRESSURE FALLING AND CARDIAC AUTONOMIC FUNCTION PARAMETERS-HEART RATE VARIABILITY AND HEART RATE TURBULENCE-IN NORMOTENSIVE SUBJECTS *C. Kilit, E. Onrat, M. Melek, A. Avsar, A. Taner, A. Celik Afyonkarahisar, TURKEY 136 INTERRELATION OF BLOOD PRESSURE VARIABILITY AND HEART RATE VARIABILITY IN THE PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. *S. Karlov, V. Tseluyko Kharkiv, UKRAINE 30 137 COMPLETENESS OF REVASCULARIZATION AND THE LONG-TERM PROGNOSIS IN PATIENTS WITH HYPERTENSION AND MULTIVESSEL CORONARY ARTERY DISEASE TREATED WITH PTCA *B. NORWA-OTTO, J. KADZIELA, A. DEBSKI, Z. CHMIELAK, A. WITKOWSKI, W. PIOTROWSKI, W. RUZYLLO WARSAW, POLAND 138 ABSTRACT WITHDRAWN 139 EARLY CHANGES OF DIASTOLIC FUNCTION IN MILD-TO-MODERATE HYPERTENSIVES *H. JAAGUS, S. SILDMAE, M. KIITAM, A. REINOLD, M. KADARIK, R. VAHISALU, A. HEDMAN, E. MAEOTS TALLINN, ESTONIA 140 QUANTIFICATION OF REGIONAL MYOCARDIAL FUNCTION BY DOPPLER TUSSUE IMAGING UNCOVERS DIFFERENCE BETWEEN ATHLETES AND HYPERTENSIVES HEART *S. Ilic, M. Deljanin Ilic, V. Ilic, D. Djordjevic NISKA BANJA, UNIVERSITY OF NIS, SERBIA - MONTENEGRO 141 MORNING RISE IN BLOOD PRESSURE IS A PREDICTOR OF LEFT VENTRICULAR HYPERTROPHY IN WELL-CONTROLLED HYPERTENSIVE PATIENTS UNDER LONG-TERM ANTIHYPERTENSIVE MEDICATION *T. Ikeda, J. Okada, M. Ikeda, C. Yamada, T. Kasatani, T. Gomi, Y. Shibuya Tokyo, JAPAN ,Tokyo, JAPAN ,Tokyo, JAPAN 142 RECEIVER OPERATING CHARACTERISTIC ANALYSIS TO DETECT THE CUT-OFF VALUES OF TISSUE DOPPLER IMAGING FOR PREDICTION OF HYPERTENSIVE PATIENTS WITH LIKELIHOOD OF CORONARY ARTERY DISEASE *A.M. Hegazy, B.A. Abdulkader KUWAIT KUWAIT 143 THE EFFECT OF LISINOPRIL TREATMENT ON LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC FUNCTION IN PATIENTS WITH MILD TO MODERATE HYPERTENSION *L.R. Hayrapetyan, E.S. Ter-Stepanyants, A.B. Danoyan, L.S. Mkrtchyan, L.A. Aleksanyan, M.F. Drambyan Yerevan, ARMENIA 144 THE LEFT VENTICULAR REMODELLING IN TWO CLINICAL FORMS OF ARTERIAL HYPERTENSION (ISOLATED SYSTOLIC AND DIASTOLIC) *S.V. Gurgenyan, S.KH. Vatinyan, K.G. Nikogosyan, L.B. Edilyan Yerevan, ARMENIA 31 145 INTERVENTRICULAR SEPTUM THICKNESS PREDICTS FUTURE SYSTOLIC HYPERTENSION IN YOUNG HEALTHY PILOTS CHAGAI. Grossman, ALON. Grossman, BELLA. Azaria, LIAV. Goldstein, ARIC. Shamiss, *EHUD. Grossman Tel Hashomer, ISRAEL ,Tel Hashomer, ISRAEL 146 IMPROVEMENT OF HYPERTENSION-INDUCED DIASTOLIC DYSFUNCTION UNDER SUSTAINED RELEASED DIPYRIDAMOLE BERNHARD. Gremmler, *KLAUS. Kisters, MATTHIAS. Kunert, HEINRICH. Schleiting, LUDGER. Ulbricht Bottrop, GERMANY ,Herne, GERMANY ,Witten, GERMANY 147 DECREASED GP130 SURVIVAL PATHWAY IN THE TRANSITION FROM LEFT VENTRICULAR HYPERTROPHY TO HEART FAILURE IN HYPERTENSIVE PATIENTS I. Loperena, A. González, B. López, *S. Ravassa, R. Querejeta, M. Larman, J. Díez Pamplona, Navarra, SPAIN ,San Sebastián, Guipúzcoa, SPAIN ,San Sebastián, Guipúzcoa, SPAIN 148 LEFT VENTRICULAR HYPERTROPHY AND FILLING PRESSURE IN UNCOMPLICATED HYPERTENSION: EVALUATION BY TISSUE DOPPLER *P. Innelli, M. Galderisi, F. Marra, A. D'Errico, A. Corbisiero, M. de Divitiis, F. Dello Vicario, O. de Divitiis Naples, ITALY 149 LEFT VENTRICULAR CONCENTRIC GEOMETRY IS ASSOCIATED WITH INCREASED FILLING PRESSURE IN UNCOMPLICATED HYPERTENSIVE PATIENTS: A TISSUE DOPPLER STUDY *M. Galderisi, G. de Simone, P. Innelli, A. D'Errico, M. Sidiropulos, M. Olibet, G. Errico, M. de Divitiis, S. Gligorova, O. de Divitiis Naples, ITALY 150 EFFECTS OF FENOFIBRATE ON THE CARDIOVASCULAR ALTERATIONS INDUCED BY ISOPROTERENOL TREATMENT FOR ONE WEEK *LE. Fukuda, APC. Davel, V. Lahera, LV. Rossoni Sao Paulo, BRAZIL ,Madrid, SPAIN 151 ABSTRACT WITHDRAWN 152 UPREGULATION AND PHOSPHORYLATION OF ALPHA ENOLASE IN HYPERTROPHIC HEART OF SPONTANEOUSLY HYPERTENSIVE RATS *N. Fang, X. Jin, L. Wang, L. Xia Shanghai, CHINA ,Shanghai, CHINA 32 153 QT/RR RELATIONSHIP IN HYPERTENSIVE PATIENTS WITH AND WITHOUT LEFT VENTRICULAR HYPERTROPHY *M. Facchini, M. Mastantuono, G. Malfatto, L. Lonati, G. Magnaghi Milano, ITALY ,Milano, ITALY ,Milano, ITALY ,Milano, ITALY ,Milano, ITALY 154 ABSTRACT WITHDRAWN 155 LEFT VENTRICULAR LONGITUDINAL SYSTOLIC FUNCTION, ENDOTHELIAL DYSFUNCTION AND CYTOKINES’ LEVELS IN HYPERTENSIVE PATIENTS *E.N. Pavlioukova, T.E. Suslova, R.S. Karpov Tomsk, RUSSIA 156 CORONARY BLOOD FLOW, LONGITUDINAL FUNCTION OF LEFT VENTRICLE AND ENDOTHELIUM-DEPENDENT VASODILATATION OF BRACHIAL ARTERY IN PATIENTS WITH CONCENTRIC LEFT VENTRICULAR HYPERTROPHY *E.N. Pavlioukova, R.S. Karpov Tomsk, RUSSIA 157 LEFT VENTRICULAR LONGITUDINAL FUNCTION IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY REGRESSION *E.N. Pavlioukova, T.A. Bahmetieva, R.S. Karpov Tomsk, RUSSIA 158 THE IMPACT OF ADEQUATE BLOOD PRESSURE CONTROL ON LEFT VENTRICULAR MASS *A. Tsakiris, M. Doumas, N. Nearchou, I. Papadakis, C. Kouremenou, P. Marnelos, K. Flessa, P. Skoufas GREECE 159 CARDIOVASCULAR RISK STRATIFICATION IN UNSELECTED MEDICAL OUTPATIENTS WITH NEWLY DETECTED ARTERIAL HYPERTENSION *T. Dieterle, D. Conen, J.-P. Sigle, G. Bengel, G. Kiefer, E. Battegay, B. Martina Basel, SWITZERLAND 160 ROLE OF ALDOSTERONE IN FUNCTIONAL AND STRUCTURAL CARDIAC ALTERATIONS ASSOCIATED WITH B-ADRENERGIC CHRONIC STIMULATION *B. MARTÍN-FERNÁNDEZ, A.P. COUTO-DAVEL, M. MIANA, N. DE LAS HERAS, D. SANZ, L.V. ROSSONI, V. LAHERA, V. CACHOFEIRO MADRID, SPAIN ,SAO PAULO, BRAZIL 33 161 CHANGES ON MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITORS-1 AND 4 IN PATIENTS WITH SYSTEMIC SCLEROSIS . THE INFLUENCE OF PULMONARY HYPERTENSION. *I. Moyssakis, E. Gialafos, D. Papadopoulos, D. Perea, M. Daskalaki, P. Sfikakis, V. Votteas Athens, GREECE ,Athens, GREECE ,Athens, GREECE 162 ECHOCARDIOGRAPHIC FINDINGS IN WEGENER´S GRANULOMATOSIS. *I. Moyssakis, M. Daskalaki, E. Gialafos, G. Katsifis, G. Vaiopoulos, A. Tziufas, V. Votteas Athens, GREECE ,Athens, GREECE 163 LEFT VENTRICULAR HYPERTROPHY AND CARDIOVASCULAR RISK STRATIFICATION: IMPACT AND COST-EFFECTIVENESS OF ECHOCARDIOGRAPHY IN RECENTLY DIAGNOSED ESSENTIAL HYPERTENSIVES S. Meani, *C. Cuspidi, C. Valerio, V. Fusi, C. Sala, A. Zanchetti Milano, ITALY ,Milano, ITALY ,Milano, ITALY 164 ABNORMAL 24-HOUR BLOOD PRESSURE PROFILE AND LEFT VENTRICULAR GEOMETRY IN PATIENTS WITH MYOTONIC DYSTROPHY *C. CATENA, G.L. COLUSSI, S. BAROSELLI, E. NADALINI, M. NOVELLO, R. LAPENNA, L. VERRIELLO, L. CECCOTTI, V. ADRAGNA, L.A. SECHI ITALY ITALY 165 THE ADDITION OF DOXAZOSINE GITS IN DIABETIC HYPERTENSIVE POPULATION IS ASSOCIATED TO A BETTER REGRESSION OF LEFT VENTRICULAR HYPERTROPHY THAN ATENOLOL A. Calderon, *V. Barrios, JP. Tomas, C. Escobar, MJ. Manzano, E. Moreno, MA. Hernandez-Presa Madrid, SPAIN ,Madrid, SPAIN ,Madrid, SPAIN 166 REGRESSION OF ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY INDUCED BY CANDESARTAN: PREDICTIVE FACTORS. DATA FROM THE SARA STUDY *V. Barrios, A. Calderon, C. Escobar, S. Barrios, LM. Molinero, O. Vegazo, R. Fernandez, E. Asin Madrid, SPAIN ,Madrid, SPAIN ,Madrid, SPAIN ,Madrid, SPAIN 167 ADRENERGIC AND NITROSATIVE IMBALANCE IN PREHYPERTENSIVE MYOCARDIAL HYPERTROPHY. A. CABASSI, *P. PATTONERI, S. VINCI, L. MOSCHINI, F. QUARTIERI, S. DANCELLI, C. LAGRASTA, R. MAESTRI, D. CORRADI, A. BORGHETTI Parma, ITALY ,Parma, ITALY 168 THE POSSIBILITIES OF ORTHOGONAL ELECTROCARDIOGRAM IN DIAGNOSTICS OF LEFT VENTRICULAR HYPERTROPHY T. SAKHNOVA, *E. BLINOVA, A. BOBOKHONOVA, L. SERGAKOVA, D. ATAULLAKHANOVA, F. GADZHAEVA, E. OSCHEPKOVA RUSSIA 34 169 MAPPING OF REPOLARIZATION BY DECARTO TECHNIQUE IN HYPERTENSIVE PATIENTS WITH ELECTROLYTE DISTURBANCES *E. BLINOVA, T. SAKHNOVA, L. TITOMIR, V. TRUNOV, E. AIDU, K. SAMEDOVA, N. CHIKHLADZE, G. LITONOVA, I. CHAZOVA MOSCOW, RUSSIA ,MOSCOW, RUSSIA 170 MODEL OF SPONTANEOUS MYOCARDIAL HYPERTROPHY IN RATS *E. BLINOVA, O. FOMINA, YU. BUDNIKOV, A. POSTNOV MOSCOW, RUSSIA 171 HYPERTENSION BLUNTS THE CARDIOPROTECTIVE EFFECTS OF PRODROMAL ANGINA PECTORIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION *A. Bezrodny, I. Prudkiy Kyiv, UKRAINE 172 PRESENCE OF HYPERTENSION AND CAUSE OF DEATH AFTER 7-YEAR FOLLOW UP IN 505 PATIENTS WITH ACUTE MYOCARDIAL INFARCTION *G. BERTON, R. CORDIANO, R. PALMIERI, S. PETUCCO, GL. GUARNIERI, P. MORMINO, R. DE TONI, P. PALATINI CONEGLIANO, ITALY ,ADRIA, ITALY ,BASSANO, ITALY ,PADOVA, ITALY 173 TRANSIENT AT1 RECEPTOR-INHIBITION IN PRE-HYPERTENSIVE SHR RESULTS IN MAINTAINED CARDIAC PROTECTION UNTIL SENESCENCE *M. Baumann, J.J.R. Hermans, B. Janssen, J.F.M. Smits, H.A.J. Struijker Boudier Maastricht, THE NETHERLANDS 174 THE FACTORS INFLUENCING ON THE ELECTRICAL INSTABILITY IN PATIENTS WITH HYPERTENSION. *TOMASZ. Baron, TOMASZ. Grodzicki Cracow, POLAND 175 AUTONOMIC REGULATION OF PACEMAKER ACTIVITY AND BLOOD PRESSURE: ROLE OF HEART NITRIC OXIDE SYNTHASES *A. Ballaszczuk, A. Fellet, P. Arza, N. Arreche, J. Bustamante, C. Arranz, A. Boveris Buenos Aires, ARGENTINA ,Buenos Aires, ARGENTINA 176 STUDY OF DIASTOLIC FUNCTION DURING SLEEP APNEA SYNDROME. ANALYSIS OF THE EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE *JP. BAGUET, JL. PEPIN, MA. LEBRUN, P. LEVY, H. PIERRE, M. PEETERS, S. MOURET, JM. MALLION GRENOBLE, FRANCE ,GRENOBLE, FRANCE 177 HYPERTENSION AND PRESENCE OF CORONARY ARTERY STENOSIS IN PATIENTS UNDERGOING CARDIAC CATHETERIZATION *JOHANN. Auer, THOMAS. Weber, ROBERT. Berent, GUDRUN. Lamm, ELISABET. Lassnig, BERND. Eber Wels, AUSTRIA ,Bad Schallerbach, AUSTRIA 35 178 DIASTOLIC BLOOD PRESSURE PREDICTS PRESENCE OF CORONARY ARTERY DISEASE IN PATIENTS WITH CHEST PAIN AT REST REFERRED FOR CORONARY ANGIOGRAPHY *JOHANN. Auer, THOMAS. Weber, WALTRAUD. Stainer, GUDRUN. Lamm, ELISABET. Lassnig, BERND. Eber Wels, AUSTRIA 179 RELATIONSHIP BETWEEN DIASTOLIC FUNCTION, CORONARY ARTERY CALCIFICATION AND LEFT VENTRICULAR MASS IN HYPERTENSIVE PATIENTS *N. Kayaturk, S. Altunkan, C. Celik, E. Altunkan Ankara, TURKEY 180 TREATMENT WITH SPIRONOLACTONE 25 MG REDUCES LEFT VENTRICULAR MASS WITHOUT CHANGING BLOOD PRESSURE. *B. Schmidt, T. Kalizki, A. Rastätter, A. Schneider, T. Schwarz, R. Schmieder GERMANY 181 SURVIVIN EXPRESSION IN CARDIAC MYXOMA S-M. Jung, S-J. Chu, *P-H. Chu TAIWAN TAIWAN TAIWAN 182 Z DISC PATHOLOGY IN CYPHER-NULL MICE: A 3D ELECTRON MICROSCOPIC STUDY *P-C. Chu, AK. Thor, J. Chu, ME. Martone TAIWAN USA USA 183 FIVE YEARS FOLLOW-UP OF PATIENTS WITH HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY AND NON-INVASIVE PARAMETERS OF BAD PROGNOSIS *D. Djordjevic, B. Lovic, M. Deljanin Ilic, S. Ilic, I. Tasic Niska Banja, SERBIA - MONTENEGRO 184 ACUTE MYOCARDIAL INFARCTION IN HYPERTENSIVE ELDERLY SUBJECTS *F. D'AMICO PATTI, ITALY 185 PLASMA NEUROPEPTIDE Y AND CATECHOLAMINES CONCENTRATIONS AND LEFT VENTRICULAR MASS IN NON DIPPERS PATIENTS WITH ESSENTIAL HYPERTENSION. *JACEK. Lewandowski, AGNIESZK. Kuch-Wocial, MARIUSZ. Lapinski Warsaw, POLAND 186 LEFT VENTRICULAR REMODELING IN DIPPERS AND NON DIPPERS PATIENTS WITH ESSENTIAL HYPERTENSION. *AGNIESZK. Kuch-Wocial, JACEK. Lewandowski, MARIUSZ. Lapinski, BARTOSZ. Symonides Warsaw, POLAND 36 187 ENDOTHELIN – 1AND NEUROPEPTIDE Y MAY INFLUENCE LEFT VENTRICULAR HYPERTROPHY IN NON-DIPPER PATIENTS WITH ESSENTIAL HYPERTENSION. *MARIUSZ. Lapinski, AGNIESZK. Kuch-Wocial, JACEK. Lewandowski Warsaw, POLAND 188 MARKERS OF INFLAMMATION IN AGEING AND HYPERTENSIVE HEART *R. A. F. Oliveira, A. P. C. Davel, M. Miana, D. Sanz-Rosa, V. Cachofeiro, L. V. Rossoni, V. Lahera Madrid, SPAIN ,São Paulo, BRAZIL 189 ST segment depression during recovery time of exercise testing and angiographic findings in patients with coronary artery disease *J. Pavlovska, B. Taneva, O. Kalpak, I. Peovska, E. Lazarevska Skopje, R.of Macedonia 37 12:30 - 15:30 Hall 10 190 P03 Large Arteries Poster Session INFLUENCE OF EPROSARTAN ON PULSE PRESSURE, AUGMENTATION-INDEX, PULSE WAVE VELOCITY AND LEFT VENTRICULAR MASS INDEX IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION *S. Sock, S. Perl, T. Weber, E. Kvas, R. Zweiker Styria, AUSTRIA ,Upper Austria, AUSTRIA 191 ARTERIAL STIFFNESS IS RELATED TO AUGMENTED SEOSONALVARIATION OF BLOOD PRESSURE IN HYPERTENSIVE PATIENTS *J.C. Youn, S.J. Rim, S.H. Park, Y.G. Ko, S.M. Kang, J.W. Ha, Y.S. Jang, N.S. Chung Seoul, SOUTH KOREA 192 RELATION OF BLOOD PRESSURE VARIABILITY WITH ARTERIAL WALL CHARACTERISTICS *W. Wojciechowska, M. Cwynar, K. Stolarz, A. Olszanecka, T. Grodzicki, K. Kawecka-Jaszcz Cracow, POLAND ,Cracow, POLAND 193 THE EFFECT OF QUINAPRIL ON BLOOD VISCOSITY AND PULSE WAVE VELOCITYINITIAL RESULTS *M. Rajzer, W. Wojciechowska, M. Klocek, K. Kawecka-Jaszcz Cracow, POLAND 194 RELATIONSHIP BETWEEN INDICES OF ARTERIAL STIFFNESS, BLOOD PRESSURE, BLOOD VISCOSITY AND SHEAR STRESS *M. Rajzer, W. Wojciechowska, L. Bryniarski, K. Kawecka-Jaszcz Cracow, POLAND 195 UNSTIMULATED AUGMENTATION INDEX IS RELATED TO ENDOTHELIAL DYSFUNCTION IN PATIENTS UP TO 60 YEARS OF AGE *THOMAS. Weber, RENKE. Maas, JOHANN. Auer, GUDRUN. Lamm, E. Lassnig, RAINER. Böger, MICHAEL. O´Rourke, BERND. Eber Wels, AUSTRIA ,Hamburg, GERMANY ,Sydney, AUSTRALIA 196 LACK OF AGE-RELATED INCREASE OF AUGMENTATION INDEX IN MEN WITH ESTABLISHED CORONARY ARTERY DISEASE *THOMAS. Weber, JOHANN. Auer, MICHAEL. O´Rourke, ELISABET. Lassnig, GUDRUN. Lamm, BERND. Eber Wels, AUSTRIA ,Sydney, AUSTRALIA 38 197 ISOLATED SYSTOLIC HYPERTENSION IS CHARACTERISED BY INCREASED AORTIC STIFFNESS AND ENDOTHELIAL DYSFUNCTION. *SHARON. WALLACE, YASMIN. YASMIN, KAISA. MAKI-PETAJA, ANTHONY. BOOTH, CARMEL. MCENIERY, JOHN. BROWN, IAN. WILKINSON Cambridge, UNITED KINGDOM ,Cambridge, UNITED KINGDOM 198 AORTIC STIFFNESS IN RELATION TO ERECTILE DYSFUNCTION IN PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE *C. Vlachopoulos, N. Ioakeimidis, K. Rokkas, K. Aznaouridis, I. Dima, A. Tsokanis, A. Askitis, C. Stefanadis Athens, GREECE 199 COFFEE CONSUMPTION IS ASSOCIATED WITH ENHANCED WAVE REFLECTIONS IN HYPERTENSIVE PATIENTS N. Alexopoulos, G. Vyssoulis, *C. Vlachopoulos, A. Zervoudaki, P. Pietri, G. Antonakoudis, K. Aznaouridis, C. Stefanadis Athens, GREECE 200 PLASMA FIBRINOGEN IS A MARKER OF AORTIC STIFFNESS IN SMOKER HYPERTENSIVES K. Aznaouridis, *C. Vlachopoulos, G. Vyssoulis, P. Pietri, A. Zervoudaki, S. Kyvelou, C. Stefanadis Athens, GREECE 201 SHORT-TERM DAILY ADMINISTRATION OF L-ARGININE IMPROVES AORTIC ELASTIC PROPERTIES AND WAVE REFLECTIONS IN HEALTHY SMOKERS G. Siasos, *C. Vlachopoulos, N. Ioakeimidis, I. Andreou, N. Alexopoulos, A. Baou, D. Tousoulis, C. Stefanadis Athens, GREECE 202 EVALUATION OF ARTERIAL DISTENSIBILITY IN HYPERTENSIVE PATIENTS TREATED WITH IRBESARTAN *A. VICENTE CASANOVA, J. AZNAR VICENTE, J. REDON MAS VALENCIA, SPAIN ,ALICANTE, SPAIN ,VALENCIA, SPAIN 203 VALIDATION OF A NOVEL AUTOMATED IMT DETECTION ALGORITHM *S. Vermeersch, E. Rietzschel, M. De Buyzere, T. Gillebert, P. Verdonck, P. Segers Ghent University, Ghent, BELGIUM ,Ghent University, Ghent, BELGIUM 204 VALUE OF CHEST X-RAY STUDY AND MRI IN PATIENTS WITH ARTERIAL HYPERTENSION AND MARFAN`S SYNDROME I. Korobkova, *O. Belichenko, V. Lazutkina, D. Ustyuzhanin, S. Shahvorostova, S. Guryakov Moscow, RUSSIA 205 ARTERIAL STIFFNESS IS CORRELATED WITH SERUM URIC ACID BUT NOT C-REACTIVE PROTEIN IN ESSENTIAL HYPERTENSION *WC. Tsai, CC. Lin, WT. Li, CH. Lee, JH. Chen Dou-Liou, TAIWAN ,Tainan, TAIWAN 39 206 LARGE ARTERIES ARE ALREADY ALTERED IN PATIENTS WITH NEWLY DIAGNOSED ESSENTIAL HYPERTENSION *C.A. SZMIGIELSKI, M. RACZKOWSKA, G. STYCZYNSKI, P. PRUSZCZYK, Z. GACIONG WARSAW, POLAND 207 ACUTE REDUCTION OF BLOOD PRESSURE DOES NOT NORMALISE LARGE ARTERY STIFFNESS IN ESSENTIAL HYPERTENSION *A.D. Stewart, B. Jiang, S.C. Millasseau, J.M. Ritter, P.J. Chowienczyk London, UNITED KINGDOM 208 CORRELATIONS OF ARTERIAL PARAMETERS AND LIPIDS IN POSTMENOPAUSAL WOMEN *A. Starodubova, G. Storozhakov, O. Kisliak, A. Kopelev Moscow, RUSSIA 209 CLINICAL MANIFESTATION AND DUPLEX SONOGRAPHIC FINDINGS IN TAKAYASU'S ARTERITIS PATIENTS WITH AORTIC ARCH SYNDROME *O.A. Sivakova, N.M. Chikhladze, T.V. Balakhonova, D.E. Gusev, G.V. Kharlap, I.YE. Chazova Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA 210 RELATIONSHIP BETWEEN STRUCTURAL CHANGES OF LARGE ARTERY AND ECHOCARDIOGRAPHIC PARAMETERS AND THE STATE OF PERIPHERAL CIRCULATION IN PATIENTS WITH ESSENTIAL HYPERTENSION *I. SHKURAT KYIV, UKRAINE 211 LATE SYSTOLIC BLOOD PRESSURE MEASUREMENT IS USEFUL FOR ATHEROSCLEROSIS ASSESSMENT *K. Takeda, S. Harada, J. Moriguchi, Y. Tada, N. Shinomiya, T. Kobayashi, Y. Miyawaki Kyoto, JAPAN ,Kyoto, JAPAN 212 ABSTRACT WITHDRAWN 213 ABSTRACT WITHDRAWN 214 ELASTIC AND MUSCULAR ARTERIES STIFFNESS AND INFLUENCE OF LOSARTAN VS AMLODIPINE IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION *G.D. Radchenko, YU.N. Sirenko, S.M. Kushnir, J.V. Kudina Kyiv, UKRAINE 215 EVALUATION OF INTRA-RENAL BLOOD FLOW PARAMETERS IN HYPERTENSIVE PATIENTS AFTER SURGICAL REPAIR OF TYPE A AORTIC DISSECTION. I. Michalowska, H. Janaszek-Sitkowska, M. Januszewicz, A. Biederman, M. Peczkowska, *A. Januszewicz, M. Kabat Warsaw, POLAND ,Warsaw, POLAND 216 ARTERIAL STIFFNESS IN ADULTS IS RELATED TO SALT INTAKE *J. Maldonado, M. Duro, C. Almeida, S. Bertoquini, L. Martins, J. Polonia 40 Porto, PORTUGAL ,Porto, PORTUGAL 217 IMPROVEMENT OF AORTIC REFLECTION WAVE RESPONSES SHORTLY AFTER STOPING SMOKING. A PROSPECTIVE STUDY *J. Polonia, L. Barbosa, J A. Silva, M. Rosas Matosinhos, PORTUGAL 218 CHANGE IN QKD WITH AGE: COMPARISON OF YOUNGER AND OLDER POPULATIONS *E. Pinto, CJ. Bulpitt, W. Banya, N. Beckett, R. Peters, E. Lim, J. Staessen, J. Kooner, C. Rajkumar, HYVET investigators, LOLLIPOP investigators London, UNITED KINGDOM ,London, UNITED KINGDOM ,Leuven, BELGIUM ,Brighton, UNITED KINGDOM 219 ARTERIAL STIFFNESS MODULATION WITH INTENSIVE COMPETITIVE TRAINING *J. Maldonado, T. Pereira, J. Polonia, L. Martins PORTUGAL ,Porto, PORTUGAL 220 ASSESSING THE RELATION BETWEEN SEVERITY OF CORONARY ARTERY DISEASE AND ARTERIAL STIFFNESS INDEX *M. MORADI, B. NAGHSHTABRIZI, F. EMAMI HAMEDAN, IRAN ,HAMEDAN, IRAN ,HAMEDAN, IRAN 221 THE INFLUENCE OF REGULAR EXERCISE ON PULSE PRESSURE AND ARTERIAL STIFFNESS *B. MCDONNELL, R. STAINSBY, KM. PETAJA, JR. COCKCROFT, IB. WILKINSON, CM. MCENEIRY CARDIFF, UNITED KINGDOM ,CAMBRIDGE, UNITED KINGDOM 222 ABSTRACT WITHDRAWN 223 VASCULAR EFEFCTS OF DOXAZOSIN IN ESSENTIAL HYPERTENSION *AZRA. Mahmud, JOHN. Feely 1, IRELAND ,1, IRELAND 224 ADVANCED GLYCATION END PRODUCTS AND ARTERIAL STIFFNESS IN HYPERTENSION *AZRA. Mahmud, MARIE. McNulty, JOHN. Feely 1, IRELAND ,1, ,1, 225 INTRAAORTIC PULSATILITY IS BETTER PREDICTOR OF EVENT-FREE SURVIVAL WHEN COMPARED WITH SYSTOLIC, DIASTOLIC, MEAN AND PULSE PRESSURES. THE AORTIC BLOOD PRESSURE AND SURVIVAL STUDY P. JANKOWSKI, D. CZARNECKA, *M. LOSTER, A. CURYLO, M. BRZOZOWSKA-KISZKA, K. STYCZKIEWICZ, M. KLOCH, E. KOPACZ, J. WILINSKI, K. KAWECKA-JASZCZ KRAKOW, POLAND 226 LARGE ARTERIES DAMAGE AND BLOOD FLOW VELOCTY IN MIDDLE CEREBRAL ARTERY. *A. Kwater, A. Salakowski, B. Wizner, T. Grodzicki 41 Cracow, POLAND 227 C-REACTIVE PROTEIN AND AORTIC STIFFNESS IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES *M. Klocek, K. Kawecka-Jaszcz Krakow, POLAND 228 THE EFFECT OF SMOKING ON ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS *M. Melek, C. Kilit, G. Ozkececi, A. Avsar, E. Onrat, A. Celik Afyonkarahisar, TURKEY 229 IS THERE ANY RELATION BETWEEN NOCTURNAL BLOOD PRESSURE FALLING AND ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS? *M. Melek, C. Kilit, G. Ozkececi, A. Avsar, E. Onrat, A. Celik Afyonkarahisar, TURKEY 230 ARTERIAL STIFFNESS IN CENTENARIANS IS SIMILAR TO THAT OBSERVED IN YOUNGER POPULATIONS *T. Jachymczyk, A. Klich-Raczka, J. Zyczkowska, T. Grodzicki Cracow, POLAND 231 AMBULATORY ARTERIAL STIFFNESS INDEX (AASI) PREDICTS STROKE IN A GENERAL POPULATION *T.W. HANSEN, J.A. STAESSEN, C. TORP-PEDERSEN, S. RASMUSSEN, Y. LI, E. DOLAN, L. THIJS, J.G. WANG, E. O'BRIAN, H. IBSEN, J. JEPPESEN COPENHAGEN, DENMARK ,LEUVEN, BELGIUM ,COPENHAGEN, DENMARK ,COPENHAGEN, DENMARK ,SHANGHAI, CHINA ,DUBLIN, IRELAND 232 LONG TERM EVOLUTION OF ARTERIAL STIFFNESS ON ANTIHYPERTENSIVE TREATMENT *P. Gosse, Y. Papaioanou, S. Reuter, P. Dubiez, P. Lemetayer Bordeaux, FRANCE 233 NUCLEAR MAGNETIC RESONANCE EVALUATION OF AORTIC DISTENSIBILITY S. MAESTRONI, E. FANTINI, F. BIANCHI, L. VISCARDI, M. RIGOLDI, E. MONTEMERLO, F. ZERBONI, S. SIRONI, M. FAILLA, *C. GIANNATTASIO, G. MANCIA MONZA-MI, ITALY ,MONZA -MI, ITALY ,MILANO, ITALY ,MILANO, ITALY 234 RELATIONSHIP BETWEEN MEASUREMENTS OF PULSE WAVE ANALYSIS AND FLOW MEDIATED DILATION IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS *L. GHIADONI, Y. PLANTINGA, A. MAGAGNA, F. BORES, S. TADDEI, A. SALVETTI ITALY 235 THE RELATIONSHIP OF ANGIOTENSINE II RECEPTOR POLYMORPHISM WITH STIFFNESS OF AORTA AND ARTERIES OF LOWER EXTREMITY *J. Filipovsky, O. Mayer, M. Pesta, J. Kucerova, M. Dolejsova Pilsen, CZECH REPUBLIC 42 236 THE IMPACT OF ADEQUATE BLOOD PRESSURE CONTROL ON ANKLE-BRANCHIAL INDEX *A. Tsakiris, M. Doumas, N. Nearchou, C. Kouremenou, I. Papadakis, P. Marnelos, V. Nikolaou, P. Skoufas GREECE 237 DETERMINANTS OF VASCULAR STIFFNESS IN PATIENTS WITH ADVANCED CARDIOVASCULAR DISEASE: COMPARISON OF FOUR DIFFERENT METHODS INCLUDING MAGNETIC RESONANCE IMAGING (MRI) *C. Delles, LU. Zimmerli, GA. Berg, T. Steedman, HJ. Dargie, AF. Dominiczak University of Glasgow, UNITED KINGDOM ,Western Infirmary Glasgow, UNITED KINGDOM ,University of Glasgow, UNITED KINGDOM 238 AORTIC DISTENSIBILITY IN PRIMARY AMYLOIDOSIS. THE CONTRIBUTION OF CARDIAC INVOLVEMENT. *I. Moyssakis, E. Gialafos, M. Daskalaki, L. Nanis, V. Kikilias, D. Drosos, V. Votteas Athens, GREECE 239 CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR RISK STRATIFICATION: ROLE AND COST-EFFECTIVENESS OF ECHO-DOPPLER EXAMINATION IN UNTREATED ESSENTIAL HYPERTENSIVES *C. Cuspidi, S. Meani, C. Valerio, V. Fusi, C. Sala, A. Zanchetti Milano, ITALY ,Milano, ITALY ,Milano, ITALY 240 CONTRIBUTION OF ENDOTHELINS TO MODULATION OF VASCULAR RESPONSES IN HIGH- AND LOW-PRESSURE CIRCULATORY SYSTEM OF NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS *S. Cacanyiova, J. Torok Bratislava, SLOVAK REPUBLIC 241 HOMOCYSTEIN LEVEL AND EARLY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE *PIERRE. Boutouyrie, MARIE. Briet, ERWAN. Bozec, JÉRÔME. Rossert, MARC. Froissart, PASCAL. Houillier, CHRISTIA. Jacquot, STÉPHANE. Laurent Paris, FRANCE ,Paris, FRANCE ,Paris, FRANCE 242 IMPROVEMENT OF CAROTID INTIMA MEDIA THICKNESS REPRODUCIBILITY BY CORE-LAB READING: THE CASHMERE STUDY AND GAMETE NETWORK *PIERRE. Boutouyrie, ANNA. Kearney-Schwartz, ROBINSON. Joannides, BRUNO. Pannier, BRUNO. Pornel, KRISTIAN. Kunz, ELISABET. Balkestein, WOUTER. Van den Abeele, TABASSOM. Simon Paris, FRANCE ,Paris, FRANCE ,Rouen, FRANCE ,Fleury, FRANCE ,Nancy, FRANCE ,Strasbourg, FRANCE ,Maastricht, THE NETHERLANDS ,Ghent, BELGIUM ,Bruxelles, BELGIUM 243 AGE RELATED CHANGE IN ARTERIAL PROPERTIES ALONG THE UPPER ARM *C.N:. Bjarnegård, T. Länne Jönköping, SWEDEN ,Linköping, SWEDEN 244 THE RELATIONSHIP BETWEEN CAROTID INTIMA-MEDIA THICKNESS AND LIPID PROFILES IN HEALTHY MALES WITH HYPERCHOLESTEROLAEMIA *E. Swierblewska, K. Kunicka, H. Swiatek, J. Neubauer-Geryk, P. Kruszewski, E. Miszkowska, E. Drzazga, L. Bieniaszewski, B. Wyrzykowski Gdansk, POLAND ,Gdansk, POLAND 43 245 THE RELATIONSHIP BETWEEN CLASSIC RISK FACTORS AND DIFFRENT INDICES OF COMMON CAROTID INTIMA-MEDIA COMPLEX IN HEALTHY MALES *K. Kunicka, E. Swierblewska, H. Swiatek, P. Kruszewski, J. Neubauer-Geryk, E. Miszkowska, E. Drzazga, L. Bieniaszewski, B. Wyrzykowski Gdansk, POLAND ,Gdansk, POLAND 246 ASSESSMENT OF ARTERIAL STRUCTURAL STIFFNESS BY ISCHAEMIA-INDUCED REACTIVE HYPERAEMIA IN THE HUMAN ARM M. Butlin, EH. Davidson, S. Wallace, K. Maki-Petaja, *A. Avolio, C. McEniery, IB. Wilkinson Sydney, NSW, AUSTRALIA ,Cambridge, UNITED KINGDOM 247 CAROTID WALL ENERGETICS IN HUMAN HYPERTENSION: DIFFERENTIAL EFFECTS OF ACE INHIBITOR AND CALCIUM ANTAGONIST *RL. Armentano, JG. Barra, S. Graf, FM. Pessana, D. Craiem, L. Brandani, HP. Baglivo, RA. Sanchez Buenos Aires, ARGENTINA ,Buenos Aires, ARGENTINA 248 ELDERLY HYPERTENSIVE PATIENTS: THE IMPORTANCE OF THE SCREENING OF ABDOMINAL AORTIC ANEURYSM DURING TRANSTHORACIC ECHOCARDIOGRAPHY *M. ANGHEL BUCHAREST, ROMANIA 249 ASSOCIATION BETWEEN HIGH CRP LEVELS AND LACK OF PULSE PRESSURE AMPLIFICATION IN PATIENTS AT CORONARY RISK MEYER. ELBAZ, CYRIL. VIENET, RIZZLAN. CHERRADI, BERNARD. CHAMONTIN, JACQUES. PUEL, DIDIER. CARRIE, MICHEL. SAFAR, *JACQUES. AMAT CHU Toulouse, FRANCE ,Faculté de Médecine Toulouse, FRANCE ,Hôtel Dieu Paris, FRANCE 250 LIFESTYLE MODIFICATION, ARTERIAL STRUCTURE AND ITS FUNCTION IN THOSE WHO HAVE A PRE-CLINICAL CARDIOVASCULAR DISEASE RISK FACTOR *K. Aizawa, J.K. Shoemaker, P.J. Petrella London, ON,, CANADA 251 ABSTRACT WITHDRAWN 252 CALCIUM SCORES RELATED TO MATRIX GLA PROTEIN AND VITAMIN K STATUS IN HYPERTENSIVE HUMANS *R. Rennenberg, A. Kroon, L. Schurgers, C. Vermeer, J. van Engelshoven, G. Kemerink, P. de Leeuw Maastricht, THE NETHERLANDS ,Maastricht, THE NETHERLANDS ,Maastricht, THE NETHERLANDS 253 RELATIONSHIP BETWEEN LONG PENTRAXINE PTX-3 AND CAROTID PLAQUE IN A GROUP OF HYPERTENSIVE PATIENTS *LM. Lonati, G. Magnaghi, PL. Meroni, C. Cruini, G. Peri, A. Mantovani, G. Leonetti, G. Parati Milan, ITALY ,University of Milan, ITALY ,University of Milan, ITALY ,University Milan-Bicocca, ITALY 254 RELATIONSHIP BETWEEN SERUM HOMOCYSTEINE AND AORTIC ROOT DIAMETER IN ESSENTIAL HYPERTENSIVE PATIENTS *G. Magnaghi, LM. Lonati, A. Giglio, G. Leonetti, G. Parati Milan, ITALY ,Univ. Milan-Bicocca, ITALY 44 12:30 - 15:30 Hall 10 256 P04 Clinical Trials Poster Session THE EFFECT OF PLASMA ADRENALINE ON THE PULSE WAVE VELOCITY IN THE NORMOTENSIVE VOLUNTEERS, COMPARED WITH THE HYPERTENSIVE PATIENTS *K. Yamada, S. Iino, T. Tanaka, M. Yoshikane, N. Ikeda, T. Kondo, H. Izawa, T. Murohara Kani, JAPAN ,Nagoya, JAPAN ,Nagoya, JAPAN 257 I1-IMIDAZOLINE ANTIHYPERTENSIVE COMPARED TO CALCIUM CHANNEL BLOCKER IN THE MANAGEMENT OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME X - THE MATRIX STUDY *J. Widimsky jun, J. Sirotiakova Prague, CZECH REPUBLIC ,Nitra, SLOVAK REPUBLIC 258 ACHIEVEMENT OF TREATMENT-GOALS IN THE MASTERPLAN-COHORT *A. van Zuilen, P. Blankestijn, M. Bots, J. Wetzels Utrecht, ,Nijmegen, 259 ACHIEVEMENT OF TREATMENT-GOALS IN PATIENTS WITH CHRONIC KIDNEY DISEASE *A. van Zuilen, P. Blankestijn, M. Bots, J. Wetzels, AND THE. MASTERPLAN studygroup Utrecht, THE NETHERLANDS ,Nijmegen, THE NETHERLANDS THE NETHERLANDS 260 EFFECT OF RIMONABANT ON SYSTOLIC AND DIASTOLIC BLOOD PRESSURE IN OVERWEIGHT/OBESE PATIENTS WITH/WITHOUT CO-MORBIDITIES *L. Van Gaal, A. Scheen, J-P. Després, FX. Pi-Sunyer, A. Rissanen, A. Golay Edegem-Antwerp, BELGIUM ,Liège, BELGIUM ,Québec, CANADA ,New York, USA ,Helsinki, FINLAND ,Geneva, SWITZERLAND 261 PRETREATMENT SERUM CALCIUM LEVELS ARE NEGATIVELY CORRELATED TO THE ANTIHYPERTENSIVE EFFECT OF AMLODIPINE: RESULTS FROM THE GENRES STUDY *T. Suonsyrjä, T.P. Hiltunen, T. Hannila-Handelberg, K. Kontula Helsinki, FINLAND 262 OLMEBEST-STUDY: REDUCTION OF BLOOD PRESSURE IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION - INTERIMS ANALYSIS OF THE ITALIAN SUB STUDY A. Boccanelli, *S. Ewald, M. Böhm Roma, ITALY ,München, GERMANY ,Homburg, GERMANY 263 OLMEBEST-STUDY: REDUCTION OF BLOOD PRESSURE IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION - INTERIMS ANALYSIS OF THE SPANISH SUB STUDY J.L. Rodicio, V. Barrios, *S. Ewald, M. Böhm Madrid, SPAIN ,Madrid, SPAIN ,München, GERMANY ,Homburg, GERMANY 45 264 ANTIHYPERTENSIVES AND CONGESTIVE HEART FAILURE: META-ANALYSIS OF STUDIES PUBLISHED UNTIL 1 JANUARY 2005 *HM. STEFFEN, M. HELLMICH, W. LEHMACHER, TD. WERXHAUSEN, R. GRIEBENOW UNIVERSITY OF COLOGNE, KOELN, GERMANY ,UNIVERSITY OF COLOGNE, KOELN, GERMANY ,UNIVERSITY OF COLOGNE, KOELN, GERMANY ,UNIVERSITY OF COLOGNE, KOELN, GERMANY ,UNIVERSITY OF COLOGNE, KOELN, GERMANY 265 ANTIHYPERTENSIVE EFFICACY OF VALSARTAN AND VALSARTAN/HCTZ IN ELDERLY HYPERTENSIVES: EXPLORATORY ANALYSES OF NINE CLINICAL TRIALS *M. Weir, N. Aknay, D. Purkayastha, YT. Chiang, V. Kuturu, R. Glazer, R. Rocha Maryland, USA ,New Jersey, USA 267 CONTROLLED RELEASE NIFEDIPINE AND VALSARTAN COMBINATION THERAPY IN PATIENTS WITH ESSENTIAL HYPERTENSION -ADVANCE COMBI STUDY*I. Saito, K. Fujikawa, T. Saruta Yokohama, JAPAN ,Osaka, JAPAN ,Tokyo, JAPAN 268 ADDING ALISKIREN TO RAMIPRIL IMPROVES 24-HOUR BLOOD PRESSURE CONTROL COMPARED TO RAMIPRIL ALONE IN PATIENTS WITH DIABETES AND HYPERTENSION D. TSCHOPE, *A. TAYLOR, C. KILO, G. IBRAM, H. FANG, A. SATLIN 32545 BAD OEYNHAUSEN, GERMANY ,TEXAS, USA ,SUITE 120, ST LOUIS, MISSOURI, USA ,NEW JERSEY, USA 269 ALISKIREN, A NOVEL RENIN INHIBITOR, HAS GREATER BP LOWERING THAN RAMIPRIL AND ADDITIONAL BP LOWERING WHEN COMBINED WITH RAMIPRIL IN PATIENTS WITH DIABETES AND HYPERTENSION *Y. URESIN, A. TAYLOR, C. KILO, D. TSCHOPE, M. SANTONASTASO, G. IBRAM, H. FANG, A. SATLIN ISTANBUL, TURKEY ,TEXAS, USA ,SUITE 120, ST LOUIS, MISSOURI, USA ,32545 BAD OEYNHAUSEN, GERMANY ,VITTORIO VENETO, ITALY ,NEW JERSEY, USA 270 USING FIXED COMBINATION LISINIPRIL/HYDROCHLOROTHIAZIDE IN THE HYPERTENSIVE PATIENTS AT INSUFFICIENCY EFFICIENCY OF MONOTHERAPY BY LISINIPRIL *L. Ratova, I. Chazova Moscow, RUSSIA 271 FAVOURABLE SAFETY AND TOLERABILITY PROFILE OF COADMINISTERED AMLODIPINE AND ATORVASTATIN IN PATIENTS WITH CONCOMITANT HYPERTENSION AND DYSLIPIDEMIA: RESULTS FROM THE RESPOND TRIAL *R.A. Preston, J.W. Jukema, P. Harvey, F. Sun, L. Tarasenko Miami, FL,, USA ,Leiden,, THE NETHERLANDS ,Addlestone, Surrey,, UNITED KINGDOM ,New York, NY,, USA 272 BODY MASS INDEX(BMI), SMOKING, DRINKING ALCOHOL AND CHOLESTEROL IN EUROPEAN AND CHINESE VERY ELDERLY HYPERTENSIVES *R. Peters, N. Beckett, L. Liu, D. Dumitrascu, T. McCormack, E. Pinto, A. Fletcher, C. Bulpitt, BEHALF. of HYVET investigators London, UNITED KINGDOM ,Beijing, CHINA ,Cluj, ROMANIA ,Whitby, UNITED KINGDOM ,London, UNITED KINGDOM 273 EFFICACY AND SAFETY OF CANDESARTAN CILEXETIL IN ELDERLY HYPERTENSIVE PATIENTS UNCONTROLLED WITH MONOTHERAPY OR UNTREATED. THE CHANCE STUDY *R. ASMAR, S. NISSE-DURGEAT Paris, FRANCE ,Puteaux, FRANCE 46 274 ROSIGLITAZONE VS. PLACEBO RANDOMISED TREATMENT REDUCES AMBULATORY AND OFFICE BLOOD PRESSURE AFTER ONE-YEAR IN SUBJECTS WITH INSULIN RESISTANCE *PM. Nilsson, B. Hedblad, A. Zambanini, G. Berglund Malmö, SWEDEN ,Greenford, UNITED KINGDOM 275 CARVEDILOL IN THERAPY OF POSTMENOPAUSAL HYPERTENSIVE WOMEN *K.G. NIKOGHOSYAN, S.V. GURGENYAN, S.KH. VATINYAN YEREVAN, ARMENIA ,YEREVAN, ARMENIA ,YEREVAN, ARMENIA 276 THE USE OF AMEALPEPTIDE IN THE TREATMENT OF PATIENTS WITH STAGE I AND STAGE II HYPERTENSION - DATA FROM THE AHEAD STUDY *JM. NEUTEL, M. NONAKA, S. HENDLER, MA. WEBER TUSTIN, CA, USA 277 THE COMBINATION OF TRANDOLAPRIL WITH VERAPAMIL REDUCES SNS ACTIVITY IN HYPERTENSIVE PATIENTS AS COMPARED TO A COMBINATION OF RAMIPRIL AND FELODIPINE *A. Mitchell, C. Jürgens, U. Rushentsova, H.-W. Müller, T. Philipp, R.R. Wenzel Essen, GERMANY ,Wiesbaden, GERMANY ,Zell am See, AUSTRIA 278 ASSESSMENT OF PATIENTS AND PHYSICIANS COMPLIANCE TO AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR TREATMENT BASED ON URINARY ACSDKP DETERMINATION IN A LARGE PLACEBO-CONTROLLED TRIAL *M. AZIZI, J. MENARD, S. PEYRARD, M. LIEVRE, M. MARRE, G. CHATELLIER Paris, FRANCE ,Paris, FRANCE ,Paris, FRANCE ,Lyon, FRANCE ,Paris, FRANCE ,Paris, FRANCE 279 SMALL ARTERY STRUCTURE ADAPTS TO VASODILATION RATHER THAN TO BLOOD PRESSURE DURING ANTIHYPERTENSIVE TREATMENT. *ON. Mathiassen, NH. Buus, ML. Larsen, MJ. Mulvany, KL. Christensen Aarhus, DENMARK ,Aarhus, DENMARK ,Aarhus, DENMARK 281 DARUSENTAN TREATMENT SIGNIFICANTLY IMPROVES SYSTOLIC BLOOD PRESSURE CONTROL IN PATIENTS WITH RESISTANT HYPERTENSION *G.L. BAKRIS, M.A. WEBER, S.L. LINAS, J.V. LINSEMAN, M.S. WARREN, B.L. WIENS, H.R. BLACK CHICAGO, IL, USA ,BROOKLYN, NY, USA ,DENVER, CO, USA ,WESTMINSTER, CO, USA 282 PROJECTED CARDIOVASCULAR RISK DECREASE IN HYPERTENSIVE PATIENTS WITH ANTIHYPERTENSIVE THERAPY IN PROLOG STUDY *S.A. Shalnova, S.Y. Martsevich, A.D. Deev, N.P. Kutishenko, R.G. Oganov Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA ,Moscow, RUSSIA 283 EFFECT OF THE LISINOPRIL ON 24-H BLOOD PRESSURE PROFILE AND LEFT VENTRICULAR REMODELING IN PATIENTS WITH ESSENTIAL HYPERTENSION *O. Kolokolnikova, O. Drapkina, V. Ivashkin MOSCOW, RUSSIA 47 284 DYNAMIC OF PARAMETERS 24-HOURS BLOOD PRESSURE MONITORING AND PARAMETERS OF BLOODSTREAM VELOCITY IN CEREBRAL ARTERIES UNDER INDAPAMIDE OR ENALAPRIL THERAPY IN HYPERTENSIVE PATIENTS *M. Kolodina, R. Karpov, A. Sokolov, E. Kosmacheva, I. Shelestova Krasnodar, RUSSIA ,Tomsk, RUSSIA 285 DECREASE IN PLASMA ADIPONECTIN CONCENTRATIONS WITH INCREASE IN PULSE WAVE VELOCITY IN PATIENTS WITH VASOSPASTIC ANGINA PECTORIS *C.G. PARK, S.J. HONG SEOUL, SOUTH KOREA 286 ALPHA-ADDUCIN, AGT, ACE AND AGTR1 GENE POLYMORPHISMS AS PREDICTORS OF ANTIHYPERTENSIVE EFFECTS OF AMLODIPINE, BISOPROLOL, HYDROCHLOROTHIAZIDE AND LOSARTAN IN HYPERTENSIVE MALES *T.P. Hiltunen, T. Suonsyrjä, T. Hannila-Handelberg, H. Fodstad, H.E. Miettinen, K.J. Paavonen, K. Kontula Helsinki, FINLAND 287 COMPARATIVE EFFECTS OF NEBIVOLOL ON AMBULATORY BLOOD PRESSURE IN HYPERTENSIVE MEN AND WOMEN *DE. AYALA, RC. HERMIDA, C. CALVO, L. CHAYAN, M. RODRIGUEZ, JE. LOPEZ, A. MOJON, I. ALONSO, MJ. FONTAO, R. SOLER, JR. FERNANDEZ Vigo, SPAIN ,Santago, SPAIN 288 ADMINISTRATION TIME-DEPENDENT EFFECTS OF SPIRAPRIL ON AMBULATORY PULSE PRESSURE IN PATIENTS WITH ESSENTIAL HYPERTENSION C. CALVO, *RC. HERMIDA, DE. AYALA, M. RODRIGUEZ, L. CHAYAN, JE. LOPEZ SANTIAGO, SPAIN ,VIGO, SPAIN 289 CHRONOTHERAPY WITH TORASEMIDE IN HYPERTENSIVE PATIENTS: INCREASED EFFICACY AND THERAPEUTIC COVERAGE WITH BEDTIME AS COMPARED TO MORNING ADMINISTRATION *RC. HERMIDA, C. CALVO, DE. AYALA, L. CHAYAN, M. RODRIGUEZ, JE. LOPEZ VIGO, SPAIN ,SANTIAGO, SPAIN 290 THE EFFICACY OF NEBIVOLOL EVALUATED BY AMBULATORY BLOOD PRESSURE MONITORING IS NOT ATTENUATED BY CIGARETTE SMOKING *C. CALVO, RC. HERMIDA, DE. AYALA, M. RODRIGUEZ, L. CHAYAN, JE. LOPEZ, MJ. FONTAO, RAMON. SOLER SANTIAGO, SPAIN ,Vigo, SPAIN 291 CHRONOTHERAPY IN RESISTANT HYPERTENSION: IMPROVEMENT OF RENAL FUNCTION BY INCREASING THE DAY/NIGHT BLOOD PRESSURE RATIO *RC. HERMIDA, C. CALVO, DE. AYALA, L. CHAYAN, M. RODRIGUEZ, JE. LOPEZ, A. MOJON, MJ. FONTAO, R. SOLER, JR. FERNANDEZ VIGO, SPAIN ,SANTIAGO, SPAIN 292 GENDER AND ADMINISTRATION-TIME DEPENDENT EFFECTS OF AMLODIPINE ON AMBULATORY BLOOD PRESSURE IN HYPERTENSIVE PATIENTS *C. CALVO, RC. HERMIDA, DE. AYALA, JE. LOPEZ, M. RODRIGUEZ, L. CHAYAN, MJ. FONTAO, R. SOLER SANTIAGO, SPAIN ,Vigo, SPAIN 48 293 CHRONOTHERAPY WITH SPIRAPRIL IN HYPERTENSIVE PATIENTS: CHANGES IN THE DIURNAL/NOCTURNAL BLOOD PRESSURE RATIO AS A FUNCTION OF THE CIRCADIAN TIME OF ADMINISTRATION *RC. HERMIDA, C. CALVO, DE. AYALA, L. CHAYAN, M. RODRIGUEZ, JE. LOPEZ VIGO, SPAIN ,SANTIAGO, SPAIN 294 CHRONOTHERAPY WITH NIFEDIPINE GITS IN HYPERTENSIVE PATIENTS: IMPROVEMENT OF SAFETY PROFILE WITH BEDTIME ADMINISTRATION C. CALVO, *RC. HERMIDA, DE. AYALA, M. RODRIGUEZ, L. CHAYAN, JE. LOPEZ SANTIAGO, SPAIN ,VIGO, SPAIN 295 ADMINISTRATION TIME-DEPENDENT EFFECTS OF NEBIVOLOL ON THE DIURNAL/NOCTURNAL BLOOD PRESSURE RATIO IN HYPERTENSIVE PATIENTS *RC. HERMIDA, C. CALVO, DE. AYALA, M. RODRIGUEZ, L. CHAYAN, JE. LOPEZ VIGO, SPAIN ,SANTIAGO, SPAIN 296 ADMINISTRATION TIME-DEPENDENT EFFECTS OF ANTIHYPERTENSIVE TREATMENT IN PATIENTS WITH RESISTANT HYPERTENSION *C. CALVO, RC. HERMIDA, DE. AYALA, M. RODRIGUEZ, L. CHAYAN, JE. LOPEZ SANTIAGO, SPAIN ,VIGO, SPAIN 297 CHRONOTHERAPY WITH VALSARTAN-HCTZ COMBINATION IN HYPERTENSIVE PATIENTS: IMPROVED BLOOD PRESSURE REGULATION AFTER BEDTIME ADMINISTRATION *RC. HERMIDA, C. CALVO, DE. AYALA, M. RODRIGUEZ, L. CHAYAN, JE. LOPEZ, A. MOJON, JR. FERNANDEZ VIGO, SPAIN ,SANTIAGO, SPAIN 298 COMPARITIVE EFFECTS OF NOLIPREL-FORTE® AND THE COMBINATION OF ATENOLOL AND HYDROCHLORTHIAZIDUM ON ARTERIAL BLOOD PRESSURE AND KEY PARAMETERS OF LEFT VENTRICULUM *H.G. Hayrapetyan Erebouni medikal Centre,Yerevan, ARMENIA 299 THE EFFECT OF ORAL MAGNESIUM SUPPLEMENTATION ON BLOOD PRESSURE AND INSULIN SENSITIVITY *L.S. Hadjistavri, I.M. Tziolas, P.E. Zebekakis, A.K. Diamantopoulos, P.A. Sarafidis, K.P. Aroditis, M.J. Pikilidou, A.N. Lasaridis Thessaloniki, GREECE 300 ARE ACE-INHIBITORS OR CALCIUM CHANNEL BLOCKERS SUPERIOR TO DIURETICS IN PREVENTING ANGINA OR PERIPHERAL ARTERIAL DISEASE OR THE NEED FOR REVASCULARIZATION? INSIGHTS FROM ALLHAT *G. Habib, J. Basile, D. Courtney, R. Dart, P. Einhorn, A. Ellsworth, H. Fendley, F. Leenen, D. Morrison, L. PIller, M. Rahman, L. Simpson, P. Whelton, FOR THE. ALLHAT Collabor Rsch Grp Houston, TX, USA ,Charleston, SC, USA ,Leavenworth, KS, USA ,Marshfield, WI, USA ,Bethesda, MD, USA ,Seattle, WA, USA ,Pine Bluff, AR, USA ,Ottawa, ON, CANADA ,Tucson, AZ, USA ,Houston, TX, USA 301 IS CALCIUM ANTAGONIST OR BETA-BLOCKER THE BEST TREATMENT TO ADD TO A THIAZIDE DIURETIC IN HYPERTENSIVE PATIENTS WITH AN ELEVATED PULSE PRESSURE ? *O. Hanon, J. Fourcade, JP. Fauvel, F. Villeneuve, A. Marquand, C. Dourmap, X. Girerd Paris, FRANCE ,Paris, FRANCE 49 302 BENEFICIAL EFFECTS OF RAMIPRIL ON CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS > = 70 YEARS: A SUBGROUP ANALYSIS OF THE HOPE STUDY. *M. Gianni, F. Dentali, J. Pogue, E. Lonn, S. Yusuf ITALY CANADA 303 LEFT VENTRICULAR MASS INDEX AND 48-HOURS PULSE PRESSURE IN HEMODIALYSIS PATIENTS *R. Ekart, R. Hojs, V. Kanic, S. Bevc, B. Dvorsak, B. Pecovnik-Balon Maribor, SLOVENIA ,Maribor, SLOVENIA 304 THE ADDITIONAL VALUE OF AN ACADEMIC HYPERTENSION CLINIC H. Jaspers, *J.W.M. Lenders, J. Deinum Nijmegen, THE NETHERLANDS ,Nijmegen, THE NETHERLANDS ,Nijmegen, THE NETHERLANDS 305 DOES INDAPAMIDE SR INFLUENCE THE METABOLIC PROFILE OVER THE LONG TERM OF PATIENTS INCLUDED IN THE LIVE STUDY *PH. GOSSE BORDEAUX, FRANCE 306 PREVALENCE OF HYPERTENSION AND OTHER CARDIOVASCULAR RISK FACTORS IN TWO CZECH FEMALE POPULATION SAMPLES *R. Cifkova, J. Pitha, M. Lejskova, R. Poledne, P. Stavek, V. Lanska, S. Zecova Prague, CZECH REPUBLIC ,Prague, CZECH REPUBLIC ,Prague, CZECH REPUBLIC 307 EFFECT OF TELMISARTAN IN ADDITION TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS ON LEFT VENTRICULAR STRUCTURE AND FUNCTION IN HEMODIALYZED PATIENTS WITH CHRONIC HEART FAILURE *G. Cice, A. Di Benedetto, A. D'Andrea, S. D'Isa, P. De Gregorio, R. Calabrò ITALY ITALY 308 EFFECT OF INDAPAMIDE (ARIFON RETARD) ON BLOOD PRESSURE, GLUCOSE AND LIPIDS METABOLISM IN PATIENTS WITH METABOLIC SYNDROME AND ARTERIAL HYPERTENSION *I.YE. CHAZOVA, V.B. MYCHKA, K.M. MAMYRBAEVA MOSCOW, RUSSIA 309 ABSTRACT WITHDRAWN 310 A WEB SURVEILLANCE OF ARTERIAL HYPERTENSION: CLINIC RESULTS M. D'Avino, *S. Cozzolino, A. D'Amelia, M. Rizzo, G. Caruso, R. Muschera', F. Capasso, D. Caruso Napoli, ITALY ,Napoli, ITALY ,Salerno, ITALY 311 TREATMENT OF OBSTRUCTIVE SLEEP APNEA REDUCES CARDIOVASCULAR RISK: A PROSPECTIVE STUDY. *N. Buchner, M. Esser, J. Borgel, L. Rump, B. Sanner Bochum, GERMANY ,Wuppertal, GERMANY ,Bochum, GERMANY 50 312 ANTIHYPERTENSIVE EFFICACY OF INDAPAMIDE SR IN HYPERTENSIVE PATIENTS UNCONTROLLED WITH A BACKGROUND THERAPY: THE NATIVE STUDY *J. Akram King Edward Medical College, Lahore 54660, PAKISTAN 313 RELEVANCE OF TRANSFER FUNCTION TECHNIQUE IN CLINICAL TRIALS OUTCOMES *A. Adji, K. Hirata, S. Hoegler, C. Vlachopoulos, MF. O'Rourke Sydney, NSW, AUSTRALIA 314 IMPACT ON BLOOD PRESSURE CONTROL OF A SPECIFIC TRAINING IN NEW GUIDELINES FOR MANAGEMENT OF HYPERTENSION: THE VALNORM STUDY SUB-GROUPS ANALYSIS *R. Asmar, A. Achouba, P. Brunel, B. Vaisse, T. Denolle FRANCE FRANCE FRANCE FRANCE 315 ANTIHYPERTENSIVE EFFICACY OF VALSARTAN AND VALSARTAN/HCTZ IN PATIENTS WITH STAGE 1 OR STAGE 2 HYPERTENSION: EXPLORATORY ANALYSIS OF NINE CLINCAL TRIALS *M. Weir, J. Khan, D. Purkayastha, YT. Chiang, V. Kutura, R. Glazer, R. Rocha Maryland, USA ,New Jersey, USA 316 INSULIN SENSITIZING ANGENTS DECREASE BLOOD PRESSURE ALONG WITH REDUCTION OF INSULIN RESITANCE IN POLYCYSTIC OVARY SYNDROME *S. HASHIMOTO, S. MiIDORIKAWA, M. SASAKI-YATABE, J. YATABE, M. HONMA, A. MURAOKA, H. SANADA, T. WATANABE FUKUSHIMA, JAPAN ,FUKUSHIMA, ,FUKUSHIMA, ,FUKUSHIMA, ,FUKUSHIMA, ,FUKUSHIMA, ,FUKUSHIMA, ,FUKUSHIMA, 317 CARDIAC AND STROKE DISEASE AT ENTRY TO THE HYPERTENSION IN THE VERY ELDERLY TRIAL (HYVET) - COMPARISON BETWEEN PATIENTS FROM EUROPE AND CHINA *N. Beckett, R. Peters, C. Anderson, V. Stoyanovsky, R. Antikainen, W. Banya, A. Fletcher, C. Bulpitt, BEHALF. of the HYVET investigator London, UNITED KINGDOM ,Sydney, AUSTRALIA ,Sofia, BULGARIA ,Oulu, FINLAND ,London, UNITED KINGDOM 318 THE EFFECT OF FERMENTED DAIRY PEPTIDES ON DAYTIME BLOOD PRESSURE *K. van der Zander, M. Jäkel, V. Bianco, M.M.G. Koning Vlaardingen, THE NETHERLANDS 319 DAIRY PEPTIDES: A DOSE DEPENDENT EFFECT ON BLOOD PRESSURE *P.W. de Leeuw, K. van der Zander, A.A. Kroon, R.J.M.W. Rennenberg, M.M.G. Koning Maastricht, THE NETHERLANDS ,Vlaardingen, THE NETHERLANDS 51 12:30 - 15:30 Hall 10 320 P05 Kidney Poster Session TREATMENT OF ARTERIAL HYPERTENSION AT CHRONIC NEPHRITIS: EFFECTS ON THE LEVEL OF ENDOTHELIN-1 *NATALYA. Yatsyshyn, ROMAN. Yatsyshyn, YEVGEN. Neyko Ivano-Frankivsk, UKRAINE 321 RELATIONSHIP BETWEEN PLASMA LEVELS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) AND NEPHROSCLEROSIS IN PATIENTS WITH ESSENTIAL HYPERTENSION A. Papadogiannakis, *D. Xydakis, M. Sfakianaki, K. Kostakis, K. Papachristoforou Heraklio, GREECE 322 ASSOCIATION BETWEEN ACE INSERTION/DELETION POLYMORPHISM, HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD). *M. Wanic-Kossowska, M. Kobelski, L. Koziol, E. Pawliczak, S. Czekalski Poznan University of Medical Sciences, POLAND 323 EFFECT OF ONCE-WEEKLY S.C. ERYTHROPOIETIN ADMINISTRATION IN ANEMIC PREDIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE ON QUALITY OF LIFE, BLOOD PRESSURE AND KIDNEY FUNCTION. *M. Wanic-Kossowska, M. Kobelski, A. Oko, E. Pawliczak, L. Koziol, S. Czekalski Poznan University of Medical Sciences, POLAND 324 BLOOD PRESSURE AND ERYTHROCYTE NA-MEMBRANE TRANSPORT SYSTEMS IN PATIENTS WITH LIHTIUM INDUCED NEPHROPATHY *M. Vretenarska, EK. Nakova Sofia, BULGARIA ,Sofia, BULGARIA 325 MICROALBUMINURIA IS ACCOMPANIED BY PRONOUNCED ARTERIAL STIFFENING IN ESSENTIAL HYPERTENSIVE PATIENTS WITH HIGH LEVELS OF C-REACTIVE PROTEIN *K. DIMITRIADIS, C. TSIOUFIS, I. SKIADAS, E. VEZALI, D. TOUSOULIS, C. STEFANADIS, I. KALLIKAZAROS ATHENS, GREECE 326 SHOULD THE THRESHOLD DEFINING MICROALBUMINURIA BE REVISITED? AN ASSESSMENT OF ALBUMIN EXCRETION RATE AND CARDIOVASCULAR RISK IN THE OLIVETTI HEART STUDY POPULATION. M. Versiero, *A. Barbato, F. Galletti, L. D'Elia, R. Iacone, O. Russo, A. Venezia, P. Schiattarella, P. Strazzullo Naples, ITALY 52 327 URINARY ALBUMIN EXCRETION IS ASSOCIATED WITH C-REACTIVE PROTEIN AND ENDOTHELIAL DYSFUNCTION IN ESSENTIAL HYPERTENSIVES *J. Spiliopoulou, E. Manios, G. Rammos, K. Dolianitis, E. Koroboki, G. Tsivgoulis, K. Spengos, N. Zakopoulos Athens, GREECE ,Athens, GREECE ,Athens, GREECE ,Athens, GREECE ,Athens, GREECE ,Athens, GREECE ,Athens, GREECE ,Athens, GREECE 328 HIGH BMI ACCELERATE DEVELOPING OF HYPERTENSION IN CHILDREN WITH KIDNEY DISEASES *J. Sladowska, M. Panczyk-Tomaszewska, M. Mizerska-Wasiak, M. Roszkowska-Blaim Warsaw, POLAND 329 RENAL FUNCTION AND INTIMA-MEDIA THICKNESS IN PATIENTS WITH ARTERIAL HYPERTENSION *A. SKALSKA, E. KLIMEK, T. GRODZICKI CRACOW, POLAND 330 PREDICTIVE PERFORMANCE OF COCKCROFT-GAULT AND MDRD EQUATIONS TO ASSESS RENAL FUNCTION IN A POPULATION WITH NORMAL SERUM CREATININE *MP. Schlaich, BMW. Schmidt, C. Ott, I. Fleischmann, RE. Schmieder University of Erlangen-Nürnberg, GERMANY 331 SHORT-TERM AND LONG-TERM RENOPROTECTIVE EFFECT WITH CALCIUM CHANNEL BLOCKER ON TOP OF EITHER MAXIMUM OR LOWER DOSE ANGIOTENSIN RECEPTOR BLOCKER IN HYPERTENSIVES *F. Saito, I. Ichiyama, S. Harasawa, M. Onikura, S. Furuya, K. Ohkubo, T. Asai, T. Yoshizawa, H. Takase, T. Ishii, K. Ohiwa, H. Fujita, A. Takahashi, N. Takahashi, T. Hino, Y. Ohtsuka, K. Nishino, T. Uchiyama, K. Kanmatsuse, T. Kushiro Tokyo, JAPAN ,Tokyo, JAPAN ,Tokyo, JAPAN ,Tokyo, JAPAN ,Fukuoka, JAPAN 332 BODY MASS INDEX AND AGE AS DETERMINANTS OF RENAL HEMODYNAMICS AND RESERVE CAPACITY AFTER LIVING KIDNEY DONATION *M. Rook, RJ. Bosma, WJ. van Son, S. Hofker, JJ. Homan van der Heide, PM. ter Wee, RJ. Ploeg, GJ. Navis Gronigen, THE NETHERLANDS ,Amsterdam, THE NETHERLANDS 333 FACTORS RELATED TO IMMUNOUNREACTIVE URINARY ALBUMIN EXCRETION IN THE GENERAL POPULATION F. Simal, JC. Martín-Escudero, S. Bakker, A. Dueñas, F. Perez-Fernandez, FJ. Chaves, D. de Zeeuw, *J. Redon Valladolid, SPAIN ,Groningen, THE NETHERLANDS ,Valencia, SPAIN 334 INVOLVEMENT OF THE ENDOTHELIAL ET-1/ETB RECEPTOR SYSTEM IN ERYTHROPOIETIN-INDUCED HYPERTENSION IN RENAL FAILURE RAT. *ME. Rancourt, ME. Rodrigue, R. Larivière, M. Lebel Quebec, Qc, CANADA 53 335 SLIGHTLY INCREASED CREATININE LEVEL AS A RISK FACTOR OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE. Z. Dzielinska, A. Januszewicz, *A. Prejbisz, J. Kadziela, M. Makowiecka-Ciesla, P. Tyczynski, M. Demkow, E. Florczak, R. Mielniczuk, M. Januszewicz, W. Ruzyllo Warsaw, POLAND ,Warsaw, POLAND 336 RELATIONSHIP BETWEEN INTRA-RENAL DOPPLER BLOOD FLOW PARAMETERS AND TARGET ORGAN DAMAGE IN PATIENTS WITH ESSENTIAL HYPERTENSION. E. Florczak, M. Januszewicz, I. Michalowska, M. Gajewska, M. Makowiecka-Ciesla, B. Pucilowska, *A. Prejbisz, I. Cendrowska-Demkow, M. Kabat, T. Zielinski, T. Rywik, D. Rynkun, K. Kraszewski, B. Kusmierczyk-Droszcz, P. Hoffman, A. Januszewicz Warsaw, POLAND ,Warsaw, POLAND 337 DEFECTIVE RENAL FOLATE PRESERVATION IN HYPERTENSIVE PATIENTS WITH NEPHROANGIOSCLEROTIC DAMAGE. *CHIARA. Pavan, FRANCESC. pizzolo, SIMONETT. Friso, PATRIZIA. Guarini, DOMENICO. Girelli, GIOVANNI. Faccini, ROBERTO. Corroche, OLIVIERO. Olivieri Verona, ITALY ,Verona, ITALY 338 SPIRONOLACTONE PREVENTS L-NAME-INDUCED HYPERTENSION BY IMPROVING NITRIC OXIDE/CGMP PATHWAY *O. Pechanova, J. Matuskova, L. Jendekova, S. Kojsova, L. Paulis, F. Simko Bratislava, SLOVAK REPUBLIC ,Bratislava, SLOVAK REPUBLIC ,Prague, CZECH REPUBLIC 339 PREVALENCE OF MICROALBUMINURIA IN TYPE 2 DIABETIC HYPERTENSIVE PATIENTS IN FRANCE (MICROALB STUDY) *M. LAVILLE, M. KREMPF, S. OM, T. DENOLLE Lyon, FRANCE ,Nantes, FRANCE ,Paris, FRANCE ,Dinard, FRANCE 340 COMPARISON OF ESTIMATED GLOMERULAR FILTRATION RATE AND SERUM CREATININE LEVEL TO PREDICT MORBIMORTALITY AFTER CARDIAC VALVE REPLACEMENT *A. Oliveras, M. Cladellas, S. Vázquez, J. Vila, J. Bruguera, J. Lloveras Barcelona., SPAIN ,Barcelona., SPAIN ,Barcelona., SPAIN 341 HOMOCYSTEINE-LOWERING THERAPY IN HYPERTENSIVE PATIENTS WITH CHRONIC RENAL INSUFICIENCY *V. MONHART, V. HAMPLOVA, V. BLAHA, B. CHOLUJ Prague, CZECH REPUBLIC ,Hradec Kralove, CZECH REPUBLIC ,Prague, CZECH REPUBLIC 342 IS MDRD FORMULA A GOOD ESTIMATOR OF GLOMERULAR FILTRATION RATE IN CIRRHOTIC PATIENTS? *R. MARTINEZ, J. GONZALEZ-REVALDERIA, N. DEL AMO, N. GARIN, L. LOPEZ, E. MIRAVALLES GETAFE, MADRID, SPAIN 54 343 SIMILAR PREVALENCE OF CHRONIC KIDNEY DISEASE IN NORMOTENSIVE AND HYPERTENSIVE PATIENTS WITH NORMAL SERUM CREATININE UNDERGOING CORONAROGRAPHY DUE TO ISCHEMIC HEART DISEASE H. Bachorzewska-Gajewska, *J. Malyszko, E. Sitniewska, P. Kralisz, JS. Malyszko, WJ. Musial, S. Dobrzycki Bialystok, POLAND ,Bialystok, POLAND ,Bialystok, POLAND 344 BENEFICIAL EFFECTS OF ATORVASTATIN ON INFLAMMATORY PARAMETERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD). M. Goicoechea, S. García de Vinuesa, M. Puerta, J. Kanter, FJ. Gómez Campderá, V. Cachofeiro, V. Lahera, *J. Luño Madrid, SPAIN ,Madrid, SPAIN 345 MONITORING OF RENAL RESISTANCE INDEX VARIABILITY IN THE DOPPLER CAPTOPRIL TEST IN PATIENTS WITH SECONDARY HYPERTENSION DUE TO CHRONIC GLOMERULONEPHRITIS *A. LUBAS, G. ZELICHOWSKI, Z. WANKOWICZ Warsaw, POLAND 346 VARIABILITY OF RENAL RESISTANCE INDEX IN THE DOPPLER CAPTOPRIL TEST IN CONTROLLED HYPOTENSIVE THERAPY OF PATIENTS WITH ESSENTIAL HYPERTENSION *A. Lubas, G. Zelichowski, Z. Wankowicz Warsaw, POLAND 347 RENAL FUNCTION IN A MODEL OF HYPERTENSION INDUCED BY ADENOSINE RECEPTOR BLOCKADE *J. Marques-Lopes, M. Morato, T. Sousa, D. Pinho, M. Couto, S. Fontes, A. Albino-Teixeira Porto, PORTUGAL ,Porto, PORTUGAL 348 FOLLOW-UP ,COMPARATIVE STUDY MALNUTRITION IN CHRONIC HAEMODIALYSED PATIENTS ( SGA ,MNA ,BIA,LAP ) *LAJOS. Locsey, BELA. Borbas, ANIKO. Dan, BEATRIX. Szlanka, ISTVAN. Menes Debrecen, HUNGARY ,Debrecen, HUNGARY 349 RELATIONSHIP BETWEEN AUGMENTATION INDEX, PULSUS WAVE VELOCITY IN METABOLIC ALTERATIONS AFTER RENAL TRANSPLANTATION *LAJOS. Locsey, BELA. Borbas, BEATRIX. Szlanka, ISTVAN. Menes, LASZLO. Szabo, BALAZS. Mazurka, LASZLO. Asztalos, ISTVAN. Lorincz Debrecen, HUNGARY ,Debrecen, HUNGARY ,Debrecen, HUNGARY 350 RELATIONSHIP BETWEEN SERUM CYSTATIN C, HOMOCYSTEINE CONCENTRATION AND PARAOXONASE ACTIVITY ,POLYMORPHISM IN RENAL FAILURE *LAJOS. Locsey, ILDIKO. Seres, BELA. Borbas, ANIKO. Dan, LASZLO. Asztalos, GYORGY. Paragh Debrecen, HUNGARY ,Debrecen, HUNGARY ,Debrecen, HUNGARY 55 351 ASSOCIATION AMONG THE BLOOD PRESSURE AND PROTEINURIA PATIENTS WITH IGA NEPHROPATHY. *MICHAL. Kozlowski, BEATA. Sulikowska, JADWIGA. Korenkiewicz, ANNA. Stefanska, GRAZYNA. Odrowaz-Sypniewska, JACEK. Manitius Nicolaus Copernicus University Torun, POLAND ,Nicolaus Copernicus University Torun, POLAND ,Nicolaus Copernicus University Torun, POLAND 352 RELATIONSHIP BETWEEN MARKERS OF OXIDATIVE STRESS, ADVANCED GLICATION END PRODUCTS AND HYPERTENSION AND PROGRESSION OF RENAL FAILURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE *ROBERT. Kurowsk, MAGDA. Grajewska, PAWEL. Strozecki, ANNA. Stefanska, GRAZYNA. Sypniewska, JACEK. Manitius Nicolaus Copernicus University Torun, POLAND ,Nicolaus Copernicus University Torun, POLAND 353 FUNCTION OF INTRARENAL VESSELS IN IGA NEPHROPATHY PATIENTS AND ITS ASSOCIATIONS WITH SOME CLINICAL PARAMETERS. *BEATA. Sulikowska, MICHAL. Kozlowski, BOLESLAW. Rutkowski, WIESLAWA. Szydlowska-Lysiak, GRAZYNA. Sypniewka, JACEK. Manitius Nicolaus Copernicus University, Torun, POLAND ,Medical University, Gdansk, POLAND ,Nicolaus Copernicus University, Torun, POLAND 354 ABSTRACT WITHDRAWN 355 KIDNEY FUNCTION IN ESSENTIAL HYPERTENSIVE PATIENTS WITH IMPAIRED RENAL FUNCTION ACCORDING TO 12-YEAR OBSERVATION. *T. KOSTYRYA, E. SVYSHCHENKO, V. RADCHENKO, O. SOLODYANIKOVA KYIV, UKRAINE ,KYIV, UKRAINE ,KYIV, UKRAINE ,KYIV, UKRAINE 356 RENAL ANGIOPLASTY AND STENTING. IS IT CLINICALLY EFFECTIVE? *E. Kolossvary, A. Kolllár, K. Farkas, I. Kiss Budapest, HUNGARY ,Budapest, HUNGARY ,Budapest, HUNGARY 357 ASSOCIATION OF GENETIC VARIATION IN TRANSFORMING GROWTH FACTORS BETA1 AND BETA3 WITH RENAL DYSFUNCTION IN NON-DIABETIC CHINESE BC. Hu, SL. Chu, GL. Wang, DL. Zhu, *JG. Wang Shanghai, CHINA 358 EVEN MILD REDUCTION IN GLOMERULAR FILTRATION RATE IS ASSOCIATED WITH SYMPATHETIC ACTIVATION IN PATIENTS WITH ESSENTIAL HYPERTENSION *D. Hering, W. Kucharska, R. Szczech, M. Chrostowska, T. Kara, V.K. Somers, K. Narkiewicz Gdansk, POLAND ,Gdansk, POLAND ,Gdansk, POLAND ,Gdansk, POLAND ,Rochester, MN, USA ,Rochester, MN, USA ,Gdansk, POLAND 359 ABNORMALITIES IN SYMPATHETIC CARDIOVASCULAR DRIVE IN MILD RENAL FAILURE *F. QUARTI TREVANO, F. ARENARE, A. FACCHINI, G. SERAVALLE, S. FURIANI, G. BUCCIANTI, G. GRASSI, G. MANCIA Monza, Milan, ITALY ,Milan, ITALY ,Cinisello Balsamo, Milan, ITALY 56 360 AMBULATORY BLOOD PRESSURE STATUS IN HYPERTENSIVE PATIENTS WITH RENAL DISEASE. ANALYSIS OF A 20,000-PATIENT DATABASE IN SPAIN. *M. GOROSTIDI, J. SEGURA, J. SOBRINO, M.C. GARCES, J. PECHUAN, P. SAINZ, J.F. ZUAZAGOITIA, J. DIAZ, A. COCA, L.M. RUILOPE SPAIN 361 HYPERTENSIVE PATIENTS WITH KIDNEY DISEASE SHOW AMBULATORY BLOOD PRESSURE PARAMETERS AT THE HIGHEST LEVEL OF CARDIOVASCULAR RISK. ANALYSIS OF A 20,000-PATIENT DATABASE IN SPAIN. *M. GOROSTIDI, J. SEGURA, J. SOBRINO, F.J. GARCIA-NORRO, L. GARCIA-GIRALDA, F.J. ORTE, M. ROYO, J.J. BELLVIS, A. COCA, L.M. RUILOPE SPAIN 362 DIFFERENCES IN GLOMERULAR FILTRATION RATE ESTIMATION DUE TO SERUM CREATININE ASSAY *J. GONZALEZ-REVALDERIA, T. PASCUAL, M. DE PAULA, N. DEL AMO, R. MARTINEZ, E. MIRAVALLES MADRID, SPAIN 363 MDRD PREDICTION EQUATION OF GLOMERULAR FILTRATION AND ITS RELATION TO PATIENT AGE *J. GONZALEZ-REVALDERIA, R. MARTINEZ, M. DE PAULA, T. PASCUAL, N. DEL AMO, E. MIRAVALLES MADRID, SPAIN 364 SMOKING INCREASES MICROALBUMINURIA IN PATIENTS WITH ESSENTIAL HYPERTENSION T. GIALERNIOS, *G. VYSSOULIS, E. KARPANOU, A. TRIANTAFYLLOU, S. DIMITRAKOPOULOS, A. MARINAKIS, C. STEFANADIS ATHENS, GREECE 365 DOES AGE ALTER THE RENAL RESPONSE TO SELECTIVE ALDOSTERONE BLOCKADE? *M. Epstein, R. Mukherjee, R. Patni, B. Beckerman Miami, Fl, USA ,New York, NY, USA 366 DOES BASELINE RENAL FUNCTION DETERMINE THE INCIDENCE OF HYPERKALEMIA IN DIABETIC PATIENTS TREATED WITH AN ACE INHIBITOR AND A SELECTIVE ALDOSTERONE BLOCKER? *M. Epstein, R. Mukherjee, R. Patni, B. Beckerman Miami, FL, USA ,New York, NY, USA 367 HAEMODYNAMIC & RENIN-ANGIOTENSIN SYSTEM RESPONSES TO FLUID ULTRAFILTRATION IN HAEMODIALYSIS PATIENTS *TIMOTHY. Doulton, MONIQUE. Wood, NIRMALA. Markandu, GRAHAM. MacGregor LONDON, UNITED KINGDOM 368 ARTERIAL STIFFNESS IN PATIENTS WITH END-STAGE RENAL DISEASE (ESRD): DIRECT VISUALISATION OF AORTIC COMPLIANCE USING MAGNETIC RESONANCE IMAGING (MRI) *LU. Zimmerli, PB. Mark, T. Steedman, AJ. Jardine, GA. Berg, HJ. Dargie, C. Delles, AF. Dominiczak University of Glasgow, UNITED KINGDOM ,University of Glasgow, UNITED KINGDOM ,Western Infirmary Glasgow, UNITED KINGDOM 57 369 CHANGES OF LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTION AFTER RENAL TRANSPLANTATION *I. MOYSSAKIS, M. DASKALAKI, E. GIALAFOS, O. PAPAZACHOU, L. NANIS, S. KYRIAKIDIS, V. VOTTEAS ATHENS, GREECE ,ATHENS, GREECE 370 STENT SUPPORTED ANGIOPLASTY IN ATHEROSCLEROTIC RENAL ARTERY STENOSIS: PROSPECTIVE FOLLOW-UP. *J. Ceral, M. Borovec, A. Krajina, M. Lojik, J. Raupach Hradec Kralove, CZECH REPUBLIC ,Hradec Kralove, CZECH REPUBLIC 371 CARDIAC AUTONOMIC FUNCTIONS IN PATIENTS WITH CHRONIC RENAL FAILURE: A SUBGROUP STUDY *ATAC. CELIK, MEHMET. MELEK, SEREF. YUKSEL, ERSEL. ONRAT, ALAETTIN. AVSAR, CELAL. KILIT AFYONKARAHISAR, TURKEY ,AFYONKARAHISAR, TURKEY 372 OXIDATIVE STRESS AND POST-TRANSPLANT HYPERTENSION IN PEDIATRIC KIDNEY TRANSPLANTED PATIENTS. *LA. Calò, R. Dall'Amico, E. Pagnin, L. Bertipaglia, G. Zacchello, A. Semplicini, AC. Pessina Padova, ITALY ,Thiene, ITALY ,Padova, ITALY 373 ADIPONECTIN AND RENAL FUNCTION IN ESSENTIAL HYPERTENSION. ANNA. MICZKE, *WIESLAW. BRYL, MACIEJ. OWECKI, KAROLINA. HOFFMANN, PAWEL. BOGDANSKI, MACIEJ. CYMERYS, DANUTA. PUPEK-MUSIALIK, JERZY. SOWINSKI POZNAN, POLAND ,POZNAN, POLAND 374 ULTRASONOGRAPHIC EXAMINATION IN RENAL ARTERY STENOSIS - DIAGNOSTIC BENEFIT OF RENAL-AORTIC RATIO AND PEAK SYSTOLIC VELOCITY *M. BOROVEC, J. CERAL, P. RYSKA, A. KRAJINA Hradec Kralove, CZECH REPUBLIC ,Hradec Kralove, CZECH REPUBLIC 375 PRESENCE OF HYPERTENSION AND BLOOD PRESSURE LEVELS ARE INDEPENDENTLY ASSOCIATED TO IMPAIRED RENAL FUNCTION DURING ACUTE MYOCARDIAL INFARCTION *G. BERTON, R. PALMIERI, R. CORDIANO, GL. GUARNIERI, S. PETUCCO, V. PAGLIARA, R. DE TONI, P. MORMINO, P. PALATINI CONEGLIANO, ITALY ,ADRIA, ITALY ,BASSANO, ITALY ,TREVISO, ITALY ,PADOVA, ITALY 376 GREATER RISK OF HYPERTENSION ASSOCIATED WITH ELEVATED SERUM LEPTIN IN OBESITY IS PROBABLY MEDIATED BY AN INCREASED RATE OF PROXIMAL TUBULAR SODIUM REABSORPTION. *P. Strazzullo, F. Galletti, G. Barba, A. Barbato, O. Russo, R. Iacone, A. Siani, F.P. Cappuccio, E. Farinaro Naples, ITALY ,Avellino, ITALY ,Coventry, UNITED KINGDOM 377 IS THE BLOOD PRESSURE MEASUREMENT IMPORTANT ENOUGH IN ROUTIN PHYSICAL EXAMINATION OF CHILDREN WITH RECURRENT URINARY TRACT INFECTION(UTI)? *H. Babaei, S. Kavandi, H.R. Parhizi, M.R. Kavandi Zanjan, IRAN ,Zanjan, IRAN ,Hamburg, GERMANY ,Zanjan, IRAN 58 378 MICROALBUMINURIA CURRENTLY USED DID NOT REFLECT THE METABOLIC SYNDROME BUT WAS RELATED TO THE DURATION OF HYPERTENSION *N. Ashizawa, S. Seto, K. Yano JAPAN 379 INFLUENCES OF MODERATE ZINC DEFICIENCY DURING PRENATAL LIFE AND GROWTH ON RENAL NITRIC OXIDE SYSTEM *C.T. Arranz, A.L. Tomat, L.C. Girgulsky, C. Vallone, L. Veiras, R. Elesgaray, H. Fasoli, A.M. Balaszczuk, M.A. Costa Buenos Aires, ARGENTINA ,Buenos Aires, ARGENTINA ,Buenos Aires, ARGENTINA ,Buenos Aires, ARGENTINA 380 NOVEL APPROACHES TO ANALYZE GLOMERULAR PROTEINS FROM SMALLEST SCALE MURINE AND HUMAN SAMPLES USING FLUORESCENCE DIFFERENCE GEL ELECTROPHORESIS SATURATION LABELLING S. Potthoff, B. Sitek, T. Schulenborg, J. Stegbauer, T. Vinke, HE. Meyer, LC. Rump, *O. Vonend Bochum, GERMANY ,Bochum, GERMANY 381 COMPARATIVE ANALYSIS OF CIRCADIAN BLOOD PRESSURE PROFILE IN NONDIABETIC NEPHROPATHIES *MIHAI. Voiculescu, CAMELIA. Ionescu, GENER. Ismail, EMILIA. Gilice, ELENA. Busuioc, MIHAELA. Lixandru, SIMONA. Marin Bucharest, ROMANIA 382 FREQUENCY AND SHORT-TIME PROGNOSTIC SIGNIFICANCE OF REFRACTORY HYPERTENSION IN CKD PATIENTS *CAMELIA. Ionescu, MIHAI. Voiculescu, GENER. Ismail, EMILIA. Gilice, ELENA. Busuioc, ELENA. Badea Bucharest, ROMANIA 383 NEPHROSCLEROSIS OF PRIMARY HYPERTENSION STARTS FIRST IN THE LEFT KIDNEY AND THIS SIGN COULD BE CALLED AS ERGUN SIGN. Y. Ergun, *Y. Sagliker, K. Aikimbaer, I. Yildiz, H. Firinciogullari Adana, TURKEY ,Adana, TURKEY ,Adana, TURKEY ,Adana, TURKEY ,Adana, TURKEY 59 12:30 - 15:30 Hall 10 384 P06 Organ Damage Poster Session STRUCTURAL AND FUNCTIONAL TRIGGERS OF PAROXYSMAL ATRIAL FIBRILLATION IN HYPERTENSIVES *I. SKIADAS, C. TSIOUFIS, K. DIMITRIADIS, K. THOMOPOULOS, D. CHATZIS, P. TOUTOUZAS, C. STEFANADIS, I. KALLIKAZAROS ATHENS, GREECE 385 LEFT VENTRICULAR ADAPTATIONS IN HYPERTENSIVES WITH PRIMARY ALDOSTERONISM. A DOPPLER TISSUE IMAGING APPROACH *D. TSIACHRIS, C. TSIOUFIS, E. CHATZISTAMATIOU, E. TAXIARCHOU, D. SIRSELOUDIS, E. VEZALI, C. STEFANADIS, I. KALLIKAZAROS ATHENS, GREECE 386 DIASTOLIC DYSFUNCTION, CONCENTRIC REMODELING, AND ARTERIAL STIFFNESS: A TRIPLE DAMAGE OF ADVERSE CARDIOVASCULAR PROGNOSIS IN HYPERTENSIVES WITH OBSTRUCTIVE SLEEP APNEA SYNDROME *K. THOMOPOULOS, C. TSIOUFIS, D. SIRSELOUDIS, A. AMFILOCHIOU, M. SELIMA, I. VLASSEROS, C. STEFANADIS, I. KALLIKAZAROS ATHENS, GREECE 387 EFFECT OF ANTIHYPERTENSIVE DRUGS ON CAROTID INTIMA MEDIA THICKNESS. A META-ANALYSIS *A.I. Tropeano, N. Saleh, P. Maison, I. Macquin Mavier Creteil, FRANCE 388 STUDY OF ORGANOPROTECTIVE EFFECTS OF THE LOSARTAN VS AMLODIPIN THERAPY IN ESSENTIAL HYPERTENSION *S.N. Tolpygina, E.V. Oschepkova, L.M. Sergakova, T.I. Kotkina, A.N. Rogoza State Research Center for Preventive Medicine, Mos, RUSSIA ,Cardiology research complex, Moscow, RUSSIA ,Cardiology research complex, Moscow, RUSSIA ,Cardiology research complex, Moscow, RUSSIA ,Cardiology research complex, Moscow,, RUSSIA 389 EFFECT OF FOSINOPRIL ON PROGRESSION OF THE ASYMPTOMATIC CAROTID ATHEROSCLEROSIS AT HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY *IVAN S. Tasic, DRAGAN. Mijalkovic, DRAGAN. Djordjevic, BRANKO. Lovic, DIMITRIJ. Jankovic Niska Banja, SERBIA - MONTENEGRO 390 ARTERIAL HYPERTENSION AND CARDIO-RESPIRATORY FAILURE DEVELOPED: SOME DIAGNOSTICS ASPECTS OF THE PROBLEM IN ELDERLY PATIENTS *L.P. Sydorchuk, I.I. Sydorchuk, R.I. Sydorchuk Chernivtsi, UKRAINE 60 391 CAROTID INTIMA-MEDIA THICKNESS IS INDEPENDENTLY ASSOCIATED WITH LEFT ATRIAL DIMENSIONS AND SERUM LEVELS OF APOLIPOPROTEIN B IN UNTREATED ESSENTIAL HYPERTENSIVES *J. Spiliopoulou, E. Manios, E. Koroboki, K. Dolianitis, G. Tsivgoulis, K. Spengos, CH. Papamichail, S. Toumanidis, N. Zakopoulos Athens, GREECE ,Athens, GREECE 392 PLASMA ENDOTHELIN CONCENTRATION AND ANTIOXIDANT STATUS, CARDIOVASCULAR RISK PROFILE AND TARGET ORGAN DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION *A. SKALSKA, E. KLIMEK, T. GRODZICKI CRACOW, POLAND 393 PLASMINOGEN ACTIVATOR INHIBITOR 1 AS MARKER OF TARGET ORGAN DAMAGE *A. SCICOLONE, N. CRESPI, V. SANCHEZ, G. SCICOLONE, J. VICENTE, P. Lipszyc BUENOS AIRES PROV, ARGENTINA ,BUENOS AIRES PROV, ARGENTINA ,BUENOS AIRES, ARGENTINA 394 METABOLIC SYNDROME IS AN INDEPENDENT PREDICTOR OF SYSTOLIC MYOCARDIAL FUNCTION ASSESSED BY TISSUE DOPPLER IMAGING IN HYPERTENSIVE PATIENTS WITH PRESERVED EJECTION FRACTION *S. Sciarretta, A. Ferrucci, GM. Ciavarella, V. Venturelli, P. De Paolis, G. Tocci, L. De Biase, M. Volpe Rome, ITALY ,Rome, ITALY 395 INAPPROPRIATE LV MASS IS ASSOCIATED TO INCREASED CAROTID INTIMA MEDIA THICKNESS IN A GENERAL POPULATION. THE VOBARNO STUDY. *M. Salvetti, ML. Muiesan, A. Paini, C. Monteduro, G. Galbassini, B. Bonzi, E. Belotti, B. Stanga, L. Micheletti, E. Agabiti Rosei University of Brescia, ITALY 396 RELATION OF HOMOCYSTEINEMIA, WITH OTHER VASCULAR RISK FACTORS, AND CONGNITIVE DAMAGE. A. Garcia Castiñeira, M. Rodiguez Fernandez, *A. Pose Reino, S. Lojo Rocamonde, JM. Mayan Santos, JC. Estévez Nuñez, I. Mendez Naya Universidade de Santiago de Compostela., SPAIN ,Complexo Hospitalario Universitario de Santiago de, SPAIN ,Universidade de Santiago de Compostela, SPAIN 397 ADIPONECTIN PLASMA CONCENTRATION IN NON-OBESE HYPERTENSIVE MEN WITH INCREASED CAROTID INTIMA MEDIA THICKNESS WITH AND WITHOUT LEFT VENTRICULAR HYPERTROPHY K. Paschalis-Purtak, B. Pucilowska, A. Klisiewicz, J. Janas, T. Zielinski, A. Prejbisz, E. Szwench, *A. Januszewicz Warsaw, POLAND 398 CAROTID ARTERIES INTIMA MEDIA THICKNESS OF PREDICTS DEATH AND CARDIOVASCULAR EVENTS IN HIGH RISK HYPERTENSIVE PATIENTS REFERRED FOR CORONARY ANGIOGRAPHY. T. Zielinski, Z. Dzielinska, *A. Januszewicz, D. Rynkun, M. Makowiecka-Ciesla, P. Tyczynski, M. Demkow, A. Prejbisz, J. Kadziela, E. Florczak, M. Naruszewicz, J. Korewicki, W. Ruzyllo Warsaw, POLAND ,Szczecin, POLAND 61 399 ABSTRACT WITHDRAWN 400 NONDIPPERS HAVE HIGHER INCIDENCE OF ABNORMAL CARDIAC STRUCTURE AND FUNCTION AND LESS FAVOURABLE LIPID GLUCOSE AND URIC ACID PROFILE IN PRE-HYPERTENSIVE AND HYPERTENSIVE MEN *A. PITTARAS, P. KOKKINOS, S. SINGH, A. MANOLIS ATHENS, GREECE ,ATHENS, GREECE ,WASHINGTON, DC, USA 401 LEFT VENTRICULAR STRUCTURE AND FUNCTION AND EXERCISE RESPONSES IN PRE-HYPERTENSIVE WOMEN *ANDREAS. PIttaras, P. Kokkinos, P. Narayan, S. Leonidi, S. Singh, A. Manolis Athens, GREECE ,Athens, GREECE ,Washington DC, USA 402 DETERMINANTS OF LEFT VENTRICULAR HYPERTROPHY IN A GREEK HYPERTENSIVE POPULATION. *M.J. Pikilidou, P.A. Sarafidis, I.M. Tziolas, P. Zebekakis, P.C. Stafylas, L.S. Hadjistavri, M.J. Lasaridis Thessaloniki, GREECE 403 ASSOCIATION OF URINE ALBUMIN TO CREATININE RATIO AND C-REACTIVE PROTEIN IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES. *P.A. Sarafidis, A.N. Lasaridis, M.J. Pikilidou, A.D. Hitoglou-Makedou, P.C. Stafylas, I.M. Tziolas, A. Kanaki, G.L. Bakris Thessaloniki, GREECE ,Chicago, IL, USA ,Thessaloniki, GREECE 404 NT-PROBNP AS A DIAGNOSTIC MARKER OF CARDIAC GEOMETRY IN ESSENTIAL HYPERTENSION *M. METTIMANO, A. RUSSO, A. BRUNO, A. GIULIANI, E. DI STASIO, C. ZUPPI, L. SAVI ROME, ITALY ,ROME, ITALY 405 LEFT VENTRICULAR PATTERNS IN TREATED HYPERTENSIVES *R. Prieto, N. Martell, M. Avila, M. Lopez-Eady, A. Fernandez-Cruz, M. Luque SPAIN 406 UNDETECTED CHRONIC KIDNEY DISEASE AND METABOLIC SYNDROME IN HYPERTENSIVE PATIENTS TREATED IN HOSPITAL - BASED HYPERTENSION UNITS IN SPAIN *M. Luque, F. de Alvaro, V. Samz de Burgoa SPAIN SPAIN SPAIN 407 ARTERIAL STIFFNESS IN IGA NEPHROPATHY - THE ROLE OF METABOLIC PARAMETERS *I. KESOI, B. SAGI, T. VAS, T. KOVACS, I. WITTMANN, J. NAGY PECS, HUNGARY 62 408 SOME ASPECTS OF CARDIOVASCULAR REMODELING IN HYPERTENSIVE POSTMENOPAUSAL WOMEN *A.A. Katsap, O.O. Bolshakova, O.S. Kolesnik, A.A. Pushkarev, E.V. Smirnova, A.N. Krutikov, N.V. Vakhrameeva, E.I. Baranova Saint-Petersburg, RUSSIA 409 ASSESSMENT OF LEFT VENTRICULAR FUNCTION IN ASYMPTOMATIC HYPERTENSION PATIENTS *A. Kalina, I. Palasti HUNGARY 410 GLOMERULAR FILTRATION IN HYPERTENSIVE PATIENTS AND ITS RELATIONSHIP WITH AMBULATORY BLOOD PRESSURE MONITORING *F. JAÉN, J.D. MEDIAVILLA, C. GARCÍA, P. MACÍAS, N. NAVARRETE, J.M. SABIO, C. FERNÁNDEZ-TORRES GRANADA, SPAIN 411 SUPPRESSIVE EFFECTS OF GRAPEFRUIT JUICE ON PROGRESSION OF ATHEROSCLEROSIS IN APO-E KNOCKOUT MICE *I. Ichiyama, M. Watanabe, T. Asai, Y. Kitahara, Y. Sato, S. Kanbe, S. Harasawa, K. Okubo, R. Koike, M. Hisaki, H. Fujita, A. Takahashi, H. Abeta, F. Saito, Y. Otsuka, T. Kushiro Tokyo, JAPAN 412 CAROTID ARTERY INTIMA-MEDIA THICKNESS IS ASSOCIATED WITH CORONARY ARTERY DISEASE *H.G.H. HEUTEN, M. CLAEYS, I. GOOVAERTS, G. ENNEKENS, C. VRINTS EDEGEM, BELGIUM 413 THE ROLE OF SERUM URIC ACID IN MICROALBUMINURIA AND LEFT VENTRICULAR HYPERTROPHY, IN PATIENTS WITH ESSENTIAL HYPERTENSION *G. VYSSOULIS, E. KARPANOU, T. GIALERNIOS, S. DIMITRAKOPOULOS, P. PIETRI, S-M. KYVELOU, C. STEFANADIS ATHENS, GREECE 414 PREVALANCE OF TARGET ORGAN DAMAGE AND ITS RELATIONSHIP WITH HS-CRP AND HOMOCYSTEINE LEVELS IN RESISTANT HYPERTENSIVES *E. Duygu, E. Durgun, F. Aliyev, VA. Vural, S. Erdine Istanbul, TURKEY ,Istanbul, TURKEY 415 RELATION BETWEEN OBSTRUCTIVE SLEEP APNEA AND ECHOCARDIOGRAPHIC FINDINGS IN HYPERTENSIVE PATIENTS ON MULTI-DRUG THERAPY *E. Duygu, E. Durgun, F. Aliyev, VA. Vural, S. Erdine Istanbul, TURKEY 416 PERINDOPRIL/INDAPAMIDE FIXED COMBINATION REDUCES LEFT VENTRICULAR MASS IN HYPERTENSIVE PATIENTS WITH OR WITHOUT OPTIMAL BLOOD PRESSURE CONTROL *P. GOSSE, P. GUÉRET, G. de SIMONE, O. DUBOURG, R. SCHMIEDER, Y. KARPOV, B. DAHLÖF BORDEAUX, FRANCE ,CRÉTEIL, FRANCE ,NAPOLI, ITALY ,BOULOGNE BILLANCOURT, FRANCE ,ERLANGEN, GERMANY ,MOSCOW, RUSSIA ,GÖTEBORG, SWEDEN 63 417 RELATION BETWEEN THE WHOLE BLOOD VISCOSITY (WBV) AND CARDIAC, CEREBRAL AND RENAL DAMAGE IN ARTERIAL HYPERTENSION *M. RIZZO, M. D'AVINO, G. CARUSO, R. MUSCHERA', F. CAPASSO, D. CARUSO NAPOLI, ITALY 418 RISK FACTORS OF TARGET ORGAN DAMAGE IN A DIABETIC HYPERTENSIVE POPULATION. CARDHIAC STUDY. V. Barrios, JP. Tomas, *C. Escobar, A. Calderon, MJ. Manzano, E. Moreno, MA. Hernandez-Presa Madrid, SPAIN ,Madrid, SPAIN ,Madrid, SPAIN 419 WEIGHTED 24 H STANDARD DEVIATION OF SYSTOLIC BLOOD PRESSURE IS RELATED TO CAROTID INTIMA MEDIA THICKNESS BETTER THAN CONVENTIONAL MEASURES OF 24H BLOOD PRESSURE VARIABILITY. *G. Bilo, A. Giglio, K. Styczkiewicz, L. Lonati, K. Kawecka-Jaszcz, G. Leonetti, G. Mancia, G. Parati Milan, ITALY ,Milan, ITALY ,Krakow, POLAND 420 UREMIC CARDIOMYOPATHY AND POTENTIAL CARDIOPROTECTIVE COUNTERREGULATORY MECHANISMS IN THE 5/6 NEPHRECTOMY MOUSE MODEL *M. Baumann, A. Kribben, J. Fu, K. Wu, J. Becker, T. Domurath, M. Gössl, H.A.J. Struijker Boudier, R. Erbel, O. Witzke Maastricht, THE NETHERLANDS ,Essen, GERMANY ,Essen, GERMANY ,Essen, GERMANY 421 ASYMMETRIC LEFT VENTRICLE HYPERTROPHY IN ESSENTIAL HYPERTENSION: ELECTROCARDIOGRAPHIC DATA *A. Barsukov, E. Pronina, S. Shoustov, L. Kyrsina, T. Eliseeva Saint-Petersburg, RUSSIA 422 ECHOCARDIOGRAPHIC AND TISSUE DOPPLER EXAMNATIONS IN YOUNG PATIENTS WITH HYPERTENSION *T. FULOP, I. HEGEDUS, A. BODI, A. PETER, I. RACZ, I. BEDNARSKY, E. KRISTOF, I. EDES, D. PALL, E. KATONA DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY ,DEBRECEN, HUNGARY 423 EARLY RENAL DAMAGES IN ESSENTIAL HYPERTYENSION: ITS RELATIONSHIP WITH SYMPATHETIC NERVUOS SYSTEM *I.V. Emelyanov, N.K. Merkulova, A.O. Konradi Saint-Petersburg, RUSSIA 424 CLINICAL CHARACTERISTICS OF HYPOADIPONECTINEMIA IN PAITENTS WITH ESSENSIAL HYPERTENSION *NORIHISA. Ito, MITSURU. Ohishi, TAKASHI. Takagi, MINAKO. Terai, YUJI. Tatara, HIROMI. Rakugi, TOSHIO. Ogihara 425 ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND CAROTID ATHEROSCLEROSIS: THE ROLE OF ANKLE BRACHIAL INDEX (ABI) *A. Giglio, L.M. Lonati, G. Caldara, G. Magnaghi, G. Bilo, G. Leonetti, G. Parati Milan, ITALY ,Milan, ITALY 64 426 EFFECT OF HIGH DOSE STATIN PLUS ACE-INHIBITOR TREATMENT ON INFLAMMATORY MARKERS DURING IN PATIENTS SUBJECTED TO CORONARY BY-PASS SURGERY (CABG) *A. Radaelli, C. Loardi, G. Balestri, M.L. Lavitrano, L. Menicanti, G. Paolini, D. Santo, P. Castiglioni, A.U. Ferrari MONZA, ITALY ,MONZA, ITALY ,MILANO, ITALY ,S.DONATO, ITALY ,MONZA, ITALY ,MILANO, ITALY 65 12:30 - 15:30 Hall 10 427 P07 Diabetes Poster Session 7 ASSOCIATION BETWEEN LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AND RENAL HEMODYNAMIC CHANGE IN PATIENTS WITH TYPE 2 DIABETES *A. Zinoviev Nishny Novgorod, RUSSIA 428 THE EFFECT OF GLUCOSE METABOLISM ON THE INCIDENCE OF ERECTILE DYSFUNCTION IN HYPERTENSIVE PATIENTS N. Alexopoulos, G. Vyssoulis, *C. Vlachopoulos, P. Pietri, A. Zervoudaki, S. Zezas, C. Stefanadis Athens, GREECE 429 ABSTRACT WITHDRAWN 430 EFFECT OF THE RENIN-ANGIOTENSIN SYSTEM BLOCKADE ON THE BLOOD PRESSURE AND BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS WITH OR WITHOUT DIABETES MELLITUS *A. Vachulova, B. Vohnout, A. Teren, J. Lietava, A. Dukat Bratislava, SLOVAK REPUBLIC 431 THE DIRECT ANTI-ATHEROSCLEROTIC EFFECT OF PPARS LIGANDS IS MEDIATED BY THE INHIBITION OF ACE EXPRESSION IN STREPTOZOTOCIN-INDUCED DIABETIC RAT AORTA *H. Toba, S. Miki, A. Yoshimura, N. Sawai, R. Tsukamoto, Y. Morita, M. Kobara, T. Nakata Kyoto, JAPAN 432 LOSARTAN REDUCES THE BURDEN AND COST OF DIABETIC END-STAGE RENAL DISEASE IN GREECE P.C. Stafylas, *P.A. Sarafidis, A.N. Lasaridis, D.M. Grekas, N.V. Dombros, E. Tsakni, V.H. Aletras, D.A. Niakas, G.L. Bakris Thessaloniki, GREECE ,Chicago, USA ,Thessaloniki, GREECE ,Thessaloniki, GREECE ,Patra, GREECE 433 THE WORSE THE CONTROL OF DIABETES, THE WORSE THE CONTROL OF BLOOD PRESSURE? CONTROL OF HYPERTENSION IN DIABETIC PATIENTS AMONG CZECH PRIMARY CARE PHYSICIANS. *M. Soucek, J. Widimsky, V. Lanska Brno, CZECH REPUBLIC ,Prague, CZECH REPUBLIC ,Prague, CZECH REPUBLIC 66 434 AGE-DEPENDENT EFFECT ON CASPASE-MEDIATED APOPTOSIS BY AMADORI ADDUCTS IN HUMAN PERITONEAL CELLS. *CAROLINA. SÁNCHEZ-RODRÍGUEZ, SUSANA. VALLEJO, MARIAM. EL ASSAR, VERÓNICA. AZCUTIA, CONCHA. PEIRÓ, CARLOS.F. SÁNCHEZ-FERRER, LEOCADIO. RODRÍGUEZ-MAÑAS, JULIÁN. NEVADO GETAFE,MADRID, SPAIN ,GETAFE,MADRID, SPAIN ,GETAFE,MADRID, SPAIN ,MADRID, SPAIN ,MADRID, SPAIN ,MADRID, SPAIN ,GETAFE,MADRID, SPAIN ,GETAFE,MADRID, SPAIN 435 THE EFFECT OF TRANDOLAPRIL AND ITS FIXED-DOSE COMBINATION WITH VERAPAMIL ON SOLUBLE ADHESION MOLECULES EXPRESSION IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES. *A.F. Rubio-Guerra, H. Vargas-Robles, G. Vargas-Ayala, B.A. Escalante-Acosta México D.F., MEXICO ,México D.F, MEXICO 436 CARDIOVASCULAR RISK FACTOR MANAGEMENT IN TYPE 2 DIABETICS IN SPAIN. THE DIVA STUDY. *E. ALEGRÍA, J.R. GONZÁLEZ, R. GOMIS, M.J. SALVADOR, J.A. CASASNOVAS, V. LÓPEZ, D. ACOSTA, J. SALVADOR, A. HERNÁNDEZ, A. MATALI Pamplona, SPAIN ,Santiago de Compostela, SPAIN ,Barcelona, SPAIN ,Barcelona, SPAIN ,Zaragoza, SPAIN ,Sevilla, SPAIN ,Sevilla, SPAIN ,Pamplona, SPAIN ,Valencia, SPAIN ,Barcelona, SPAIN 437 EFFECT OF TELMISARTAN ON INSULIN SENSITIVITY IN PATIENTS WITH TYPE 2 DIABETES AND METABOLIC SYNDROME O. GONZÁLEZ-ALBARRÁN, J. SEGURA, *LM. RUILOPE MADRID, SPAIN ,MADRID, SPAIN 438 LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC PERFORMANCE AND REMODELLING IN DIABETIC PATIENTS WITH OR WITHOUT HYPERTENSION *P. Pattoneri, A. Piazza, E. Catellani, R. Iotti, M. Michelini, D. Dall'Asta, A. Guberti, V. Manicardi Montecchio Emilia (RE), ITALY ,Montecchio Emilia (RE), ITALY 439 EFFICACY AND SAFETY OF CANDESARTAN CILEXETIL IN UNCONTROLLED HYPERTENSIVE DIABETIC ELDERLY POPULATION. CHANCE DIABETES SUB-STUDY. *R. ASMAR, S. NISSE-DURGEAT Paris, FRANCE ,Puteaux, FRANCE 440 CARDIOMYOCYTE APOPTOSIS AND STRESS RESPONSE ACTIVATION IN SPONTANEOUSLY DIABETIC GOTO-KAKIZAKI RATS ERIK. Vahtola, MARJUT. Louhelainen, SAARA. Merasto, ESSI. Martonen, SATU. Penttinen, PETRI. Kaheinen, JOUKO. Levijoki, *EERO. Mervaala Helsinki, FINLAND ,Espoo, FINLAND 441 MASKED HYPERTENSION IN TYPE 2 DIABETES MELLITUS: PREVALENCE AND INFLUENCE ON CARDIAC REMODELING. *C. MARCHESI, AM. MARESCA, E. LAURITA, E. NICOLINI, F. SOLBIATI, M. GIANNI, M. MONZA, ME. GIUDICI, AM. GRANDI ITALY 67 442 BENEFICIAL EFFECT OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR / ANGIOTENSIN RECEPTOR BLOCKER COMBINATION IS SUPPORTED BY ITS EFFECT ON PRO-INFLAMMATORY MARKERS *S. Ljubic, J. Bozikov, I. Pavlic-Renar, Z. Metelko Zagreb, CROATIA ,Zagreb, CROATIA 443 EFFECT OF HYPOGLYCAEMIA ON 24-HOUR AMBULATORY BLOOD PRESSURE IN TYPE 1 DIABETICS *P. KRUSZEWSKI, B. WOLNIK, L. BIENIASZEWSKI, H. SWIATEK, J. NEUBAUER-GERYK, K. KUNICKA, E. SWIERBLEWSKA, B. WYRZYKOWSKI GDANSK, POLAND ,GDANSK, POLAND 444 DIFFERENTIAL ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF NEBIVOLOL AND METOPROLOL IN HYPERTENSIVE DIABETIC PATIENTS *O.A. Koshelskaya, O.V. Gruzdeva, R.S. Karpov Tomsk, RUSSIA 445 SIMVASTATIN IN COMBINATION WITH ANTIHYPERTENSIVE THERAPY IN DIABETES: EFFECT ON PLASMA LEVELS OF STABLE NO-METABOLITES AND OF PROINFLAMMATORY CYTOCINES *O.A. Koshelskaya, T.E. Souslova, R.S. Karpov Tomsk, RUSSIA 446 FACTORS DETERMINING AORTIC STIFFNESS IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES AND CORONARY ARTERY DISEASE *M. Klocek, M. Rajzer, K. Kawecka-Jaszcz Krakow, POLAND 447 CHRONOTHERAPY IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES: REMODELING OF THE ALTERED CIRCADIAN BLOOD PRESSURE PATTERN AND INCREASED BLOOD PRESSURE CONTROL BY TIME-SPECIFIED TREAT DE. AYALA, *RC. HERMIDA, C. CALVO, JE. LOPEZ, M. RODRIGUEZ, L. CHAYAN, MJ. FONTAO, R. SOLER, A. MOJON, JR. FERNANDEZ VIGO, SPAIN ,SANTIAGO, SPAIN 448 PATIENTS WITH TYPE-2 DIABETES VERSUS NON DIABETIC HIGH-RISK SUBJECTS: EFFECT OF SIMVASTATIN ON ANGIOTENSIN II TYPE-1 RECEPTOR MRNA EXPRESSION IN LEUKOCYTES. *L. Guasti, F. Marino, M. Cosentino, M. Ferrari, C. Klersy, C. Crespi, M. Cimpanelli, RC. Maio, E. Rasini, G. Gaudio, A. Loraschi, L. Maroni, D. Restelli, C. Simoni, L. Castiglioni, I. Franzetti, P. Marnini, S. Lecchini, A. Venco University of Insubria, Varese, ITALY ,IRCCS S. Matteo, Pavia, ITALY 449 LATENT DIABETES IN PATIENTS WITH HYPERTENSION AND METABOLIC SYNDROME *A. Gotsis, P. Bozia, A. Labrou, S. Dourtsiou, A. Savvopoulou, L. Papadopoulou, L. Borghi, D. Theodoridis, E. Marinos, S. Karras, Z. Pappa, O. Koutsogiannis, A. Panagiotidou Komotini, GREECE ,Komotini, GREECE 68 450 ASSESSING CARDIOVASCULAR RISK IN PATIENTS WITH HYPERTENSION AND DIABETES BY MEANS OF AMBULATORY BLOOD PRESSURE MONITORING. ANALYSIS OF A 20,000-PATIENT DATABASE IN SPAIN. *M. GOROSTIDI, J. SOBRINO, J. SEGURA, M. PINILLA, A.A. REGUEIRO, F. ALGILAGA, I. CAMACHO, R. FREIXA, A. COCA, L.M. RUILOPE SPAIN 451 INSULIN LEVELS ARE ASSOCIATED WITH THE ANCLE-BRACHIAL INDEX IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME P. PIETRI, *G. VYSSOULIS, A. ZERVOUDAKI, G. ANTONAKOUDIS, A. DELIGEORGIS, C. VLACHOPOULOS, C. STEFANADIS ATHENS, GREECE 452 HYPERTENSION, DIABETES AND CHRONOTHERAPY WITH OLMESARTAN: A NEW THERAPEUTIC FOCUS IN PRIMARY CARE ATTENTION *L. GARCIA-GIRALDA, L. GUIRAO, I. CASAS, J. LOPEZ, FJ. GARCIA-GIRALDA, JV. ALFARO, G. SANCHEZ, G. BAGDHAN, C. SANDOVAL SMS, ,SMS, ,SMS, ,SMS, 453 PKC PATHWAY IS INVOLVED IN THE INCREMENT OF NA+K+-ATPASE ACTIVITY IN AORTIC RINGS FROM STREPTOZOTOCIN DIABETIC RATS *LC. Gallo, APC. Davel, LV. Rossoni Sao Paulo, BRAZIL 454 EFFECTS OF LIVING ARRANGEMENTS AND COGNITIVE FUNCTION ON BLOOD PRESSURE AND METABORIC CONTROL IN OLDER PATIENTS WITH TYPE 2 DIABETES MELLITUS *N. Furuhashi, T. Hirose, M. Kuroda, M. Kimura, T. Furuta, H. Sarui, N. Takeda Nakatugawa, JAPAN ,Gero, JAPAN ,Gifu, JAPAN 455 DIFFERENCES IN THE MORPHOLOGICAL RESPONSE OF NORMAL AND DIABETIC HEARTS TO CHRONIC LEFT VENTRICULAR PRESSURE OVERLOAD *I. Falcão-Pires, M. Vasconcelos, B. Faria, F. Salguerio, A. Leite-Moreira Porto, PORTUGAL 456 IMPACT OF GLYCEMIC CONTROL ON REGIONAL CEREBRAL PERFUSION. A STUDY WITH SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY R. Battista, C. Di Russo, L. De Siati, A. Scuteri, F. De Sensi, G. Camici, M. Volpe, *F. Cosentino Sora (FR), ITALY ,Sora (FR), ITALY ,Rome, ITALY ,Rome, ITALY ,Zurich, SWITZERLAND 457 PIOGLITAZONE IN TYPE 2 DIABETICS WITH REFRACTORY HYPERTENSION *B. DE RIVAS, M. LUQUE, N. MARTELL, A. FERNANDEZ-CRUZ MADRID, SPAIN 69 458 SHORT-TERM REPRODUCIBILITY OF NON-DIPPING PATTERN IN TYPE 2 DIABETIC HYPERTENSIVE PATIENTS *C. Cuspidi, S. Meani, L. Lonati, V. Fusi, C. Valerio, C. Sala, G. Magnaghi, A. Zanchetti Milano, ITALY ,Milano, ITALY ,Milano, ITALY ,Milano, ITALY 459 THREE METHODS TO DETECT RENAL DYSFUNTION IN TYPE 2 DIABETIC PATIENTS *F.X. COS, P. CARRILLO, M. PIE, T. CARRERA, M. SIMO, M.I. FERNANDEZ Barcelona, SPAIN ,Barcelona, SPAIN ,Barcelona, SPAIN 460 HYPERTENSION IN DIABETICS : ASSOCIATED RISK FACTORS AND CARDIOVASCULAR COMPLICATIONS *A. Chibane, S. Benkhedda, L. Makhlouf, N. Lanasri, S. Taharboucht, A. Biad ALGERS, ALGERIA ,ALGERS, ALGERIA 461 PREVALANCE OF DIABETES AS ASSOCIATED RISK FACTOR : RESULTS FROM A NATIONAL SURVEY *S. Benkhedda, A. Chibane, A. Atif, S. Latreche, N. Bendaoud, D. Ziari, M. Temmar, K. Merad ALGERS, ALGERIA ,ALGERS, ALGERIA 462 RELATIONSHIP BETWEEN BLUNTED NOCTURNAL FALL IN BLOOD PRESSURE AND THE OCCURRENCE OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE DIABETIC PATIENTS *BÉATRICE. BOUHANICK, VANINA. BONGARD, JACQUES. AMAR, JACQUES. GUITTARD, THIERRY. BATTISTON, BERNARD. CHAMONTIN CHU Rangueil Toulouse, FRANCE ,CHU Toulouse, FRANCE ,CHURangueil Toulouse, FRANCE ,CHURangueil Toulouse, FRANCE ,CHURangueil Toulouse, FRANCE ,CHURangueil Toulouse, FRANCE 463 RELATÝONSHÝP BETWEEN DIABETES AND SUBCLINICAL ATHEROSCLEROSIS IN HYPERTENSIVE PATIENTS *S. Altunkan, B. Seref, N. Kayaturk, E. Altunkan Ankara, TURKEY ,Ankara, TURKEY 464 HIGH BLOOD PRESSURE AND STRESS REDUCTION IN DIABETICS WITH DEVICE GUIDED PACED BREATHING: A RANDOMIZED CONTROLLED STUDY *MOSHE. Schein, ARIELA. Alter, SIMON. Levine, TUVIA. Baevsky, ALONA. Nessing, BENJAMIN. Gavish Jerusalem, ISRAEL ISRAEL ISRAEL 465 ASSOCIATION OF METABOLIC SYNDROME AND THEIR COMPONENTS WITH CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DM. A CROSS-SECTIONAL STUDY IN SPAIN *O. Gonzalez-Albarran, M. Lahera, T. Anton, R. Sanchon, J. Sancho SPAIN 466 LERCANIDIPINE IS BETTER TOLERATED THAN OTHER DYHIDROPYRIDINES IN DIABETIC HYPERTENSIVE PATIENTS IN DAILY CLINICAL PRACTICE. DATA FROM THE TOLERANCE STUDY *V. BARRIOS, J. L. LLISTERRI, A. NAVARRO, J. HONORATO, A. CALDERÓN, M. DE LA FIGUERA, J. SEGURA MADRID, SPAIN ,VALENCIA, SPAIN ,SAN SEBASTIÁN DE LOS REYES, MADRID, SPAIN ,PAMPLONA, SPAIN ,SAN SEBASTIÁN DE LOS REYES, MADRID, SPAIN ,SAN ADRIÁ DEL BESÓS, SPAIN ,MADRID, SPAIN 70 13\06\2006 - 12:30 - 15:30 Hall 10 468 P08 Brain Poster Session 8 PS08 MRI IN ASSESSMENT OF BRAIN PERFUSION IN PATIENTS WITH ARTERIAL HYPERTENSION *D. Ustyuzhanin, M. Kozhuhova, T. Pustovitova, O. Stukalova, V. Sinitsyn, S. Ternovoy Moscow, RUSSIA ,Moscow, RUSSIA 469 EFFICACY OF PROFLUSAK ON BRAIN PERFUSION IN PATIENTS WITH METABOLIC SYNDROME, ARTERIAL HYPERTENSION AND DEPRESSION. *V. SHIMCHIK, E. POLYAKOVA, V. GORNOSTAEV, V. MYCHKA, I. CHAZOVA, V. SERGIENKO MOSCOW, RUSSIA ,MOSCOW, RUSSIA ,MOSCOW, RUSSIA ,MOSCOW, RUSSIA ,MOSCOW, RUSSIA ,MOSCOW, RUSSIA 470 BLOOD PRESSURE PATTERN, COGNITIVE PERFORMANCES AND CEREBRAL DAMAGE IN ASYMPTOMATIC ESSENTIAL HYPERTENSIVE PATIENTS *C. Paglieri, D. Bisbocci, F. Rabbia, P. Cerrato, M. Bergui, A. Canadè, ML. Genesia, D. Naso, E. Testa, E. Puglisi, C. Magnino, J. Zhong, F. Veglio Turin, ITALY ,Turin, ITALY ,Turin, ITALY 471 THE CAUDAL VENTROLATERAL MEDULLA PARTICIPATES IN THE DEVELOPMENT AND MAINTENANCE OF ADENOSINE RECEPTOR BLOCKADE-INDUCED HYPERTENSION *D. Pinho, J. Marques-Lopes, M. Morato, T. Sousa, I. Tavares, A. Albino-Teixeira Porto, PORTUGAL ,Porto, PORTUGAL ,Porto, PORTUGAL 472 CEREBRAL FLOW AUTOREGULATION AND PRESENCE OF SILENT BRAIN ISCHAEMIA IN HYPERTENSIVE MEN. TRANSCRANIAL DOPPLER AND MAGNETIC RESONANCE STUDY. *G. Kozera, M. Dubaniewicz, A. Dmochowska-Madej, M. Mielczarek, K. Chwojnicki, M. Krzesniak-Bogdan, T. Zdrojewski, B. Wyrzykowski, W.M. Nyka 1, POLAND ,2, POLAND ,3, POLAND 473 CEREBROVASCULAR PATHOLOGY IN HYPERTENSIVE MEN WITH TYPE II DIABETES. MRI, EEG AND TRANSCRANIAL DOPPLER STUDY. *G. Kozera, M. Dubaniewicz, M. Krzesniak - Bogdan, M. Mielczarek, A. Dmochowska - Madej, K. Chwojnicki, T. Zdrojewski, M. Studniarek, B. Wyrzykowski, W.M. Nyka 1, POLAND ,2, POLAND ,3, POLAND ,1, 2, 3, POLAND 474 RELATIONSHIP BETWEEN BRAIN STRUCTURAL CHANGES AND CEREBRAL HEMODYNAMICS IN PATIENTS WITH ESSENTIAL HYPERTENSION *O. Gulkevych, E. Svyshchenko, L. Bezrodna Kyiv, UKRAINE Page 1 71 475 CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH ACUTE STROKE *P.J. Gao, W.J. Zhou, K.D. Ji, G.Y. Yang, D.L. Zhu Shanghai, CHINA 476 RELATIONSCHEP BETWEEN ENDOTHELIAL DYSFUNCTION, NITRIC OXIDE AND BRIAN DAMAGE IN HYPERTENSION PATIENTS WITH DIABETES MELLITUS TYPE 2 *A.Y. Falkovskaya, V.F. Mordovin, P.I. Lukyanenok, T.E. Suslova, A.V. Schurov, T.A. Schelkovnikova, N.V. Belokopitova, I.A. Astanina RUSSIA 477 NON DIPPERS AND CEREBROVASCULAR DISEASE PATHOGENESIS *MJ. Esquillor Rodrigo, A. García Noaín, P. Gonzalez García, A. Martínez-Berganza Asensio, P. Cía Gómez ZARAGOZA, SPAIN 478 ANTI-INFLAMMATORY RESPONSE IN ACUTE ISCHEMIC STROKE IN RELATION TO BLOOD PRESSURE LEVELS *SP. EFSTATHIOU, AG. TSIAKOU, DI. TSIOULOS, YE. GRATSIAS, AD. ACHIMASTOS, TD. MOUNTOKALAKIS HYGEIAS MELATHRON, ATHENS, GREECE ,SOTIRIA HOSPITAL, ATHENS, GREECE ,SOTIRIA HOSPITAL, ATHENS, GREECE ,HYGEIAS MELATHRON, ATHENS, GREECE ,SOTIRIA HOSPITAL, ATHENS, GREECE ,HYGEIAS MELATHRON, ATHENS, GREECE 479 BLOOD PRESSUREINTHE INITIAL PHASE OF ACUTE ISCHAEMIC STROKE: EVOLUTION AND ITS ROLE AS A PROGNOSIS FACTOR, ACCORDING TO PREVIOUSLY DIAGNOSED HYPERTENSION *LM. Ceresuela, P. Armario, M. Martin-Baranera, R. Hernandez-del-Rey, E. Iribarnegaray, A. Avila, J. Bello, JL. Tovar, J. Alvarez-Sabin SPAIN SPAIN SPAIN SPAIN SPAIN SPAIN SPAIN SPAIN SPAIN 480 MANAGEMENT OF HYPERTENSION IN ACUTE STROKE IN A RURAL AREA. ROLE OF PRIMARY CARE *L. CASTILLA-GUERRA, M. BALBUENA, MC. FERNANDEZ-MORENO, A. ESPINO-MONTORO, C. ALVAREZ-LACAYO, C. GONZALEZ, F. POZUELO, E. NIMO, JM. LOPEZ-CHOZAS HOSPITAL DE LA MERCED.OSUNA.SEVILLE, SPAIN ,HOSPITAL DE VALME. SEVILLE, SPAIN ,HOSPITAL VIRGEN DEL ROCIO, SPAIN 481 ANTIHYPERTENSIVE THERAPY AFTER ACUTE STROKE. DIFFERENCES BETWEEN ELDERLY AND YOUNGER PATIENTS. *L. CASTILLA-GUERRA, M. BALBUENA, MC. FERNANDEZ-MORENO, A. ESPINO-MONTORO, C. ALVAREZ-LACAYO, C. GONZALEZ, E. NIMO, F. POZUELO, MD. JIMENEZ, JM. LOPEZ-CHOZAS HOSPITAL DE LA MERCED. OSUNA. SEVILLE, SPAIN ,HOSPITAL DE VALME. SEVILLE, SPAIN ,HOSPITAL VIRGEN DEL ROCIO. SEVILLE, SPAIN ,HOSPITAL VIRGEN DEL ROCIO. SEVILLE, SPAIN 482 ASSESSMENT OF COGNITIVE IMPAIRMENT IN HYPERTENSIVE PATIENTS OVER 60 YEARS OLD. COGNIPRES 2004 STUDY *E. VINYOLES BARGALLÓ, M. DE LA FIGUERA VON WICHMAN, A. MATALI GILARRANZ, S. ARMENGOL BERTOLÍN BARCELONA, SPAIN ,BARCELONA, SPAIN ,BARCELONA, SPAIN ,BARCELONA, SPAIN 483 THE EFFECT OF MOXONODINE ON VERTEBROBASILLARY CIRCULATION IN HYPERTENSIVE PATIENTS *N.T.. Aliyeva-Karayeva, I.G. Alizade Baku, AZERBAIJAN ,Baku, AZERBAIJAN Page 2 72 484 3D VISUALIZATION - INTRODUCTION OF A NEW TECHNIQUE FOR THE EVALUATION OF NEUROVASCULAR COMPRESSION IN ARTERIAL HYPERTENSION. *RAMIN. Naraghi, REGINA. Toescher-Weber, HELGA. Frank, ROLAND. Schmieder, KARL. Hilgers, LJLIANA. Hastreiter, RUDOLF. Fahlbusch, PETER. Hastreiter Erlangen, GERMANY ,Erlangen, GERMANY ,Erlangen, GERMANY ,Erlangen, GERMANY ,Leiptig, GERMANY 485 MODERN STRATEGIES OF IMAGE PROCESSING FOR NEUROVASCULAR COMPRESSION IN ARTERIAL HYPERTENSION *PETER. Hastreiter, NATALIE. Dodenhoeft, REGINA. Troescher-Weber, LJLIANA. Hastreiter, MICHAEL. Buchfelder, RAMIN. Naraghi Erlangen, GERMANY ,Erlangen, GERMANY ,Leipzig, GERMANY 486 INFLUENCE OF ABNORMAL NOCTURNAL BLOOD PRESSURE DIPPING ON FIVE YEARS' DYNAMICS OF STRUCTURAL ATTRIBUTES OF HYPERTENSIVE ENCEPHALOPATHY *NL. Afanasyeva, VF. Mordovin, GV. Semke, SE. Pekarski, TM. Ripp Tomsk, RUSSIA ,Tomsk, RUSSIA ,Tomsk, RUSSIA ,Tomsk, RUSSIA ,Tomsk, RUSSIA 487 INCREASE OF VARIABILITY OF BLOOD PRESSURE AS PREDICTOR OF FIVE YEARS' DYNAMICS OF STRUCTURAL ATTRIBUTES OF HYPERTENSIVE ENCEPHALOPATHY *NL. Afanasyeva, VF. Mordovin Tomsk, RUSSIA ,Tomsk, RUSSIA 488 CEREBROVASCULAR EPISODES IN PATIENTS WITH ESSENTIAL HYPERTENSION ARE NOT RELATED TO PLASMA HOMOCYSTEIN, INTERLEUKIN-6 AND C REACTIVE PROTEIN. *AGNIESZK. Kazmierczak, HANNA. Berent, JACEK. Lewandowski, PIOTR. Gryglas, MARIUSZ. Lapinski, MAGDALEN. Gola, MAREK. Golebiewski, ZBIGNIEW. Gaciong Warsaw, POLAND ,Warsaw, POLAND ,Warsaw, POLAND 73 13\06\2006 - 12:30 - 15:30 Hall 10 489 P09 Pharmacoeconomics Poster Session 9 PS09 THE LINK BETWEEN NITRIC OXIDE SYSTEM AND ALDOSTERONE: LONG TERM ORAL SUPPLEMENTATION OF L-ARGININE IMPROVES ARTERIAL ELASTICITY AND HEMODYNAMIC VARIABLES M. Shargorodsky, H. Gutman, D. Gavish, R. Brendeis, Z. Matas, *R. Zimlichman Holon, ISRAEL ,Holon, ISRAEL ,Tel Aviv University, Tel Aviv, ISRAEL ,Nes Ziona, ISRAEL 490 CHARACTERISTICS OF HYPERTENSIVE PATIENTS LIKELY TO BE NON-PERSISTENT WITH MEDICATION IN FRANCE (FR), GERMANY (DE), AND THE UK L. Annemans, E. Spaepen, C. Nash, *G. Vincze, ZM. Khan Brussels, BELGIUM ,Brussels, BELGIUM ,London, UNITED KINGDOM ,Basel, SWITZERLAND 491 REHABILITATION COMPLEX FOR HYPERTENSIVE PATIENTS: COMPARATIVE STUDY *L.P. Sydorchuk, R.I. Sydorchuk, I.I. Sydorchuk Chernivtsi, UKRAINE 492 COST-EFFECTIVENESS OF LOSARTAN IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY IN GREECE *P.A. Sarafidis, P.C. Stafylas, A.N. Lasaridis, D.M. Grekas, N.V. Dombros, E. Tsakni, V.H. Aletras, D.A. Niakas, G.L. Bakris Thessaloniki, GREECE ,Chicago, USA ,Thessaloniki, GREECE ,Thessaloniki, GREECE ,Patra, GREECE 493 ECONOMIC CONSEQUENCES OF NON-COMPLIANCE IN THE TREATMENT OF DIABETES, HYPERTENSION AND DYSLIPIDEMIA – A SYSTEMATIC REVIEW *N. Muszbek, A. Benedict, A. Keskinaslan, Z. Khan London, UNITED KINGDOM ,Basel, SWITZERLAND 494 SIGNIFICANCE OF COMPLIANCE IN TREATMENT OF DIABETES, HYPERTENSION AND DYSLIPIDEMIA – A SYSTEMATIC REVIEW *AGNES. Benedict, NOEMI. Muszbek, ABDULKAD. Keskinaslan, ZEBA. Khan UBC, UNITED KINGDOM ,Basel, SWITZERLAND Page 1 74 13\06\2006 - 12:30 - 15:30 Hall 10 495 P10 Safety of Polycombination Poster Session 10 PS10 SAFETY AND EFFICACY OF DOXAZOSIN AS AN ADD-ON ANTIHYPERTENSIVE THERAPY *R. roccaforte, G. fragasso, R. spaladore, G. calori, F. arioli, A. margonato milan, ITALY 496 GENERAL PRACTITIONERS' IMPRESSION ON COMPLIANCE TO THE COMBINED THERAPY OF HYPERTENSIVE PATIENTS *B. Georgiev, N. Gotcheva, D. Gotchev, V. Baytcheva, V. Christov, Z. Kamenov Sofia, BULGARIA ,Sofia, BULGARIA ,Sofia, BULGARIA 75 13:30 - 15:00 Angiotensin receptor blockade in prevention of cardiovascular and metabolic outcomes Auditorium Chairmen: P. Meredith (Glasgow, UK) L. Ruilope (Madrid, Spain) Vascular benefits of angiotensin receptor blocker in hypertension A. Voors Groningenm, The Netherlands Metabolic and diabetes preventive effects of RAS blockade - clinical implications S. Kjeldsen Oslo, Norway Prevention of heart failure - role of blood pressure control and angiotensin receptor blockade P. Meredith Glasgow, UK Positioning angiotensin receptor blockers in the treatment of chronic heart failure R. McKelvie Hamilton, ON, Canada 76 12:45 - 14:15 Evaluating total CV risk in hypertension: current appraisal and future perspectives Room 101/102 Teaching Seminar 1 - Working group 8 on Integrated Approach to the High Risk Patient Chairmen M. VOLPE (ROMA, ITALY) F. RODRIGUEZ ARTALEJO (MADRID, SPAIN) Identification of total CV risk in the Clinical pratice. The European Approach P. Sleight Oxford, U.K. Identification of total CV risk in the clinical practice. The USA approach. J. Izzo Buffalo, U.S.A. Do new markers of risk fit into the clinical assessment strategy ? M. Volpe Rome, ITALY 77 12:45 - 14:15 Renovascular hypertension and ischemic nephropathy Room 103 Teaching Seminar 5 Chairmen A. MORGANTI (MILANO, ITALY) A. DE LA SIERRA (BARCELONA, SPAIN) Diagnosis and treatment of renal artery stenosis: limitations of functional tests to assess outcome P. De Leeuw Maastricht, THE NETHERLANDS The effects of angioplasty on renal function: recent data and continuing uncertainties P.F. Plouin Paris, FRANCE 78 12:45 - 14:15 High BP research relating to developing countries Room 104 Topical Workshop 10 Chairmen K. CRUICKSHANK (WILMSLOW, UNITED KINGDOM) J. M'BUYAMBA-KABAUGU (Kinshasa, CONGO) Early origins of adult phenotype of hypertension in developing country populations T. Forrester Mona, CAMBODIA CVS risk factor epidemiology in South Asian countries D. Prabhakaran New Dehli, INDIA Community based randomised trial of salt reduction in Ghana F. Cappuccio Coventry, U.K. Measure of arterial stiffness in African origin populations D. Lemogoum Brussels, BELGIUM Effect of developing country migration on CVS risk profiles in Europe A. Roca-Cusacs Barcelona, SPAIN 79 12:45 - 14:15 Vascular effects by anti-diabetes and lipid-lowering drugs, important for blood pressure control ? Room 105/106 Teaching Seminar 7 - Working Group 6 on Hypertension in Diabetes Chairmen P. NILSSON (MALMO, SWEDEN) R. CIFKOVA (PRAGUE, CZECH REPUBLIC) The role of insulin, sulphonylurea and metformin P. Nilsson Malmo, SWEDEN Glitazones and blood pressure lowering - a systematic review P. Sarafidis Thessaloniki, GREECE The influence of lipid-lowering drugs on blood pressure C. Borghi Bologna, ITALY Discussion & Closing Remarks R. Cifkova Prague, CZECH REPUBLIC 80 15:30 - 17:00 Auditorium 3C Epidemiology Paraller Oral Session Chairmen V. BERTOMEU MARTINEZ (SAN JUAN ALICANTE, SPAIN) M. VOLPE (ROMA, ITALY) GLOMERULAR HYPERFILTRATION – A NEW MARKER OF METABOLIC SYNDROME IN YOUNG MEN FROM GENERAL POPULATION *M. TOMASZEWSKI, F.J. CHARCHAR, M. GAWRON-KISZKA, W. GRZESZCZAK, E. ZUKOWSKA-SZCZECHOWSKA, C. MARIC, A.F. DOMINICZAK GLASGOW, UNITED KINGDOM ,LEICESTER, UNITED KINGDOM ,ZABRZE, POLAND ,WASHINGTON DC., USA PROGNOSTIC SIGNIFICANCE OF THE NOCTURNAL DECLINE IN SYSTOLIC BLOOD PRESSURE: DUBLIN OUTCOME STUDY. *E. DOLAN, AV. STANTON, L. THIJS, N. ATKINS, P. McCORMACK, JA. STAESSEN, E. O'BRIEN Royal College of Surgeons in Ireland, Dublin, IRELAND ,University of Leuven, Leuven, BELGIUM LECTURE: HIGH RATE AND CARDIOVASCULAR PROGNOSIS P. Palatini Padua, ITALY MORTALITY IN THE PRESENCE OF THE METABOLIC SYNDROME IN A FRENCH POPULATION OF NORMOTENSIVE AND HYPERTENSIVE SUBJECTS. *F. THOMAS, B. PANNIER, A. BENETOS, K. BEAN, E. ESCHWEGE, L. GUIZE PARIS, FRANCE ,NANCY, FRANCE ,VILLEJUIF, FRANCE ETHNIC AND GENDER DIFFERENCES IN LONGITUDINAL DEVELOPMENT OF AMBULATORY BLOOD PRESSURE IN YOUTH: RESULTS FROM A 15-YEAR STUDY *H. Snieder, X. Wang, G.A. Harshfield, F.A. Treiber Augusta, GA, USA 81 15:30 - 17:00 Room 101/102 3A Metabolic Symdrome and Diabetes Paraller Oral Session Chairmen H. IBSEN (GLOSTRUP, DENMARK) O. GONZALEZ ALBARRAN ( MADRID, SPAIN) LECTURE: DIFFERENCE IN GLUCOSE TOLERANCE BETWEEN ANTIHYPERTENSIVE COMBINATION DRUGS IN METABOLIC SYNDROME PATIENTS G. Bakris Chicago, USA PATHOGENETIC FACTORS OF ATHEROSCLEROSIS ARE DISPARATELY INFLUENCED BY TELMISARTAN AND RAMIPRIL IN TYPE 2 DIABETES *RE. Schmieder, MP. Schlaich, A. Mimran, JP. Fauvel, L. Ruilope Erlangen, GERMANY ,Montpellier, FRANCE ,Lyon, FRANCE ,Madrid, SPAIN AMBULATORY BLOOD PRESSURE STATUS IN HYPERTENSIVE PATIENTS WITH DIABETES. ANALYSIS OF A 20,000-PATIENT DATABASE IN SPAIN. *M. GOROSTIDI, J. SOBRINO, J. SEGURA, J.M. MARTINEZ, A. PRIETO, J. COMERMA, I. CHAGOYEN, A. GONZALEZ, A. COCA, L.M. RUILOPE SPAIN CONTINUOUSLY MONITORED INTERSTITIAL GLUCOSE DIRECTLY ASSOCIATES WITH ARTERIAL BLOOD PRESSURE IN NORMO- AND HYPERTENSIVE HUMANS WITH EITHER NORMAL OR IMPAIRED GLUCOSE TOLERANCE *C.J. Dolianitis, M.J. Theodorakis, E. Manios, M. Alevizaki, K.S. Stamatelopoulos, I. Spiliopoulou, E. Anastasiou, N.A. Zakopoulos Athens, GREECE ASSOCIATION BETWEEN ELEVATED BLOOD PRESSURE AND SURROGATE MARKERS FOR INSULIN RESISTANCE IN A DEFINED POPULATION. THE SÖDERÅKRA CARDIOVASCULAR RISK FACTOR STUDY *U. Petersson, C J. Östgren, L. Brudin, K. Brismar, P M. Nilsson Söderåkra, SWEDEN ,Linköping, SWEDEN ,Linköping, SWEDEN ,Solna, SWEDEN ,Malmö, SWEDEN 82 15:30 - 17:00 Room 103 3B Genetics Paraller Oral Session Chairmen A. DOMINICZAK (GLASGOW, U.K.) J.C. RODRIGUEZ (TENERIFE, SPAIN) EMERGENCE OF NOVEL GENETIC EFFECTS ON LEFT VENTRICULAR STRUCTURE IN ADOLESCENCE: LONGITUDINAL EVIDENCE FROM THE GEORGIA CARDIOVASCULAR TWIN STUDY *H. Snieder, D. Ge, F.A. Treiber, G.A. Kapuku Augusta, GA, USA ANGIOTENSIN II RECEPTOR 1 AND 2 POLYMORPHISMS INFLUENCE BLOOD PRESSURE AND TARGET ORGAN DAMAGE IN STAGE 1 HYPERTENSIVES *M. Winnicki, G. Ceolotto, P. Bratti, F. Dorigatti, P. Visentin, R. De Toni, L. Mos, M. Santonastaso, F. Ragazzo, A.C. Pessina, P. Palatini Gdansk, POLAND ,Padova, ITALY GENETIC AND TRANSCRIPTOMIC ANALYSIS OF CHROMOSOME 1 BLOOD PRESSURE QTL IN THE SPONTANEOUSLY HYPERTENSIVE RAT *FJ. Charchar, J. Clemitson, RJ. Dixon, S. Haines, L. Hall, A. Bingham, B. Patel, M. Lo, J. Sassard, N.J. Samani Leicester, UNITED KINGDOM ,Lyon, FRANCE VARIANTS OF THE HUMAN MU TYPE GLUTATHIONE-S-TRANSFERASE (GSTM) GENE FAMILY ARE ASSOCIATED WITH HYPERTENSION *C. Delles, AC. Braga Marcano, PB. Munroe, S. Padmanabhan, JD. McClure, NJ. Brain, MJ. Brown, NJ. Samani, D. Clayton, M. Farrall, J. Webster, JMC. Connell, MJ. Caulfield, AF. Dominiczak University of Glasgow, UNITED KINGDOM ,Barts & The London Medical & Dental School, UNITED KINGDOM ,University of Cambridge, UNITED KINGDOM ,University of Leicester, UNITED KINGDOM ,University of Cambridge, UNITED KINGDOM ,University of Oxford, UNITED KINGDOM ,Aberdeen Royal Infirmary, UNITED KINGDOM HIGH SODIUM INTAKE MODULATES LEFT VENTRICULAR MASS IN PATIENTS WITH THE G-EXPRESSION OF THE +1675 A/G ANGIOTENSIN II RECEPTOR TYPE 2 GENE (AT2-R) *C. Ott, S. Titze, KF. Hilgers, MP. Schlaich, RE. Schmieder Erlangen, GERMANY THE ARG389GLY VARIANT OF THE BETA-1 ADRENERGIC RECEPTOR IS ASSOCIATED WITH FAMILIAL, EARLY ONSET MYOCARDIAL INFARCTION IN A SWEDISH POPULATION *F. von Wowern, O. Melander, J. Carlson, B. Hedblad, G. Berglund Malmö, SWEDEN ,Malmö, SWEDEN ,Malmö, SWEDEN 83 15:30 - 17:00 OSAS and cardiovascular variability. Impact on cardiovascular risk. Symposium in collaboration with the European Cost Action B26 on obstructive sleep apnea. Room 104 How to Session 3 - Working Group 1 on Blood Pressure and Heart Rate Variability Chairmen G. PARATI (MILANO, ITALY) P. LAVIE (Haifa, ISRAEL) OSAS and circadian cardiovascular regulation P. Levy Grenoble, FRANCE OSAS, metabolic alterations and cardiovascular complications F. Barbè Lleida, SPAIN OSAS, stroke and ischemic heart disease J. Hedner Goteborg, SWEDEN OSAS treatment and outcome W. McNicholas Dublin, IRELAND Discussion and conclusion 84 15:30 - 17:00 How to evaluate renal function in clinical practice Room 107 How to Session 2 - Working Group 4 on Hypertension and the Kidney Chairmen P. DE LEEUW (MAASTRICHT, THE NETHERLANDS) R. SCHMIEDER (NURNBERG, GERMANY) Methods of estimation of renal function in subjects with supposedly normal GFR A. Mimran Montpellier, FRANCE The increased cardiovascular risk in patients with renal dysfunction - is endothelial dysfunction the missing link ? A. Kroon Maastricht, THE NETHERLANDS How to measure renal endothelial function, clinical significance and therapeutic interactions R. Schmieder Nurnberg, GERMANY Split renal function in renovascular disease P. Plouin Paris, FRANCE Critical assessment of the specific renoprotective action of RAS blockade E. Ritz Heidelberg, GERMANY 85 17:00 - 18:15 From arterial hypertension to intra-abdominal adiposity Auditorium Plenary Session Chairmen L. RUILOPE (MADRID, SPAIN) A. SHARMA (HAMILTON, CANADA) From hypertension to abdominal obesity. Relevance and pathophysiology R. Fagard Leuven, BELGIUM Multiple cardiometabolic risk, IAA, MetS within population J. Tuomilheto Helsinki, FINLAND Surgery Treatment C. Narkiewicz Gdansk, POLAND Therapeutic management & future prospective (Global overview) L. Van Gaal Edegem-Antwerp, BELGIUM 86
